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Osteoarthritis (OA) is the most common degenerative joint disease affecting more 
than 40% of people above the age of 65 (Neogi et al., 2013). Obesity is one of the 
main risk factors of OA and has become a major problem in Western societies. With 
sedentary lifestyle and the aging of the population, it is estimated that more than 50% 
of British adults will be obese in 2030 (Wang et al., 2011). So far, the effect of 
obesity on joint degeneration has primarily been explained by the increased load on 
the joints. However, a growing number of studies have revealed that adipose tissue 
can affect cartilage and other joint tissues at a molecular level. The main goal of this 
thesis was to investigate the role of local knee joint tissues in obese patients with 
OA. 
The expression of molecular markers was investigated in local knee tissues: 
cartilage, synovium, infrapatellar fat pad (IPFP) and subchondral bone collected 
during Total Knee Replacement (TKR). A range of techniques (RT-PCR, Real Time 
qPCR, WB, IHC/ICC and ELISA) was used to examine the differences between 
genes and proteins expression in both lean and obese patients with OA. Further, the 
local immune cell infiltration was investigated in knee adipose tissue depots 
(synovium and IPFP) using flow cytometry. In addition, the subchondral bone 
microstructure was analysed using micro-Computed Tomography (µCT) and IHC 
techniques. 
Chondrocytes from OA patients were found to express a range of obesity-related 
genes. ADIPOR1 was produced significantly higher than ADIPOR2 in OA 
chondrocytes. Furthermore, CCL2 was produced at higher while PPARγ and visfatin 
were produced at a lower level in obese patients’ chondrocytes in comparison to lean 
ones. Synovium and IPFP also expressed a range of obesity-related genes. PPARγ 
and visfatin expression was lower in obese synovium and IPFP in comparison to 
lean. Surprisingly, adiponectin was expressed at a significantly lower level in obese 
patients’ synovium. In contrast, adiponectin was not differently expressed in lean and 
obese patients’ IPFP. The IPFP was found to be a significantly higher producer of 




has an increased expression of VCAM-1, TLR4 and CCL2 in obese patients. 
An increased number of macrophages (defined by CD45+CD14+ and 
CD14+CD206+ markers expression) was detected in the synovium and IPFP from 
obese OA patients. Furthermore, there was an increased number of CD86+CD14+ 
cells in the synovium from obese patients. Other macrophage-related proteins 
including HLA-DR, CD36 were also expressed at a higher level in synovium from 
obese patients. T-lymphocyte detection revealed a higher number of 
CD3+CD4+ T cells in the synovium (but not IPFP) from obese patients but no 
change in the CD3+CD8+ population in both the synovium and IPFP. Subchondral 
bone analysis revealed possible differences in this tissue in obese male patients with 
OA in comparison to lean patients. μCT examination of subchondral bone showed a 
significantly lower bone mineral density (BMD) in obese in comparison to lean male 
OA patients. IHC analysis of bone sections suggested that there was an increased 
number of bone marrow adipose tissue macrophages. In addition, osteoblasts 
obtained from obese OA donors expressed a significantly higher level of ADIPOR2 
and lower level of PPARγ mRNA in comparison to lean patients’ osteoblasts. 
The data obtained suggests that there were differences between lean and obese 
patients with OA at a molecular level. This proposes possible future directions for 
targeting these diseases. The limitation of the study were as follows: 1) possible 
different stages of end-stage OA between analysed patients, which could lead to 
differences in obtained data, 2) no non-OA control samples included in the study.  
However, the presented study may suggest that all tissues in the knee joint contribute 
to the interplay between OA and obesity. In addition, the data obtained is the first to 
suggest that there are differences in gene and protein expression in the synovium and 
IPFP from the same donor. Furthermore, there are differences in the immune cell 
populations in local adipose tissue depots (synovium and IPFP) from OA joints, 
which are linked to obesity. All of this data has helped to increase our understanding 






Osteoarthritis (OA) is the most common degenerative joint disease affecting more 
than 40% of people above the age of 65 (Neogi et al., 2013). Obesity is one of the 
main risk factors for OA and has become a major problem in Western societies. With 
sedentary lifestyle and the aging of the population, it is estimated that more than 50% 
of British adults will be obese in 2030 (Wang et al., 2011). So far, the effect of 
obesity on OA has primarily been explained by the increased load on the joints. 
However, a growing number of studies have revealed that adipose tissue can affect 
cartilage and other joint tissues at the molecular level. Thus, the main goal of this 
thesis was to investigate the behaviour of local knee joint tissues in obese patients 
with OA. 
The expression of molecular markers was investigated in local knee tissues: 
cartilage, synovium, infrapatellar fat pad (IPFP) and subchondral bone collected 
during Total Knee Replacement (TKR). A range of molecular biology techniques 
was used to examine differences between genes and protein expression between lean 
and obese patients with OA. In addition, the immune cell infiltration in the adipose 
tissue depots (synovium and IPFP) was investigated and the microstructure of the 
subchondral bone was analysed. 
The data obtained suggested that cells from cartilage and bone (chondrocytes and 
osteoblasts) in addition to local tissues, surrounding the knee joint in OA patients, 
expressed a range of obesity-related genes and proteins. Obese patients’ tissues 
expressed certain markers at higher levels including proteins, which stimulate cell 
migration such as CCL2 and other markers at lower levels including visfatin and 
PPARγ. 
Local knee fatty tissues from obese patients were found to have an increased number 
of immune cells, which could facilitate OA progression. The bone microstructure 
was also analysed in samples from lean and obese OA patients and revealed that 




male subjects with OA in addition to an increased number of immune cells within the 
bone marrow. 
The data obtained suggest that there were differences between lean and obese 
patients with OA at a molecular level, which could be suitable targets for drug 
modifying agents for these diseases. Furthermore, the findings of this thesis suggest 
that all tissues building the knee joint could be potent agents in the OA and obesity 
pathogenesis. In addition, the data obtained suggest for the first time that there are 
differences in gene and protein expression in the synovium and IPFP from the same 
donor. Moreover, there were differences in the immune cells population in local 
adipose tissue depots (synovium and IPFP) connected with obesity in OA joints. All 
of this data has helped to increase our understanding of the interaction between 
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 Literature Review 
 
1.1 Introduction  
Osteoarthritis (OA) is the most common type of arthritis among UK citizens. Every 
year, more than 140,000 hip and knee replacements are performed in order to reduce 
pain and improve living conditions (from Arthritis UK). OA is a degenerative joint 
disease leading to disability. Currently, joint replacement is the most common 
treatment for end-stage disease and the most effective way to eliminate pain. 
Obesity is a steadily increasing problem in developed countries and is considered to 
be a strong risk factor for OA (Silverwood et al., 2015). Although there are millions 
of people affected by OA, the detailed mechanism and precise cellular and molecular 
details have only been partially elucidated. The main goal of this project was to 
analyse further the molecular details of OA between patients undergoing knee 
replacement surgery with attention to the role of obesity in OA 
pathogenesis/progression. The main focus was on four different tissues, which make 
up the knee joint, namely: cartilage, synovial tissue, knee fat pad (so called 
infrapatellar fat pad (IPFP)), and bone. 
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1.2 Osteoarthritis 
1.2.1 Cartilage composition 
Cartilage is a connective tissue, which forms the articulating surface of synovial 
joints. Its unique composition is important in maintaining the joint structure and 
function. Human knee joint articular cartilage is 2-4 mm thick. It is an avascular 
tissue, which does not possess a lymphatic supply. It, therefore, relies on adjacent 
tissues including synovium or subchondral bone to provide essential nutrients as well 
as remove metabolic products.  
Proteoglycans and collagens are macromolecules produced by cartilage. They are 
assembled in a specific order forming four layers that allow cartilage tissue to 
maintain frictionless movement of the whole joint. Aggrecan which is the major 
proteoglycan in the cartilage together with small glycoprotein called link protein 
binds to a long chain of hyaluronic acid (HA) and form multimolecular structures 
called proteoglycan aggregates. The negative charge of proteoglycans aggregates 
enables cartilage to maintain high water content (up to 75%). The specific structure 
of collagens and proteoglycans enables cartilage to respond to the compressive forces 
which it experiences (Silverwood et al., 2015).  
In normal, healthy cartilage, there is a balance between processes responsible for 
matrix synthesis and those responsible for degradation. Chondrocytes within articular 
cartilage are the exclusive source of extracellular matrix (ECM). These dynamic 
changes help in sustaining the protective role of cartilage in weight-bearing. 
Cartilage is strong, flexible and semi-rigid. There are three types of cartilage: 
hyaline, fibrocartilage and elastic. The most common is hyaline cartilage, the main 
constituent of synovial joints including knees and hips. Fibrocartilage can be found 
in tendons and in vertebral discs while elastic cartilage is found in the external ear. 
There are two main cell types found in cartilage: immature/progenitor chondroblast 
that divide, proliferate, produce and secrete all ECM components once they are 
trapped in the ECM and become chondrocytes which reside in lacunae and maintain 
production of ECM.  
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Healthy articular cartilage can be divided into various zones (see Figure 1.1). The 
Superficial/Tangential zone (STZ), represents 10-20% of the total cartilage volume 
and protects the structure from shear stresses. Collagen fibres within this zone are 
tightly packed and in parallel alignment. Their shape is flat and they are specialised 
to produce collagen II and lubricin which helps in lubrication of the joint surfaces. 
Proteoglycan production is low in this zone. Below the STZ there is the middle zone 
(MZ) which represents 40-60% of total cartilage volume. Collagen fibrils in the MZ 
are thicker and organised perpendicularly, while chondrocytes are fewer and more 
spherical. The middle zone is composed mainly of proteoglycans. The role of MZ is 
to provide resistance to compressive forces. The Deep Zone (DZ) representing 30-
40% of total cartilage, in which collagen fibrils are arranged vertically, distributes 
loads and also provides resistance to compressive forces. It contains the thickest 
collagen fibrils, the highest proteoglycan content, and lowest water concentration. 
Below the deep zone, there is a calcified cartilage distinguished from the DZ by the 
tidemark. The tidemark is a basophilic line, which designates the boundary between 
calcified and uncalcified cartilage. Calcified cartilage separates the uncalcified 
cartilage from the subchondral bone (Sophia Fox et al., 2009). 
 
Figure 1. 1 The structure and composition of articular cartilage. 





The Role of Severe Obesity in Osteoarthritis 
 Doctoral Degree The University of Edinburgh 2016 
 4 
1.2.2 Knee Joint 
The knee joint is the largest joint in the human body (Kulowski, 2007). It consists of 
three articulations: two tibiofemoral compartments between the tibia and femur and 
one patellofemoral articulation between the patella and femur. The knee joint is a 
synovial, hinge joint, which allows flexion, extension and slight internal and external 
rotation. The tibiofemoral compartments include the capsule, several types of 
ligaments and the menisci (see Figure 1.2). 
The articular joint capsule is an envelope surrounding the synovial joint. It consists 
of an outer fibrous tissue and an inner synovial layer. The menisci (medial and 
lateral) are crescent-shaped articular discs that partly divide the joint space between 
the tibia and femur. They comprise connective tissue rich in collagen fibers and 
chondrocyte-like cells. The main role of the menisci is to increase the area of contact 
between the two bone surfaces. Therefore, they decrease compressive stress to help 
with lubrication of articular cartilage, in addition to shock absorption. Ligaments 
composed of fibrous connective tissue connect bones to other bones. In the knee 
joint, they provide stability by limiting certain movements of the joint. 
The main role of patellofemoral ligaments is to prevent displacement of the patella. 
The infrapatellar fat pad is the largest fatty tissue depot in the joint, it lies posterior to 
the patella ligament. 
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Figure 1. 2 Knee parasagittal section-lateral to the midline of the knee.  
The main components of the knee are presented. Image adapted from Encyclopedia Britannica inc. 
 
1.2.3 Cartilage in OA 
When the structure of healthy cartilage is disrupted, its protective role is lost. The 
damage can result from previous joint injury, but is also strongly correlated with 
aging, gender, and obesity. Though the aetiology of OA is not fully understood, 
genetic, environmental, mechanical and metabolic factors are considered to play an 
important role. OA is a multifactorial disease affecting not only the cartilage but also 
other tissues of the joint including bone, fat pad and synovium, which are all 
involved in the further progression of OA. Currently, there are no satisfactory 
treatments for OA. Available drugs only relieve symptoms of OA rather than 
modifying progression of the disease. 
Degeneration of cartilage begins with overproduction of aggrecanases, members of A 
Disintegrin, a Metalloproteinase with Thrombospondin Motifs (ADAMTS) family 
(Bondeson et al., 2008). Aggrecanases are proteases responsible for degrading 
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aggrecan. These events result in stopping the water intake and is followed by an 
overproduction of matrix metalloproteinases (MMPs) degrading collagen and other 
cartilage components as well as cysteine proteinases (Milner et al., 2006). 
Overproduction of these degrading proteins leads to a predominance of catabolic 
processes and an inevitable loss of cartilage. Destruction of aggrecan and collagen II 
leads to the loss of proper function of cartilage and is believed to be the first step in 
the onset of OA (Rousseau et al., 2007). Representative Cartilage degeneration 
showed in Figure 1.3. 
 
Figure 1. 3 Histology of normal human and osteoarthritic cartilage. 
Hematoxylin and Eosin Staining. Picture was taken from 
http://medcell.med.yale.edu/histology/connective_tissue_lab/osteoarthritis.php 
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Several pro-inflammatory factors have been described as having a role in OA 
progression. Degradation of collagen or aggrecan results in the formation of so-
called “neoepitopes” that can eventually lead to inflammation and progression of the 
disease (Cibere et al., 2009). Commonly known pro-inflammatory cytokines such as 
IL-1β, TNF-α, IL-6 and a variety of chemokines have been reported to have 
important roles in OA (Kapoor et al., 2011). In addition, recently described Damage 
Associated Molecular Pattern molecules (DAMPs), which can induce immune 
responses (Chockalingam et al., 2013; de Seny et al., 2013) have been described. 
These include Serum Amyloid A (SAA) and Tenascin-C (TN-C). TN-C expression 
has been described in human chondrocytes (Cheng et al., 2012) although, its role in 
OA progression has not been well defined.  
Other factors, reported to trigger OA include cell apoptosis and free fatty acids 
(Alvarez-Garcia et al., 2014). In a recent cohort study, which included more than 
7,000 OA patients, the authors described several chromosome loci associated with 
OA. Fat mass and obesity associated gene (FTO) was one of the genes within the 
described loci. High expression of FTO is correlated with obesity, which could play 
an important role in OA (Zeggini et al., 2012). 
The mechanism of early events leading to the development of OA has not yet been 
completely described. Several theories have been proposed. Changes in both 
cartilage and subchondral bone have been suggested as triggers of OA (Bettica et al., 
2002; Madry et al., 2012). 
Proteins including collagen type II or X, hyaluronan, MMP-13, and others have been 
proposed to be potent OA biomarkers. Lesions seen in the superficial zone are 
characterised by fibrillation of cartilage and loss of proteoglycans. There is also a 
change in chondrocytes phenotype, they become hypertrophic in comparison to 
healthy, mature, matrix-producing and senescent chondrocytes. The final stage of 
chondrocyte hypertrophy is calcium deposition. This process, called endochondral 
ossification, is desirable in the normal growth-plate during bone maturation (Sun et 
al., 2014). In OA, however, this phenotype change can lead to the matrix 
reorganisation and inflammation of the cartilage. OA chondrocytes are also reported 
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to produce more alkaline phosphatase (ALP), which is a typical bone protein 
(Pfander et al., 2001). Figure 1.4 shows the main symptoms of OA. 
 
Figure 1. 4 Knee joint components’ contribution to OA pathogenesis.  
Diagram taken from (Hunter, 2011) Pharmacologic therapy for osteoarthritis—the era of disease 
modification Nat. Rev. Rheumatol 
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1.3 Obesity 
A number of studies have shown that obesity correlates with the incidence of OA not 
only in weight-bearing joints including knees (Dougados et al., 1992; Marks, 2007) 
but also for non-weight bearing joints OA, such as the joints in the hands, as 
demonstrated by a cohort study (Grotle et al., 2008). Body mass index (BMI) is 
strongly correlated with knee OA, but only weakly with hip OA (Sturmer et al., 
2000).  
Fat tissue can no longer be considered just as an energy storage (Kershaw et al., 
2004). It is also an effective endocrine organ. Not only does it produce hormones in a 
paracrine manner, but also is an efficient source of systemically secreted substances. 
All of the above suggests that adipose tissue could be a potent target in osteoarthritic 
research. 
1.3.1 Adipose tissue 
1.3.1.1 Types of adipose tissue 
Adipose tissue is a connective tissue composed mainly of adipocytes. Two main 
adipose tissue types exist: White Adipose Tissue (WAT) and Brown Adipose Tissue 
(BAT). Some recent studies described an intermediate type, so called, Beige Adipose 
Tissue (Wu et al., 2012). White Adipose Tissue fat cells are highly specialised in the 
synthesis, storage and release of triglycerides (Lanthier et al., 2014). The diameter of 
white adipose tissue adipocyte can reach up to 200 µm (Wree et al., 2014). The cell 
comprises one large or several medium size lipid droplets. In healthy adipose tissue 
adipocytes are in a sufficient contact with the capillary system. 
Brown adipose tissue specialises in energy expenditure and heat generation. It is 
mainly found in newborns and hibernating animals. Brown adipocytes are very 
characteristic with several small lipid droplets next to a high number of mitochondria 
(containing iron), which play an important role in thermoregulation and make it 
brown (Nam et al., 2015). The brown adipose tissue content decreases with age and 
is mainly detected in supraclavicular and paraspinal regions in adults (Yoneshiro et 
al., 2011).  
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1.3.1.2 Location of White Adipose Tissue (WAT) 
White adipose tissue can be divided into several types depending on its location 
including subcutaneous adipose tissue (SAT) which lies under the skin and 
omental/visceral adipose tissue (VAT) which lies within the peritoneum. In healthy 
subjects (with normal weight) the majority of adipose tissue (up to 80%) is 
subcutaneous and only 10-20% is visceral adipose tissue. SAT can be characterised 
by a lower number of larger adipocytes while VAT has a higher number of smaller 
adipocytes. SAT is known to have greater angiogenic properties and higher capillary 
density than VAT (Lanthier et al., 2014). Whereas VAT has comparatively a higher 
number of resident macrophages (Amano et al., 2014). Several specific adipose 
tissue types comprise VAT including pericardial, periaortic, perigonadal and 
perirenal. All of these fatty tissue depots play a role in organ protection, fatty acid 
metabolism and healing in the healthy organism but are also very important in the 
pathogenesis of many diseases for example atherosclerosis (Li et al., 2015). 
1.3.2 Obesity as a chronic inflammation 
Obesity has become a major problem in developed societies. It has been calculated 
that 50% of British adult will be obese by 2030 (Wang et al., 2011). Obesity is 
characterised by an excess of WAT due to overfeeding and lack of physical exercise. 
It is known to increase the likelihood of such diseases as Type 2 Diabetes Mellitus 
(T2DM), heart conditions (ischemic heart disease, myocardial infarction), stroke 
(Saydah et al., 2014), OA (Sturmer et al., 2000) and some types of cancer (Bianchini 
et al., 2002). Obesity is defined based on the body mass index (BMI) or waist-to-hip 
ratio (WHR). The BMI index is defined as body weight (in kilograms) divided by the 
square of body height (in meters) and BMI score from 20-25 is considered as normal 
weight, 25-30 as overweight, 30 to 35 Class I (moderate) Obesity, 35 to 40 Class II 
(severe) Obesity, above>40 Class III (very severe) Obesity. 
Obesity is a low-grade inflammatory status. Fatty tissue is no longer considered to be 
a passive organ. It produces a huge variety of molecules and contains different 
populations of cells. In lean subjects, protein production, cell phenotype 
proliferation, differentiation and cell death are homeostatically maintained. During 
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weight gain, there is a switch to low-grade inflammation in the whole organism, 
resulting from the influx of pro-inflammatory macrophages into adipose tissue, 
together with other cells of the immune system including CD8+ T, mast and B cells 
(see Figure 1.5) (Kanneganti et al., 2012). Additionally, adipocytes themselves start 
producing cytokines, and so-called “bad” adipokines. These changes affect other 
tissues including blood vessels and the pancreas leading to atherosclerosis and 
T2DM (Osborn et al., 2012). 
 
Figure 1. 5 General scheme of immune changes within the adipose tissue with weight gain.  
The difference in proinflammatory markers and adipose tissue leukocytes can be characterized with 
weight gain. Adapted from (Kanneganti et al., 2012) 
 
Recent studies have demonstrated that obesity has a huge impact on cartilage 
metabolism (Yaykasli et al., 2015). Increased release of glycosaminoglycans (GAG) 
has been postulated as a marker of cartilage destruction. A higher content of free 
GAGs produced by cartilage explants has been positively correlated with BMI of the 
subject  (Buchholz et al., 2010). Another study reported that mRNA for proteins 
including Peroxisome Proliferator-Activated Receptor α (PPARα), Bone 
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Morphogenic Protein 7 (BMP-7) and Interleukin 1 β (IL-1β) were highly induced in 
OA and correlated with BMI (Iliopoulos et al., 2008).  
1.3.3 Adipokines and cytokines in obesity 
Adipokines are proteins, produced by WAT, that have an important autocrine role 
within fat but also influence other organs in the body. They regulate appetite, energy 
expenditure and lipid uptake as well as being responsible for glucose and insulin 
homeostasis. The first adipokine described and most often reviewed is leptin, a 
product of the ob gene in mice (homolog for human LEP gene). It is mainly 
produced by adipocytes and is responsible for the hypothalamic signalling that 
reduces appetite (McGarry, 1995). The leptin receptor (LEPR) is expressed in the 
central nervous system (Gautron et al., 2011) and leptin administration increases 
peripheral glucose intake and reduces appetite (Rossetti et al., 1997). Leptin has 
many other functions, including regulation of muscle glucose metabolism (Yau et al., 
2014), induction of CD4+ T cells proliferation (Cassano et al., 2014), the production 
of chemokines and macrophage activation (Kiguchi et al., 2009). Mice with genetic 
knockdown of leptin (or leptin receptor) are obese (ob/ob and db/db respectively) 
(Pelleymounter et al., 1995). Although leptin reduces appetite, its expression is 
increased in human obesity (Considine et al., 1996). Hyperleptinemia in human 
subjects is explained as the resistance of peripheral tissues to leptin which leads to 
failure in weight management (Myers et al., 2008). 
The second most widely examined adipokine is adiponectin commonly seen as a 
“good” adipokine. It has anti-inflammatory properties and its level is negatively 
correlated with obesity. Adiponectin circulates in different multimeric forms and can 
form trimers, hexamers in addition to high molecular weight multimers (HWM). The 
HMW form is the most active and important in sensitivity of cells to insulin and in 
protecting patients from diabetes. Adiponectin is known to inhibit smooth muscle 
cell proliferation and to decrease the production of some adhesive proteins, which 
makes it an anti-atherosclerotic factor. It enhances the sensitivity to insulin of many 
cells and helps maintain the anti-inflammatory macrophage phenotype (Arita et al., 
2002; Okauchi et al., 2009; Lovren et al., 2010).  
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Recent findings suggest that the production of adipokines is not exclusive to 
adipocytes. Other cell populations (including macrophages) can also be potent 
producers of adipokines. Pro-inflammatory molecules such as cytokines and 
chemokines are abundantly produced within fat tissue. Obese patients produce 
systemically more IL-1β in addition to IL-18 and IL-6 (Syrenicz et al., 2006; 
Murdolo et al., 2008) as compared to lean individuals. It has been postulated that 
these proteins have a major influence on obesity-related conditions including 
atherosclerosis and diabetes (Dalmas et al., 2014; Shi et al., 2015). For instance, IL-
1β is a major catabolic factor in cartilage degradation. IL-18 has been reported to 
induce prostaglandin E2 (PGE2) - an important inflammatory mediator in the 
synovial membrane while IL-6 is involved in bone remodelling (Iannone et al., 
2010). 
Although obesity is highly correlated with OA and is considered to be a risk factor 
for this disease, the role of adipose tissue- derived factors in the progression of OA 
has not been fully described.  
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1.4 Synovium in OA 
Synovial tissue, an important compartment of the knee joint, consists of two layers: 
intima and subintima. The inner layer – the intima consists of two types of cells: 
fibroblast-like and macrophage-like synoviocytes. Fibroblast-like synoviocytes 
(FLS) are important in the secretion of the proteins hyaluronan and lubricin, which 
maintain the viscosity of the synovial fluid and retain water within the joint. In 
healthy, normal synovium, the intima does not exceed two layers of cells and is 
approximately 25 µm thick. The outer layer – the subintima in the knee joint consists 
of loose fibrous and fatty tissue. The whole structure also includes microvessels and 
small nerves.  
Synovial Fluid (SF) is a viscous fluid found in the synovial cavity. Its main role is to 
reduce friction between the articular cartilage surfaces found in the joint. In the 
healthy condition SF consists mainly of hyaluronic acid and lubricin (Hui et al., 
2012). 
Healthy, intact synovium provides sufficient lubrication for both cartilage-cartilage 
contact and synovium-cartilage contact. Lubricin and hyaluronic acid reduce friction 
and provide lubrication. There is an active transport of small plasma proteins 
(including growth factors) into the joint cavity. Proteins enter the SF via synovial 
microvasculature but their transport depends on the molecular weight and the charge 
of the protein (Weinberger et al., 1989). In normal conditions, high-weight molecules 
including hyaluronic acid and proteoglycans remain within the joint cavity while 
smaller proteins are able to exit.  
In various diseases, this balance is disrupted by reorganisation of the synovial 
membrane (due to hyperplasia or inflammation), resulting in a noticeable change in 
the protein concentration in the SF. Proteins produced by the synovium are key 
players in the pathogenesis of many arthritic diseases including rheumatoid arthritis 
(RA) (Castro-Santos et al., 2015). Although OA is considered less inflammatory than 
RA, some authors have reported mild to severe inflammation and synovitis in OA 
(Haywood et al., 2003).  
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In synovitis, there are three different pathological changes which have been 
described within the synovium: 1) hyperplasia 2) stromal activation 3) inflammation 
(Krenn et al., 2006). Hyperplasia of the synovium is defined as an increased cell 
number in the intima. Fibroblast-like synoviocytes proliferate and the general intima 
thickness increases. Activation of the stroma occurs in sublining areas and is defined 
as slight to severe oedema. The third feature of synovitis is the inflammatory 
infiltration characterised by slight to severe leukocyte invasion.  
Production of pro-inflammatory cytokines including IL-1β, TNF-α, IL-6 and IL-8 by 
synovium have been reported to be important in OA progression (Sokolove et al., 
2013). However, synovium also produces anti-inflammatory cytokines for example 
IL-4, IL-10 and IL-1Ra (Sutton et al., 2009). Fibroblast-like synoviocytes are very 
potent producers of pro-inflammatory and pro-catabolic molecules. OA Fibroblast-
like synoviocytes produce TNF-α, IL-1β and MMPs (Shen et al., 2014). 
Synovium contains not only synoviocytes but also immune cells including 
macrophages, T-cells, B-cells and mast cells. There is an altered CD4/CD8 ratio of 
the T-cell subtypes found in OA patients in comparison to healthy people (Revell et 
al., 1988; Saito et al., 2002). The subtypes of T cells in the synovial membrane are 
considered to have a unique role in cytokine production and in the pathogenesis of 
arthritis (Schulze-Koops et al., 2001).  
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1.5 Infrapatellar (Hoffa’s) Fat Pad (IPFP) in OA 
The infrapatellar fat pad, also known as Hoffa’s pad, is located within the knee 
capsule deep to the patella but outside the synovium. Hoffa’s pad occupies dead 
space within the joint together with two smaller fatty depots called the quadriceps 
and pre-femoral fat bodies. Those fatty structures maintain the joint cavity and 
promote efficient lubrication (Morini et al., 1998). The origin of the IPFP is 
unknown, some authors suggest it is most similar to a subcutaneous fat deposit 
(Vahlensieck et al., 2002) due to the fibrous structures surrounding the adipocytes. 
Other authors state that it is more similar to a visceral fat deposit  (Ioan-Facsinay et 
al., 2013).  
IPFP is a rich source of mesenchymal stem cells (MSC) with high chondrogenic 
(Felimban et al., 2014) but lower adipogenic and osteogenic potential in comparison 
with subcutaneous adipose tissue MSC from the same donor (Lopa et al., 2014). It is 
also a source of inflammatory cells including leukocytes (Klein-Wieringa et al., 
2011) or CD31+ endothelial cells. MSC isolated from OA IPFP had comparable or 
slightly weaker osteogenic potential in comparison to MSCs from RA patient 
patients (Skalska et al., 2014).  
Some studies have reported a positive role of the IPFP in mediating OA – related 
pain due to shock absorption (Han et al., 2014), however, the IPFP adjacent to the 
synovial layer is considered to be an active source of many cells and factors involved 
in OA (see Figure 1.6). The IPFP produces IL-6 (Ushiyama et al., 2003) at a level 
almost 2-fold greater than the subcutaneous adipose tissue (SAT) depots. The IPFP 
also produces 40% less leptin and 70% more adiponectin (Distel et al., 2009)(Gegout 
et al., 2008). It has been demonstrated as having a potential role in the induction of 
synovial inflammation in OA patients: IPFP-conditioned medium has been reported 
to stimulate synovial fibroblast-like synoviocytes to produce IL-6 and IL-8 (both at 
the mRNA and protein levels) in addition to MMP-1,3,9 and 13 possibly through the 
action of prostaglandin-2 (PGE-2) (Eymard et al., 2014). The IPFP-conditioned 
medium was able to stimulate pro-fibrotic properties of these cells by increasing 
collagen production and by stimulating cell migration (Bastiaansen-Jenniskens et al., 
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2013). Conversely, IPFP-conditioned media reduced nitric oxide (NO) production 
and MMP-1 gene expression in cartilage, inhibited IL-1β mediated up-regulation of 
MMP-1 and MMP-3 gene expression while stimulating collagen II gene expression 
(Bastiaansen-Jenniskens et al., 2012). 
 
Figure 1. 6 Infrapatellar Fat Pad Contribution to OA. 
Diagram taken from (Ioan-Facsinay et al., 2013) showing the contribution of IPFP to OA. IPFP is a 
potent producer of cytokines, adipokines and other obesity relates factors including FFA. 
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1.6 Subchondral bone in OA 
1.6.1 Bone role, composition, structure and types 
Bone is a mineralized connective tissue that supports and protects the whole 
organism as well as being a very important organ in hematopoiesis. Bone marrow is 
a crucial hematopoietic milieu and facilities leukocyte maturation. Bone is highly 
specialized in the deposition of calcium phosphate within the collagen matrix. 
Calcium phosphate is the main inorganic component of the bone which is organized 
in a chemical arrangement called hydroxyapatite that provides fracture resistance. 
The main organic compound of the bone is collagen type I. 
There are two main types of bone: cortical and cancellous. Cortical bone (also named 
compact bone) as its name suggests forms the cortex (outer shell) of bone structure. 
It is denser, harder and stronger than cancellous bone. The main function of cortical 
bone is to provide support, protection and to be a specific lever for movement. 
Cancellous, also called trabecular or spongy bone, is less dense and more porous than 
cortical bone. It is highly vascular and very often contains red bone marrow where 
hematopoiesis occurs. It can be typically found at the end of the long bones proximal 
to joints and in the inside of the vertebrae. 
Although bone is the hardest and the most rigid tissue within the body, it is 
constantly remodelled by two main cell types, osteoblasts and osteoclasts. 
Osteoblasts specialize in bone matrix formation while osteoclasts are specialized in 
bone resorption. When osteoblasts become trapped within the bone matrix in lacunae 
they mature into osteocytes. They are connected to each other via cytoplasmic 
extensions which lie in canaliculi and exchange nutrients and metabolites through 
gap junctions. Osteocytes are non-proliferating, fully mature and long-lived cells 
with an average life span of about 25 years. Osteoclasts are large, multinucleated 
cells, which originate from macrophages. Their main role is bone resorption and 
remodelling (Buckwalter et al., 1987). Osteoclasts have the ability to resorb bone and 
can be found on the bone surface in shallow pits of trabecular bone. They produce 
specific proteins including tartrate-resistant acid phosphatase (TRAP) or various 
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lysosomal enzymes and serine proteases. Macrophages Colony stimulating factor 
(M-CSF) plays a crucial role in osteoclastogenesis (Teitelbaum, 2000). Osteoclast 
precursor cells express Receptor Activator of Nuclear Factor Kappa-B (RANK) 
which is activated during binding to osteoblast-specific protein Receptor Activator of 
Nuclear Factor kappa-B Ligand (RANKL) which leads to osteoclasts activation and 
bone resorption. RANKL can also bind to its decoy receptor osteoprotegrin (OPG) 
which is a negative regulator of bone resorption due to blocking RANK and RANKL 
binding. 
1.6.2 Subchondral bone 
The tissue lying directly under the cartilage is subchondral bone which can be further 
divided into the subchondral bone plate and trabecular bone. The subchondral bone 
plate is composed of 1-3 mm corticalised bone. It separates calcified cartilage from 
the bone marrow-containing trabecular bone. The trabecular compartment of the 
articular joint is highly vascularized and provides nutrients to the deep zones of 
cartilage. Subchondral bone by its specific organization is a specialized structure that 
responds to the loads applied to the joint (Madry et al., 2010).  
1.6.3 Subchondral bone role in OA 
Progression of OA is associated with several changes within subchondral bone. 
Overloading of the joint is associated with increased microdamage and 
microfractures of the subchondral bone (Henrotin et al., 2012). The rate of bone 
remodelling changes during disease progression (Chen et al., 2015). Furthermore, 
subchondral cortical and cancellous bone are architecturally, physiologically and 
mechanically different and respond differently to OA (Grynpas et al., 1991). Early 
stages of OA can be characterized by increased vascularity and reduced bone density 
while in later stages, there is subchondral sclerosis and decreased bone resorption 
without decreased bone formation (Klose-Jensen et al., 2015). Furthermore, there is a 
duplication of tidemark and penetration of the vessels reported during OA 
pathogenesis in humans (Bonde et al., 2005)  
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Some animal models, i.e. non-human primates and guinea pigs (Carlson et al., 1994; 
Huebner et al., 2002) suggest that thickening of the subchondral plate occurs prior to 
cartilage damage, rather than vice versa.  
1.7 The role of adipokines in OA 
As previously mentioned, adipose tissue is an endocrine organ. It releases cytokines, 
including IL-1β and tumour necrosis factor-α (TNF-α), and adipokines, including 
leptin adiponectin, visfatin, resistin, lipocalin and chemerin. The adipokine family 
affects a wide variety of physiological and pathophysiological processes, including 
food intake, energy expenditure, lipid and glucose metabolism, inflammation, insulin 
metabolism and bone formation. Products from adipose tissue are also viewed as 
potential systemic factors, which link obesity to arthritis. The recent studies 
concerning the involvement of adipokines in OA will now be discussed. 
1.7.1 Leptin 
Several studies have reported that the serum level of leptin positively correlates with 
OA (Gandhi et al., 2010; Boer et al., 2012) and have stated that it has an important 
role in the progression of OA (Vuolteenaho et al., 2014). Leptin is produced in 
explant cultures of cartilage, infrapatellar fat pad, synovium and osteophytes from 
the joints of OA patients (Gegout et al., 2008). It can also be found in osteoarthritic 
chondrocytes (Francin et al., 2011). Normal non-OA cartilage produces considerably 
less leptin than even mildly OA cartilage (Simopoulou et al., 2007). Boer et al. 
reported that the plasma level of this protein correlated with other OA biomarkers 
including C-terminal tellopeptide of type II collagen, monoclonal antibody 846 
against chondroitin sulphate (Boer et al., 2012). Hui et al stated that leptin is a pro-
inflammatory adipokine, which either alone or with IL-1β, induces collagen release 
in bovine cartilage by up-regulation of collagenolytic and gelatinolitic activity (Hui 
et al., 2012). Leptin has also been shown to induce MMP-3, MMP-9, and ADAMTS-
4 and -5 production in addition to proteoglycan depletion in chondrocytes but also to 
induce collagen II mRNA expression in rat cartilage (Bao et al., 2010). Leptin 
induces production of MMP-1, MMP-3 and MMP-13 in human cartilage (Koskinen 
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et al., 2011). In addition, higher leptin levels and leptin receptor expression have 
been reported in areas of more advanced osteoarthritic change within the cartilage of 
the same joint (both mRNA and protein level) (Simopoulou et al., 2007). 
Production of MMP-1 and MMP-13 by chondrocytes is induced by conditioned 
media from the infrapatellar fat pad (IPFP), what was reduced by blocking leptin 
with a specific antibody (Hui et al., 2012). Whereas, leptin can also enhance 
production of pro-inflammatory markers in human chondrocytes, including nitric 
oxide (NO), prostaglandin E2 (PGE2), IL-6 and IL-8 (Vuolteenaho et al., 2009). 
Together with adiponectin, leptin can induce Vascular Cell Adhesion Molecule 1 
(VCAM-1) expression by chondrocytes (Conde et al., 2012).  
The level of leptin in synovial fluid (SF) is increased in obese OA patients while its 
circulating inhibitors (sOb-b and SOC-3) are decreased (Vuolteenaho et al., 2012). In 
chondrocytes from obese patients, unlike those from lean patients, high doses of 
leptin induce Insulin-like Growth Factor 1 (IGF-1) and collagen II (Pallu et al., 
2010). On the basis of these studies, a potential role of leptin in the local progression 
of OA has been postulated and it has been suggested that decreasing the level of 
leptin by weight reduction could be a mechanism for improved physical function and 
reduced symptoms in OA patients (Richette et al., 2011).  
1.7.2 Leptin receptor 
The leptin receptor (Ob-R) is encoded by the db gene in rodents (LEPR in 
humans) and belongs to the class I cytokine receptor superfamily (Zabeau et al., 
2004). It has 6 isoforms, the longest of which is Ob-Rb, expressed by several 
different cell types including pancreatic cells, epithelial cells and T lymphocytes 
(Park et al., 2001; Papathanassoglou et al., 2006; Morioka et al., 2007). The soluble 
form of Ob-R is present in joint fluids (Vuolteenaho et al., 2012). Vuolteenaho et al 
have demonstrated that leptin and Ob-R level is significantly induced in both 
synovial fluid and serum in severe OA. Although many studies have confirmed the 
pro-inflammatory role of leptin in OA, Griffin et. al. showed that, even though a 
high-fat diet-induced OA in C57B/6 mice, direct injection of leptin into the joint did 
not induce alteration in synthesis of extracellular matrix by healthy cartilage, 
The Role of Severe Obesity in Osteoarthritis 
 Doctoral Degree The University of Edinburgh 2016 
 22 
indicating that leptin was not a direct mediator of OA (Griffin et al., 2010). Of 
particular interest was the finding that obese, leptin-deficient mice (ob/ob) or leptin-
receptor-deficient mice (db/db) do not develop spontaneous OA (Griffin et al., 2010).  
1.7.3  Adiponectin 
Adiponectin is 30kDa protein that possesses several Gly-X-Pro repeats next to a 
cluster of Gly-X-Y domains which altogether forms collagen-like domains. 
Furthermore, the C-terminal aminoacids sequence form globular domain (Scherer et 
al., 1995; Nakano et al., 1996). Adiponectin is known to circulate in different 
molecular oligoforms (monomer, trimer and multimers) (Kadowaki et al., 2005) and 
a shorter, cleaved globular form. Adiponectin needs to be glycosylated in order to 
gain biological activity (Chandran et al., 2003). The monomeric form of adiponectin 
is not detected in the circulation and the globular form can only be found in small 
quantities (Wedellova et al., 2013). Fully functional adiponectin is a trimer. Four to 
six trimers associate to form a high-molecular-weight structure (HMW adiponectin), 
which is the predominant form of adiponectin in blood. It is a highly expressed 
protein within adipose tissue, which circulates in the bloodstream in high 
concentrations. It constitutes approximately 0.01% of the total of plasma proteins and 
its serum level correlates negatively with obesity (Arita et al., 1999).  
Obesity is associated with both a decrease of adiponectin and adiponectin receptor 
(ADIPOR1 and ADIPOR2) levels within adipose tissue and serum. Down-regulation 
of ADIPOR1 and ADIPOR2 in the liver is associated with the development of 
T2DM (Yamauchi et al., 2001; Yamauchi et al., 2007). Boer et al showed that the 
adiponectin level in serum of OA patients negatively correlated with BMI, but 
surprisingly, its synovial fluid level correlated with pro-inflammatory cytokines 
including IL-1β (Boer et al., 2012). Adiponectin is also produced by cartilage, the 
infrapatellar fat pad, synovium and osteophytes in OA patients (Gegout et al., 2008). 
Both adiponectin receptors can be found to be expressed by chondrocytes (Chen et 
al., 2006). ADIPOR2 is expressed in all cartilage layers while ADIPOR1 within the 
superficial layer. An increased expression of ADIPOR1 and ADIPOR2 has been 
reported in OA cartilage lesions (Kang et al., 2010).  
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Serum level of adiponectin exceeded its level in the synovial fluid (Presle et al., 
2006). Both serum and synovial fluid adiponectin level conversely correlate with OA 
cartilage damage (Honsawek et al., 2010). The ratio of leptin and adiponectin level in 
serum has been found to correlate with pain in OA patients (Bas et al., 2014). 
Circulating plasma level of adiponectin have been reported to correlate with the OA 
marker: cartilage oligomeric matrix protein (COMP). Further, there were variances 
in adiponectin secretion among patients with different levels of severity of OA (King 
et al., 2014). Production of adiponectin by OA cartilage positively correlates with 
PGE2 and MMP-13 (Francin et al., 2014). Adiponectin induces secretion of IL-6, 
MMP-3, MMP-9 and MCP-1 in chondrocyte cell lines in a dose-dependent manner 
and induces an important proinflammatory molecule: inducible Nitric Oxide 
Synthase 2 (iNOS2) production (Lago et al., 2008). The role of adiponectin in OA is 
controversial. Some authors suggest it is protective (Chen et al., 2006) thus anabolic 
while others (Kang et al., 2010) report that it is a pro-inflammatory factor. Some of 
the variation might be accounted by the differences in circulating level of different 
oligomers, which each play distinct roles. Once ADIPOR1 or ADIPOR2 have been 
stimulated distinct signalling cascades mediate their signal. However, currently, the 
role of adiponectin in morbidly obese patients with OA has not been elucidated. 
1.7.4 Visfatin, Resistin, Lipocalin 2 and Chemerin 
Visfatin was first discovered as a cytokine promoting B-cell maturation hence its 
other name: pre-B-cell colony-enhancing factor 1 (PBEF1) (Samal et al., 1994). 
Later studies revealed that the same gene encodes an important intracellular enzyme 
called nicotinamide phosphoribosyltransferase (NAmPRTase or NAMPT) (Wang et 
al., 2006). It catalyses the transfer of a phosphate group onto nicotinamide D-
ribonucleotide and plays an important role in NAD and NADH synthesis pathways. 
Its third name – visfatin came from the study describing its exclusive expression in 
visceral fat (Fukuhara et al., 2005). This was contradicted as other studies showed it 
is also produced in other tissues including subcutaneous adipose tissue (Sitticharoon 
et al., 2014) and liver (Dahl et al., 2010).  
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Elevated serum and synovial fluid levels of visfatin have been described in OA 
patients (Chen et al., 2010). This adipokine is highly expressed by 
osteophytes (Gegout et al., 2008) and can be found in osteoarticular chondrocytes. 
Visfatin has been also reported to inhibit IGF-1-mediated proteoglycan synthesis and 
to inhibit production of collagen II (Yammani et al., 2012). Administration of 
visfatin enhances prostaglandin 2 (PGE2) production, MMP-3, MMP-13 and 
ADAMTS-4 and -5 expression in murine chondrocytes (Gosset et al., 2008). The 
production of these latter proteins correlates with degradation markers of collagen 
and aggrecan including CTX II in cartilage (Duan et al., 2012). 
Resistin is a pro-inflammatory mediator produced by adipose tissue, macrophages 
and neutrophils. Serum resistin levels positively correlate with obesity and 
inflammatory state (IL-1β, TNF-α production) in OA patients, but does not correlate 
with cartilage loss (Boer et al., 2012). There is also a correlation between serum level 
of resistin and radiographic changes in hand OA (Choe et al., 2012). Resistin levels 
are higher in serum than in synovial fluid (Presle et al., 2006) and this protein is 
produced by cartilage, infrapatellar fat pad, synovium and, in small amounts, by 
osteophytes within the joint of OA patients (Gegout et al., 2008). 
Lipocalin 2 (LCN2), also termed siderocalin or neutrophil gelatinase-associated 
lipocalin (NGAL), is mainly produced by adipose tissue but can also be expressed in 
neutrophil granules and can be found in chondrocytes . It forms a complex with 
MMP-9 and is believed to be involved in the pathogenesis of OA (Owen et al., 
2008). Its expression can be regulated by leptin, adiponectin and IL-1β (Gupta et al., 
2007) in addition to dexamethasone (Owen et al., 2008) . Higher LCN2 expression 
was reported in hypertrophic chondrocytes (Gupta et al., 2007). Toll-like receptor4 
(TLR4) activation can stimulate LCN2 expression in chondrocytes (Gómez et al., 
2013). 
Chemerin was first described in psoriasis patients treated with tazarotene (retinoid 
approved for treatment of psoriasis and acne). This protein is secreted by many cell 
types including adipocytes and epithelial cells. It induces chemotaxis of cells 
expressing the chemerin receptor Chemokine-Like Receptor-1 (CMKLR1) (Kaur et 
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al., 2010). It recruits dendritic cells and macrophages to sites of 
inflammation (Skrzeczynska-Moncznik et al., 2009). Chemerin expression is highly 
induced during adipocyte differentiation and has an influence on lipolysis (Goralski 
et al., 2007). Chemerin is also present in the aorta wall in atherosclerosis and is 
considered as a highly pro-inflammatory protein. High levels of chemerin have been 
described in obese patients (Shin et al., 2012). The role of chemerin in OA is not 
fully described. Although it is known that synovial cells express both chemerin and 
CMKLR1 and chemerin is present in synovial fluid, it does not have chemotactic 
properties for synoviocytes. Moreover, it stimulates TLR4 gene expression and 
CCL2 synthesis in synoviocytes (Eisinger et al., 2012). Chemerin levels are higher in 
the serum than in the synovial fluid of OA patients and its level in the synovial fluid 
of knee OA patients is correlated with disease severity evaluated with the Kellgren-
Lawrence (KL) grading (Huang et al., 2012). 
In summary, all aforementioned adipokines have been suggested in the literature to 
be potent players in OA. However, there are still many questions about the 
mechanisms and pathways they may be involved in. An understanding of how the 
levels of all of the adipokines and their receptors correlate with obesity in OA 
patients would be informative.  
1.7.5 Subchondral bone and adipokines 
The role of obesity in OA was firstly ascribed to overloading of the joints. However, 
studies  now suggest that obesity-associated OA is not purely due to the excessive 
loading (Collins et al., 2015). Obesity has been reported to have a beneficial effect on 
bone (Ribot et al., 1987; Felson et al., 1993) but more recent studies indicate that 
excess weight can have a negative effect on bone biology (Sukumar et al., 2011; 
Ootsuka et al., 2015). Obesity is known to create a chronic inflammatory state with a 
higher level of circulating pro-inflammatory cytokines, which may promote 
osteoclast activation (Cao et al., 2010). Cytokines including IL-1β or TNF-α are 
elevated in obesity and are also potent activators of osteoclasts (Hofbauer et al., 
1999).  
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Adipokines, are now considered to be important factors in the bone formation and 
remodelling (Zhang et al., 2013). Although, first described to be mainly produced by 
adipose tissue, adipokines including (1) leptin (Gordeladze et al., 2002), (2) resistin 
(Thommesen et al., 2006) and (3) adiponectin (Berner et al., 2004; Huang et al., 
2004) have now been reported to be expressed by both osteoblasts and osteoclasts.  
Leptin has been postulated to have a dual role in bone biology: mice lacking leptin 
(ob/ob) are obese and exhibit high bone density and leptin is able to stimulate loss of 
trabecular and cortical bone mass when administered locally (Steppan et al., 2000). 
Other studies have reported that leptin upregulates osteoblastogenesis, osteoblast 
proliferation and matrix synthesis (Gordeladze et al., 2002; Holloway et al., 2002) 
while inhibiting osteoclastogenesis in vitro. Another study has shown that genetically 
obese mice lacking leptin display a decreased trabecular volume in long bones, but 
increased vertebral bone mass which was reduced by leptin administration (Heep et 
al., 2009).  
Mutabaruka et al have shown that subchondral bone from OA patients produces 
more leptin than bone from normal subjects (Mutabaruka et al., 2010). In addition, 
leptin is able to stimulate its own production in subchondral bone and the 
proliferation of osteoblasts. Inhibition of leptin synthesis is associated with a reduced 
level of ALP. It has been suggested that the leptin and leptin receptor (Ob-Rb) 
signalling pathway is responsible for the elevated ALP activity in OA. There are 
opposing results on the correlation of circulating levels of leptin with human bone 
mass: serum leptin levels correlate with bone mass in obese women but do not 
correlate with markers of bone resorption/formation (Goulding et al., 1998). In 
contrast, some studies report weak or no correlation (Iwamoto et al., 2000; Yilmazi 
et al., 2005), whilst others, even report a negative correlation with BMI (Sato et al., 
2001). These differences may be due to study designs in these reports e.g. women vs 
men, obese vs. osteoporotic, pre- vs. post-menopausal subjects. 
The adiponectin serum level is an important factor in bone biology and is associated 
with an increase in trabecular bone mass (Oshima et al., 2005) due to a reduction in 
bone resorption activity of osteoclasts and possibly also due to inducing osteoblast 
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activity. Studies in mice showed that knockout of adiponectin has an impaired 
osteoblastogenesis and mineralization (Aguirre et al., 2014). Mice with up-regulated 
AdipoR1 expression exhibit increased bone volume and number of trabeculae than 
wild-type mice (Lin et al., 2014). Adiponectin increased trabecular bone mass and 
inhibited RANKL-mediated osteoclastogenesis of macrophages obtained from 
peripheral mononuclear blood cells (PMBC) in mice (Oshima et al., 2005). 
Visfatin level has been reported to be negatively correlated with BMD (Sucunza et 
al., 2009) in acromegaly. Visfatin is produced in a high amount by osteophytes 
(Chen et al., 2010) and is also a potent stimulator of IL-6 and IL-8 production by 
osteoblasts (Laiguillon et al., 2014). 
Resistin is expressed by osteoblasts and osteoclasts (Thommesen et al., 2006) and 
stimulates IL-6 expression and weakly stimulates OPG or RANKL. Lipocalin 2 is 
shown to be up-regulated during osteoclastogenesis but down-regulated in 
osteoblastogenesis (Rucci et al., 2015). Neutralisation of chemerin blocks 
osteoclastogenesis (Muruganandan et al., 2013) and augments osteoblastogenesis 
while reducing adipogenesis (Zabel et al., 2006; Muruganandan et al., 2010). 
The main findings of the role of adipokines in the pathogenesis of OA are 
summarised in Figure 1.7. 
 
Figure 1. 7 The main reported findings of the role of adipokines and adipose-tissue related 
factors in the pathogenesis of OA. 
Diagram adapted from (Poonpet et al., 2014).  
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1.8 Hypothesis and Aims 
Although OA and obesity are widely studied diseases, how they interrelate is not 
properly described and interpreted. Adipokines and adipose-derived cytokines have 
been reported to play a role in the pathogenesis of OA, however, the differences 
between obese and lean individuals with OA has not been well studied. Obesity has 
become a major problem in developed societies. It has been calculated that 50% of 
British adults will be obese by 2030 (Wang et al., 2011). Fat tissue can no longer be 
considered just as an energy store (Kershaw et al., 2004). It is also an effective 
endocrine organ. All of the presented data suggests that adipose tissue could be a 
potent aim in osteoarthritic research. A systemic role for adipose tissue-secreted 
proteins (adipokines) has been widely reported. Nonetheless, their local production 
within the knee joint hasn’t been well characterised. All of the above lead to the main 
hypothesis in this study: that the lean and obese patients with OA differ on the 
molecular, cellular and structural level in the local tissues within the knee joint. The 
main aims to prove that were: 
 To investigate the production of obesity-related markers (on gene and protein 
level) by tissues within the knee joint mainly: 




 To characterise the immune cell profile of local adipose tissues surrounding 
the knee joint with regards to obesity.  
 To investigate local changes in bone microstructure in lean and obese OA 
patients. 
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 Materials and methods 
2.1 Materials:  
2.1.1 List of reagents 
Table 1 List of reagents 
Tissue and cell isolation/cell culture reagents 
Product Company 
PBS (Phosphate buffered saline) SigmaAldrich 
0.01% Tween 20 ® (Polysorbate 20 
Surfactant) 
SigmaAldrich 
Trypsin with 0.25% EDTA 
(EthyleneDiamineTetraacetic Acid) 
Life Technologies 
Collagenase II Life Technologies 
IMDM (Iscove’s Modified Dulbecco’s 
Medium) 
Life Technologies 
DMEM (Dulbecco’s Modified Eagle 
Medium) 
Life Technologies 
Trypan Blue Fluka 
100x PenStrep (Penicilin/Streptomycin) Life Technologies 
100x Anti/Anti (Fungizone+ 
Penicilin/Streptomycin) 
Life Technologies 
FBS (Fetal Bovine Serum) Life Technologies 
Collagenase I  Life Technologies 
HBSS (Hanks’ Balanced Salt Solution) SigmaAldrich 
Red Cells Lysis Buffer  BD Bioscience 
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RNA isolation/DNA synthesis/agarose gel electrophoresis/PCR reactions reagents 
Qiazol Qiagen 
Chloroform SigmaAldrich 
Isopropyl alcohol SigmaAldrich 
Ethanol SigmaAldrich 
DNA/RNA-se free water SigmaAldrich 
Qiagen Mini RNA isolation kit Qiagen 





EDTA (Ethylenediaminetetraacetic acid) SigmaAldrich 
Sodium acetate SigmaAldrich 
Formaldehyde SigmaAldrich 
iScript BioRad 
DNAse I kit Life Technologies 
TopTaq Qiagen 
SYBRStain Life Technologies 
Tris Base SigmaAldrich 
DNA ladder BioLabs 
iTaq Master Mix Bio-Rad 
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Protein isolation/SDS-PAGE/Western Blot reagents 
Protease inhibitor Thermo Scientific 




BSA (Bovine Serum Albumin) SigmaAldrich 
Bradford Reagent Bio-Rad 
Acrylamide/Bis-Acrylamide 19:1 (40%) SigmaAldrich 




2x Laemmli Denaturating Buffer SigmaAldrich 
Protein marker (PageRuler) ThermoScientific 
Methanol SigmaAldrich 
Odyssey Blocking Buffer Li-COR 
Boric Acid SigmaAldrich 
SDS (Sodium Dodecyl Sulfate) SigmaAldrich 
 
ELISA reagents 
Human Total Adiponectin/ARP 
Quantikine ELISA kit 
R&D System 
Human MCP-1 Mini Elisa Development 
Kit 
Peprotech 
ABTS Liquid Substrate ( 2,2'-azino-bis(3-
ethylbenzothiazoline-6-sulphonic acid)  
SigmaAldrich 
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IHC/IF/ Flow Cytometry reagents 
Citric Acid Monohydrate SigmaAldrich 
Sodium citrate SigmaAldrich 
30% Hydrogen Peroxidase solution 
(H2O2) 
SigmaAldrich 
Dako Blocking Solution Dako 
Dako Diluent Dako 
DAB(3,3’-Diaminobenzidine) Buffer Cell Signalling 




DPX mounting medium Fluka 
Formaldehyde SigmaAldrich 
 
2.1.2 List of solutions 
Table 2 List and recipe of solutions. 
Buffer/Solution Recipe 
10xTBE buffer 108g Tris Base, 55g Boric Acid, 40ml 0.5M EDTA, 
ddH2O up to 2 litres adjusted for pH=8.0 
10xMOPS 41.9g MOPS, 8.2g sodium acetate, 3.72g EDTA up to 
1l ddH2O adjusted for pH=7.0 with NaOH 
The Role of Severe Obesity in Osteoarthritis 




100ml 10xMOPS buffer, 20ml 37% formaldehyde, 
880ml ddH20, stored in the dark. 
Protein lysis buffer 880µl PBS, 100µl 1xRIPA buffer, 10µl 100x protease 
inhibitor cocktail, 10µl 100x phosphatase inhibitor 
cocktail for 1ml 
Separating buffer 90.75g Tris, 2.5g SDS and 500ml ddH2O up to 500ml 
for pH=8.8 
Stacking Buffer 30.25g Tris, 2.5g SDS and 500ml ddH2O up to 500ml 
for pH=6.8 
10x Electrode buffer: 30g Tris, 72g Glycine, 10g SDS stored at 4oC for 1l  
Transfer Buffer 3.03g Tris, 14.4g Glycine, 200ml Methanol and 800ml 
ddH2O for 1l 
Peprotech ELISA 
Blocking Buffer 
2g BSA in 100ml PBST. (2%BSA in PBST) 
Peprotech Diluent 0.1g BSA in 100ml PBST (0.1% BSA in PBST). 
0.1M Citric acid 21g of citric acid monohydrate up to 1l of ddH2O 
0.1M Sodium Citrate 29.4g of sodium citrate up to 1l of ddH2O 
Citric Buffer 18ml of 0.1M of Citric acid and 82 ml of 0.1 M sodium 
citrate diluted in 1l of distilled water at pH=6 
Scott's Tap Water 30g of MgSO4, 2g of NaHCO3 up to 3l of ddH2O 
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2.2 Methods: 
2.2.1 Patient recruitment. 
Samples from consented patients undergoing primary total knee replacement surgery 
(TKR) for OA were collected. Local approval was granted for the study by the 
Lothian Research Ethics Committee and NHS Lothian Research and Development 
Management. Patients’ summary is shown in Table 4: 
Table 3 Patients summary 





RT PCR 26 32±8 68±7 19/7 
qRT PCR 20 32±10 65±11 15/5 
WB 20 32±8 68±8 13/7 
IHC 13 32±11 66±9 9/4 
Flow Cytometry 36 32±9 67±10 18/18 
µCT 24 35±10 67±6 13/11 
 
2.2.2 Tissue preparation and storage 
Tissues obtained during TKR were harvested by the surgeon and stored in Dulbecco 
Modified Media with an antimicrobial and antifungal solution (1xAnti/Anti) solution 
at 4oC for up to 1 hour after the surgery. All tissue explants for RNA and protein 
analysis were snap-frozen in Liquid Nitrogen and stored at -800C until testing. 
2.2.3 Cell culture 
All cell culture work was performed in laminar flow hoods and cells were cultured at 
370C with 5% CO2 in a specific medium. 
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2.2.3.1 Media and cell culture solution 
Anti-Anti: Penicillin 100 U/ml Streptomycin 100µg/ml and Fungizone 25ng/ml 
Chondrocyte primary medium: Iscove’s Modified Dulbecco’s Medium (IMDM) 
supplemented with 10% FBS and Anti-Anti solution. 
Standard chondrocytes medium: IMDM supplemented with 10%FBS and 100 
U/ml/100µg/ml Penicillin/Streptomycin (P/S). 
Osteoblast media: Dulbecco’s Modified Essential Medium (DMEM) supplemented 
with L-Glutamax 10%FBS and 100 U/ml/100μg/ml P/S. 
Serum Free media: IMDM with 10%FBS and 100 U/ml/100µg/ml P/S, without FBS. 
2.2.3.2 Isolation of chondrocytes from human femoral condyles and 
human tibial plateaus 
 
Cartilage from end-stage OA patients (OA diagnosed by an orthopaedic surgeon 
based on X-ray) were collected using sharp dissection to remove it from the tibial 
plateaus and the femoral condyles of the knee joints (n=20 or different when stated). 
Residual macroscopically non OA-affected-looking cartilage was selected, pooled 
and cut into small square pieces approximately 1-2mm2 and soaked for up to 1.5 hour 
in antimicrobial and antifungal solution (Anti-Anti) at room temperature. Cartilage 
fragments were then washed twice with sterile PBS and incubated for 30 min in 
10 ml of 0.25% Trypsin with EDTA at 370C with 5% CO2. Trypsin was removed and 
the cartilage pieces were washed twice with sterile PBS and incubated overnight in 
10ml 4mg/ml Collagenase II in IMDM media in 370C with 5% CO2. After complete 
digestion of the cartilage, the cells were collected in 50ml falcon tubes and strained 
through a sterile metal strainer, washed with PBS, centrifuged 5min at 300g. The 
remaining pellet was rinsed with PBS twice and centrifuged, after straining through a 
70µm strainer (Fisher Scientific, UK) cells were resuspended in 1ml IMDM, counted 
using Trypan Blue and seeded dependent on the size of the culture vessel. For 75cm2 
flask 3x106 cells were plated. For 6-well plate 380.000 cells per well were plated. 
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Cells were cultured for two days in chondrocyte primary medium (supplemented 
additionally with Fungizone) which was replaced on day 3 with standard 
chondrocyte medium.  
2.2.3.3 Isolation of osteoblasts from human femoral condyles 
The osteoblast were obtained from minimally OA-affected subchondral bone from 
lateral patellofemoral compartment of the knee. Bone was cut into approximately 2-
3mm sized pieces using rongeurs and forceps to remove any bone marrow. Bone 
chips were shaken vigorously in PBS, allowed to settle and the PBS decanted off and 
replaced with fresh PBS. The procedure was repeated 4 to 5 times until all visible 
bone marrow had been cleared. The bone fragments were then placed in 75cm2 
culture flasks containing 20ml osteoblast media. Bone chips were incubated for 7 
days without disturbance. The medium was then changed and the pieces were 
incubated for another 7 days, after 14 days the media was changed every 2-3 days. 
Once the cells reached confluence after 3-4 weeks of culture 3 ml of Trypsin-EDTA 
solution was added to harvest the adherent osteoblasts (for up to 5 min at 370C), 
10ml of osteoblast media was added and the suspension was collected and 
centrifuged at 250g for 5 min at room temperature. The supernatant was discarded, 
the cell pellet re-suspended in 1ml of osteoblast media before being passed through 
70µm filter. The cells were counted with a haemocytometer and Trypan Blue and 
seeded at the required density, usually at 5000 cells/cm2. The cells were maintained 
up to the 5th passage.  
2.2.4 Purification of total RNA from human primary cells 
(chondrocytes, osteoblasts) and tissues (synovium, 
IPFP) 
2.2.4.1 Purification of total RNA from primary cells (chondrocytes and 
osteoblasts) 
Phenol/chloroform based techniques and commercially available kits were used to 
isolate RNA from cells and tissues. The standard Qiazol method was used for mRNA 
isolation from chondrocytes and osteoblasts. Confluent cells were washed once with 
sterile PBS. 1 ml of Qiazol per 75 cm2 flask (or 500 µl per well for 6-well plates) 
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was added to the flask and scraped with a cell scraper to ensure the removal of any 
cell material adherent to the flask. The suspension was then incubated at RT for 
2 minutes and spun down at 10,000g for 3 minutes to remove insoluble debris. 200μl 
of Chloroform per 1ml QiaZOL was added to the supernatant after debris disposal. 
The suspension was mixed by vortexing for 30 seconds, incubated for 2 minutes at 
RT and centrifuged at 10,000g for 20 minutes. Following the centrifugation, the 
mixture separated into three phases: a lower red phenol-chloroform phase containing 
proteins, an inter-phase containing DNA and a colourless upper aqueous phase 
containing RNA. For mRNA extraction the aqueous phase was collected and gently 
removed to another sterile 1.5ml RNAse-free tube. An equal volume of isopropyl 
alcohol was added, mixed well, incubated for 10 minutes at RT and centrifuged at 
maximum speed for 10 minutes. The supernatant was then discarded and the 
remaining pellet was washed twice with 1 ml of 70% ethanol and centrifuged for 
5 minutes at max speed. After the centrifugation, the 70% ethanol was discarded and 
the pellet was air-dried for 5-10 minutes and dissolved in RNAse/DNAse free water.  
2.2.4.2 Fatty tissues (synovium and IPFP) mRNA isolation by 
combination Qiazol and Qiagen Mini RNA isolation kit 
With fatty tissues, the mRNA Qiazol technique appeared to be insufficient for 
obtaining clean, non-degraded mRNA. However, the combined Qiazol and Qiagen 
Mini RNA isolation kit technique yielded good RNA purity and stability. 1ml of 
Qiazol was added to up to 200mg of synovium or IPFP (snap frozen in Liquid 
Nitrogen (LN2) and homogenised by mortar and pestle). The suspension was then 
incubated at RT for 2 minutes, vortexed vigorously several times and spun down at 
10,000g for 3 minutes to remove insoluble debris. 200μl Chloroform was added to 
the supernatant after debris was removed. The suspension was mixed by vortexing 
for 30 seconds, incubated for 2 minutes at RT and centrifuged at 10,000g for 
20 minutes. Following centrifugation, the upper aqueous phase was transferred to a 
new Eppendorf and an equal volume of 100% ethanol was added. All of the mixture 
was then transferred to the column provided by the supplier (Qiagen Mini RNA 
isolation kit) and spun at >10.000g for 15 seconds. The column was then washed by 
adding 700 µl of the ‘RWI©’ washing buffer, spun at 10.000 g for 15 seconds, 
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followed by addition of 500 µl RLT buffer and centrifugation for 15s and then for 
2 min at 10.000g. Finally, mRNA was recovered from the column by adding 20-50 
µl of RNAse-free water and spinning >10.000 g for 1 min. 
2.2.4.3 RNA yield and purity by NanoDrop spectrophotometer 
RNA yield and purity were assessed by spectrophotometry using a NanoDrop 
spectrophotometer (Labtech, UK). The absorbance was measured at wavelength 260, 
280 and 230 nm. The absorbance ratio of RNA samples at 260/280nm in a range of 
1.7-2.1 and absorbance ratio at 260/230nm 1.7-2.1 were considered as highly pure.  
2.2.4.4 RNA stability check 
The integrity of RNA was checked by running a RNA Denaturating agarose gel 5 µg 
of RNA was dissolved in 2xRNA Denaturating Loading Buffer and incubated 5min 
at 650C. A Denaturating Agarose Gel was prepared by adding 0.5g agarose to 36ml 
of ddH2O and microwaving for 2-3 min in order to dissolve the agarose. 14ml of 
MOPS Running Buffer was added to the pre-cooled agarose under the fume hood, 
and 1µl of 10,000x concentrated SyberSafe stain (Invitrogen) which was used to 
visualize the RNA under the ultra-violet (UV) image analyser. The gel was allowed 
to cool down. Electrophoresis was conducted in 1xMOPS Buffer in horizontal gel 
electrophoresis system (Bio-Rad). An example of RNA stability test see Appendix 1. 
Two main bands of RNA were detected 28S rRNA and 18S rRNA (Appendix 1). 
RNA was stored in -800C. 
2.2.5 cDNA synthesis and DNAse I treatment 
A total of 1µg of RNA was reverse transcribed. To remove genomic DNA 
contamination the RNA was treated with 1 µl of DNAse I and 1µl of 
10x DNAse I buffer for 15 minutes at room temperature. To stop the reaction, 1µl of 
200µM EDTA was added and samples were further incubated at 650C for 10 min in 
order to deactivate DNAse I activity. cDNA synthesis was prepared according to the 
iScript manufacturers protocol: 1µl of RT enzyme, 4 µl of 5x RT Buffer (which 
contained random oligo-dT) and 2 µl of water was added to the sample and incubated 
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in a thermocycler in following temperatures: 5min in 250C, 30 min at 420C and 5 min 
in 850C. Samples of cDNA were stored in -200C. 
2.2.6 Reverse Transcription Polymerase Chain Reaction (RT-
PCR) 
RT-PCR was prepared according to the protocol provided by the manufacturer. The 
TopTaq polymerase reaction was prepared by adding 12.5 µl of TopTaq Buffer (2x), 
2.5 µl TopTaq Dye (10x), 1 µl diluted cDNA (10-25ng), 2 µl of mixed primers of 
interest (Forward and Reverse both 10µM), 7µl RNAse free water. The PCR reaction 
was conducted as follows: 
 Initial Denaturation Temperature:  95 oC -   3 min 
   
Denaturation Temperature:  95 oC -  30sec 
Annealing Temperature: 55-62 oC -  30-45 sec       35-40 cycles 
Extension Temperature:  72 oC -  1 min 
 
       Final Extension Temperature: 72oC - 1 min          
 Hold:     4 oC -  ∞ 
       
The nucleotide sequence of the primers used in this study: see Appendix 2. 
2.2.6.1 DNA agarose gel electrophoresis 
Following PCR the amplified products were resolved in 2% agarose gel in 0.5xTBE. 
10,000 x diluted SyberSafe stain (Invitrogen) was used to visualize the DNA under 
UV image analyser. 12-20 µl of the sample was loaded into a gel and the 
electrophoresis was maintained at a constant voltage of 110V for 40-50 min in 
running buffer-0.5xTBE in horizontal gel electrophoresis system (Bio-Rad). In order 
to measure the molecular weight (MW) of the PCR product 1 µl of DNA ladder was 
loaded onto the gel (100bp DNA Ladder, BioLabs). Following electrophoresis the 
DNA bands were visualized under UV light and the photographs of the agarose gels 
were taken from the gel documentation system. In the present study 
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Glyceroaldehyde-3-Phosphate Dehydrogenase (GAPDH) was used as a 
housekeeping gene to normalise gene expression in RT-PCR. 
2.2.7 Real Time PCR (qPCR) reaction 
Quantitative analysis of mRNA expression was performed by real time PCR (qPCR), 
which used the intercalating dye SybrGreen during polymerase chain reaction. cDNA 
of samples were prepared as in section 2.2.5 A relative gene expression was analysed 
according to fold change method (Livak et al., 2001). Primer efficiency was 
calculated before qPCR reaction (Appendix 3). Only primers with an efficiency of 
95-105% were used. SybrGreen master mix was purchased from BioRad and the 
manufacturer’s protocol was followed. Primer sequences are described in Appendix 
3. The reagents were prepared as follows: 
 1 µl of cDNA (10-25ng) 
 4 µl of Master Mix Buffer (which contains Taq polymerase and SYBRGreen) 
 1 µl of mixed  primers (final concentration 10µM each)  
 2 µl water   
The analysis was performed on the LightCycler 96 (Roche). The reactions were 
performed in triplicates for each analysed gene. Reactions employing SYBRGreen 
chemistry were subjected to melting curve analysis. Only one product was detected 
and analysed. Target gene expression was normalized using reference gene Beta-2 
Microglobulin (B2M).  
2.2.8 Protein purification 
2.2.8.1.1  Cell lysis for protein extraction 
Confluent cells were washed twice with cold PBS. 400 µl protein lysis buffer was 
added to 75cm2 cell culture flask (or 200µl per a well from 6-well plate). Cells were 
scraped, incubated for 30 min at 40C and centrifuged at 12,000g for 10 min at 40C in 
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order to get rid of all debris. The supernatant was collected and stored in -800C. The 
protein concentration was assessed using the Bradford Assay. 
2.2.8.1.2  Tissues lysis for protein extraction 
Fatty tissue was collected and snap frozen in Liquid Nitrogen (LN2). 0.2-0.5 g was 
homogenized by mortar and pestle with the addition of liquid nitrogen (LN2). 300µl-
500µl of Protein lysis buffer was added. The lysate was kept for 30min at 40C, 
vortexed several times and then centrifuged at 12,000g 10 min at 40C in order to get 
rid of all debris. The supernatant was collected and stored in -800C. The protein 
concentration was assessed using the Bradford Assay. 
2.2.8.1.3  Bradford Assay 
Protein concentration from either cell culture or tissue lysate was analysed using the 
Bradford assay (BioRad). 1µl of lysate was diluted in 4µl of water. A protein 
standard curve was prepared by serial dilution of Bovine Serum Albumin (BSA) with 
a starting concentration 1µg/ml in water in a range from 1000-62.5 ng/ml. 5 µl of 
each diluted sample (1:5) and standard in triplicates was added to 250µl Bradford 
reagent in 96-well microplate and incubated for 5 minutes at RT. Absorbance was 
read at 595nm on microplate reader iMARK (Bio-Rad, Japan).   
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2.2.9 Western Blot 
2.2.9.1 SDS-PAGE (Sodium Dodecyl Sulfate PolyAcrylamide Gel 
Electrophoresis) 
SDS-PAGE was carried out on the Small Biorad System. In brief, 12% 
Acrylamide/Bis-Acrylamide gel was prepared using the following protocol. The 
separating gel was prepared by adding 9ml of water to 6 ml of 
acrylamide/bisacrylamide followed by 5ml of Separating buffer, 100µl Ammonium 
Persulphate (AMPER) and 10µl Tetramethylethylenediamine (TEMED). Gels were 
allowed to polymerise for 30-45 min. The stacking gel was prepared by adding 
6.5 ml of distilled water, 1ml of acrylamide/bisacrylamide and 2.5ml of Stacking 
buffer followed by 50µl AMPER and 10µl TEMED. The gel was poured, the comb 
aligned and the gel was allowed to cool down and polymerise for the next 30min. 
50 µg of samples were diluted (1:1) in Laemmli Denaturating Loading Buffer (which 
contains β-mercaptoethanol), incubated at 1000C for 5 min and then chilled on ice in 
order to denature proteins. Molecular marker and samples were loaded into the gel 
wells. The gel was run for about 30 min at 80V until samples had passed through the 
stacking gel and had reached the top of the separating gel. The voltage was then 
increased to 135V and electrophoresis continued for 1-2h. 
2.2.9.2 Electrophoretic transfer 
After electrophoresis gels were allowed to equilibrate for 10-15 min in Transfer 
Buffer. Polyvinyl (PVDV) membranes were soaked for 10s in 100% methanol. The 
transfer sandwich was prepared with using buffer soaked fiber pads and filter papers 
(Whatman). 
The cassettes were assembled in BioRad TransferSystem filled with Transfer Buffer. 
The cooling unit was inserted in order to keep a cold temperature during the transfer. 
Proteins were transferred for 1 hour at 100 V.  
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2.2.9.3 Blocking and antibody incubation 
Following transfer, membranes were washed in PBS for 5 min in order to remove 
methanol traces and blocked in Odyssey Blocking buffer solution in PBS (1:1). 
Membranes were then incubated with appropriate primary antibody overnight at 40C. 
After washing 3 times in PBST membranes were incubated with the appropriate 
fluorescent conjugated secondary antibody (Li-Cor) (diluted 1:10,000) for 1h at RT 
and then washed 3x in PBST (for antibody dilution see Appendix 4). An Odyssey Fc 
Imager was used for detection and quantification of bound fluorescent antibody. To 
test non-specific binding of secondary antibodies the whole protocol was carried out 
in the absence of primary antibody. No binding was detected. 
2.2.10 Tissue explant culture 
Articular cartilage, synovium and IPFP were harvested under sterile condition after 
TKR surgery. Tissue was cut into 1-3mm3 fragments, weighed and washed 
intensively with sterile PBS before culturing for 1 day in Seeding Medium. Explants 
were cultivated for 3 days in serum-free medium. To analyse protein secretion, the 
medium was collected, spun at 500g for 5 min at RT to remove floating cells and 
debris. The remaining supernatant was stored in -800C. 
2.2.11 Enzyme-Linked Immunosorbent Assay (ELISA) 
Commercially available ELISA kits were used. For adiponectin detection, Human 
Total Adiponectin/Arcp30 Quantikine ELISA kit was used. Primary antibody pre-
coated wells were incubated with standard or sample diluted in Diluent at room 
temperature for 2h, washed 4 times with Wash Buffer, before addition of 200µl of 
conjugate and incubation for 2h at RT. Plates were washed 4 times, incubated 20 min 
with 200 µl of substrate solution in the dark. The reaction was stopped by addition of 
stop solution and the results were recorded by absorbance reading at 450nm and 
570nm for colour correction on microplate reader iMARK (Bio-Rad, Japan). 
For MCP-1/CCL2 ELISA commercially available Peprotech Human MCP-1 Mini 
Elisa Development Kit was used. 100 µl of capture antibody at 0.25µg/ml in PBS 
was added to each ELISA plate well and incubated overnight at room temperature. 
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Next day the plate was washed 4 times using 300µl/well of PBST before incubation 
with 300µl Peprotech ELISA Block Buffer for 2 hours at room temperature. After 
blocking, the plate was washed 4 times with PBST and incubated with 100µl 
standard or sample diluted in Peprotech Diluent for 3 hours at room temperature 
followed by 4 washes with PBST. Detection was conducted by adding 100µl of 
Peprotech Detection Antibody conjugated with biotin at a concentration of 0.5µg/ml 
in Peprotech Diluent for 2 hours at room temperature. The plate was then washed 
4 times with PBST before incubation with 100µl of Avidin-HRP diluted in Peprotech 
Diluent for 30min at room temperature. A final 5 washes with PBST were followed 
by addition of 100µl of ABTS Liquid Substrate and incubation at room temperature 
for colour development. The results were recorded by absorbance reading at 415nm 
and 650 nm for colour correction on microplate reader iMARK (Bio-Rad, Japan). 
The explant culture data were calculated by division of the concentration per wet 
weight of the tissue. 
2.2.12 Immunofluorescent staining (IF) 
Passage 0 chondrocytes were seeded at high density on coverslips in a 12-well plate 
and cultured for 10-14 days. Cells were washed in PBS and fixed in Cell Fixing 
Solution for 10 min at -200C, cells were then air dried, washed in PBS and blocked in 
Dako Blocking Solution for 30min at RT. Incubation with primary antibody was 
conducted overnight at 40C, followed by 3xPBST washing and incubation with 
secondary fluorescent dye-conjugated antibody for 1h at RT in the dark. Coverslips 
were washed three times with PBST then incubated for 10 min in DAPI solution 
(1:5000 in distilled water) at RT and analysed using a Fluorescent Microscope 
(Nikon E800) (For antibody dilution see Appendix 4). 
2.2.13 Immunohistochemistry (IHC) of paraffin embedded 
sections 
2.2.13.1 Tissue collection and proceeding. 
Explants from synovium, IPFP, cartilage and bone were collected after surgery and 
washed extensively in an antimicrobial solution (Anti/Anti). Tissues were then fixed 
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in 4% formaldehyde for 24 hours at RT. Following three washes with PBS all tissues 
except bone explants were then processed and embedded in paraffin by a Histology 
Service (Breakthrough Western General Hospital). Fixed bone samples were 
decalcified for up to 2 weeks in 10% EDTA (pH=7.4) with changing of the solution 
every 3-4 days before embedding. Paraffin blocks were cut into 5µm sections, which 
were deparaffinised and rehydrated sequentially using: HistoChoice (equivalent for 
Xylene) for 10min twice, 100% ethanol for 2 min twice, 80% ethanol for 2 min, 50% 
ethanol for 2 min and water for 30 seconds. 
Antigen retrieval was performed to reverse epitope masking. Antigen retrieval was 
performed in a pressure cooker (Northware). Tissue sections were incubated in a 
pressure cooker in Citric buffer (pH=6.0 see 2.1.2 List of Solution) pre-warmed for 5 
min in the microwave. After pressure release slides were left to cool for 25 min and 
then incubated in 0.04 M H2O2 solution for 10 min to block the endogenous 
peroxidase activity of tissues enzymes. Slides were then washed once in PBS for 5 
min and blocked in Dako Blocking Solution for 30 min at RT.  
Sections were incubated with appropriate primary antibody diluted in Dako Diluent 
overnight at 40C with final dilution usually 1:100 (or otherwise as stated see 
Appendix 4). On the following day, slides were washed three times with PBST for 
5 min, incubated with secondary antibody conjugated with Horseradish Peroxidase 
(HRP) for 1h at RT (dilution 1:1000). Sections were then washed three times for 
5 min in PBST. Chromogenic substrate 3,3’-Diaminobenzidine (DAB) was used to 
develop colour. 30µl of DAB was added to 1ml of DAB Buffer. 100µl of the DAB 
reagent mixture was applied onto the section. Sections were stained 5-10min 
depending on colour development. Sections were then washed with distilled water 
and counterstained by incubation in a Harris Hematoxylin solution for 10 seconds, 
followed by 20 seconds tap water washing and incubation for 20 seconds in Scott's 
Tap Water (see 2.1.2 List of Solutions). Slides were then dehydrated in serial 
changes of ethanol and HistoChoice: 50% ethanol for 30 sec, 80% ethanol for 30 sec, 
100% ethanol for 2 min twice and HistoChoice for 10min twice. Sections were then 
mounted in a DPX mounting medium. 
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2.2.13.2 IHC Scoring 
IHC stained cartilage sections were subject to analysis by blind researcher and 
confirmed by trained pathologist. The intensity of staining was scored as follows: 0- 
no staining up to 4-very high-intensity staining.  
2.2.14 Flow cytometry analysis 
2.2.14.1 Tissue digestion 
Tissues (synovium and IPFP) were harvested after TKR as previously described. The 
stromovascular fraction (SVF) from each tissue was obtained as follows: About 1-3 g 
of tissue was intensively washed with sterile PBS and minced finely with scissors 
and scalpel blade into 1-2 mm3 pieces which were then incubated for 1.5 h at 370C in 
2 mg/ml collagenase I and II mixture in 0.5% BSA in Hanks’ Balanced Salt Solution 
(HBSS) with calcium and magnesium. After digestion, the solution was passed 
through a sterilised metal strainer and centrifuged at 300g for 5 min at RT. The pellet 
after centrifugation was re-suspended in PBS and passed through a 100 µm strainer 
(Fisher) and centrifuged at 300g for 5 min at RT before addition of 1ml Red Cells 
Lysis Buffer for 10-15 min. The cell suspension was then washed with PBS and 
centrifuged at 300g for 5 min. The remaining pellet was resuspended in PBS and 
passed through a 70 µm strainer (Fisher). Cells were then diluted in order to obtain a 
density of approximately 0.5-1 million cells per 1 ml and assessed with 
Immunofluorescent Flow Cytometry Staining. 
2.2.14.2 Immunofluorescent Flow Cytometry Staining 
100 µl of cells were incubated with appropriate concentrations of specific antibody 
or antibody isotype control for 30 min at 40C in the dark. The standard antibody 
dilution was 1:100. Cells were then washed twice with PBS and centrifuged at 300g 
at RT and analysed by Flow Cytometry (for antibody dilution see Appendix 4). 
Beckman-Coulter XL Flow Cytometer was used to obtain results. Minimum 
50000 events were collected with using electronic Gate to exclude debris and dead 
cells so the data for a minimum of 10000 ‘live’ events occurred in the gate (Live 
cells gate). Data for all events were collected. The example of gating strategy is 
shown in Appendix 5. The compensation to exclude overlap between fluorescent 
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channels for two and three colour staining was applied post-acquisition using single 
colour stained by FCS Express Flow Cytometry 5 software (Example in Appendix 
5).  
2.2.15 Micro-Computed Tomography (μCT) analysis of 
Femoral Condyles from OA patients 
2.2.15.1 μCT imaging, reconstruction and analysis of Femoral 
Condyles of OA patients 
Minimally or non OA-affected posterior lateral femoral condyles obtained after TKR 
was collected and stored in -200C until analysis (as previously described). The tissues 
were placed in Skyscan ® 1172 micro-CT scanner (SkyScan, Belgium) and bone 
microstructure was evaluated using following parameters: the beam set 70kV, 
140µA, and a 6.71 µm pixel size with 0.5mm aluminum filter. Image reconstruction 
was conducted using to Skyscan ®NRecon software and analysed by Skyscan 
®CTan software. For μCT parameters evaluation 3mm3 VOI (voxel of interest) was 
chosen in the middle of the condyle below subchondral plate region as shown in 
Figure 7.2. 
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2.3 Statistical analysis 
For semi-quantitative analysis of RT-PCR, the densitometry analysis was performed 
using Image J analysis software (NIH). The intensity of the bands taken from 
photographs was recorded by the software. For Western Blot data, semi-quantitative 
analysis of bands intensity was performed by Image Studio Lite Software v.5.0. The 
arbitrary values of the band intensities obtained by the software were used for 
mathematical calculation for the expression of the gene and protein of interest. The 
ratio of the values between the gene of interest and housekeeping gene was 
considered as a ratio of gene expression. The ratio of the values between the protein 
of interest and reference protein was considered as the ratio of protein expression. 
All statistical analysis was performed using GraphPad (Prism 6.0, USA). Differences 
in gene expression by RT-PCR, Real Time PCR, IHC scoring, semi-quantitative WB 
protein expression, ELISA protein secretion, Flow Cytometry analysis and µCT 
parameters were assessed for unpaired sample by Mann-Whitney U test and 
Wilcoxon matched paired test were used to compare linear variables between groups 
and Spearman's rho correlation was used to assess the association between linear 
variables p-value < 0.05 was considered to indicate statistical significance.  
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 The differences in obesity-related 
markers expression in chondrocytes and 
cartilage from lean and obese OA patients 
3.1 Introduction 
 
The key molecular factors in OA and obesity interaction have not been fully 
described. Since obesity and osteoarthritis are multidimensional diseases, no single 
shared molecular marker has been identified. In fact, a large range of proteins has 
been postulated to play a role in a crosstalk between adipose tissue and cartilage 
(Conde et al., 2014; Sartori-Cintra et al., 2014; Conde et al., 2015). The purpose of 
this analysis was to screen possible gene and protein candidates, which may play an 
important role in adipose tissue and cartilage interaction. 
Cartilage is very specific yet a very difficult tissue to analyse. Its three-dimensional 
structure which is mainly made up of the matrix with only a relatively small number 
of cells makes it very hard to investigate using standard molecular biology 
techniques including mRNA and protein isolation. Hence, the culture of chondrocyte 
monolayers is a widely used technique in gene and protein expression studies of 
cartilage biology (Owen et al., 2008; Zeggini et al., 2012), though this has limitations 
as it does not mimic the 3D cartilage environment it can be useful for preliminary 
examination. Chondrocytes isolated by cartilage digestion, kept at the lowest 
passage, maintain chondrogenic gene expression including Type II Collagen 
(COL2A1) and Aggrecan (ACAN) (Ono et al., 2013) and can be a potential model in 
OA studies (Marlovits et al., 2004). However, with further passaging these 
chondrocytes loose chondrogenic potential (de-differentiate) and become fibroblasts 
(Caron et al., 2012). 
In the present study, genes and protein candidates, which could play an important 
role in obesity’s contribution to OA were screened. Chondrocyte gene expression of 
the main adipokines, including adiponectin (ADIPOQ), leptin (LEP), visfatin 
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(NAMPT), chemerin (TIG2), lipocalin 2 (LCN2) and some of their reported 
receptors such as ADIPOR1, ADIPOR2 (for adiponectin), LEPR (for leptin) and 
CMKLR1 (chemokine-like receptor 1) (for chemerin) were investigated. 
Additionally, the gene expression of two important nuclear factors which play a role 
in adipogenesis: namely PPARγ (Peroxisome Proliferator-Activated Receptor γ) and 
C/EBPβ (CAAT/Enhancer-binding protein β) was analysed. Also, reported pro-
inflammatory chemokine CCL2/MCP-1 and recently described genes such as FTO 
(fat-mass associated gene) connected with obesity and OA, TN-C (tenascin C) 
postulated to be up-regulated during cartilage damage (Nakoshi et al., 2010), surface 
markers such as VCAM1 (Vascular Cell Adhesion Molecule 1) which is an 
important adhesion molecule during lymphocytes migration to the site of 
inflammation(Conde et al., 2012) and TLR4 (Toll-like receptor 4) which is a key 
DAMP receptor and is postulated to play key role in both obesity and OA were 
investigated (Jialal et al., 2014; Gomez et al., 2015). 
At the protein level, 3 main candidates were investigated: visfatin, PPARγ, and 
CCL2. 
3.1.1 Aims 
One of the hypotheses of the present study was that the molecular pathways involved 
in osteoarthritis are different in obese and lean patients. Therefore, differences in 
expression of obesity markers were investigated in cartilage and chondrocytes of 
patients undergoing knee replacement surgery. The main aim of this part of the study 
was: 
1. To screen for gene expression of possible candidates for molecular 
players in the pathogenesis of the OA/obesity interaction.  
2. To find if there was a differential expression of obesity-related 
biomarkers in chondrocytes and cartilage from OA patients between 
obese and lean individuals. 
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3.2 Chondrocytes Gene Expression Analysis 
 
3.2.1 Semi-quantitative Reverse Transcription Polymerase 
Chain Reaction (RT-PCR) analysis  
3.2.1.1 Chondrogenic potential of chondrocytes in monolayer cell 
culture  
The human chondrocytes obtained after Collagenase II digestions were cultured in 
passage 0 up to 14 days. Before assessing the expression of obesity related genes in 
isolated chondrocytes RT-PCR for chondrogenic genes ACAN (Aggrecan) and 
COL2A1 (collagen type II) was used to confirm they retained chondrogenic potential 
(see Figure 3.1). 
 
Figure 3. 1 Expression of the chondrogenic marker in chondrocytes isolated from OA cartilage.  
Chondrocytes from monolayer cell culture at passage 0 maintain chondrogenic potential. Expression 
of chondrogenic genes: ACAN and COL2A1 next to reference gene GAPDH were presented in 8 
samples (Representative RT-PCR result for all analysed samples). L-lean patient, Ob- Obese patient. 
 
RT-PCR confirmed the maintenance of chondrogenic bio-markers (Figure 3.1) by 
isolated chondrocytes. Cultured chondrocytes do not de-differentiate. 
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3.2.1.2 Expression of obesity/OA-related genes by chondrocytes in 
monolayer cell culture  
The expression of obesity-related genes by chondrocytes was ascertained after 10-14 
days in monolayer cell culture using RT-PCR (see Figure 3.2). 
 
Figure 3. 2 Representative expression of OA/obesity-related genes in chondrocytes in monolayer 
culture.  
Expression of main adipokines ADIPOQ (adiponectin), LEP (leptin), TIG2 (chemerin), NAMPT 
(visfatin), LCN2 (Lipocalin 2), their receptors (ADIPOR1, ADIPOR2, CMKLR1, LEPR), chemokine 
monocyte-chemotactic protein 1 (CCL2), nuclear factors (C/EBPβ, PPARγ) and other inflammation-
related proteins: FTO, TN-C, TLR4 and VCAM1 was confirmed by RT-PCR in monolayer 
chondrocyte cell culture maintained at passage 0. A representative RT-PCR result is shown. 
 
Adiponectin (ADIPOQ) and leptin (LEP) expression was very low or undetectable, 
however, expression of their receptors ADIPOR1 and ADIPOR2 and LEPR was 
confirmed in cultured chondrocytes. mRNA for two adipokine genes; lipocalin 2 
(LCN2) and visfatin (NAMPT) was also detected. Chemerin (TIG2) and its receptor 
CMKLR1 (chemokine-like receptor 1) were expressed in chondrocytes as well.  
Chemokine Monocyte-Chemotactic Protein 1 (MCP-1) also called chemokine (C-C) 
ligand 2 (CCL2) and Fat mass associated gene (FTO), recently shown to correlate 
with OA progression, were also detected in OA chondrocytes. Transcription factors 
including CAAT Enhancer-Binding protein β (C/EBPβ) and Peroxisome Proliferator-
Activated Receptor γ (PPARγ) were also expressed in the human chondrocytes. 
Tenascin-C (TN-C) and two pro-inflammatory surface markers: Toll-Like Receptor 4 
(TLR4) and Vascular Cell Adhesion Molecule 1 (VCAM1), were also present in the 
cultured human chondrocytes (Figure 3.2). 
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3.2.1.3 Differences in gene expression in monolayer cell culture of 
chondrocytes from lean and obese patients with OA  
Chondrocytes were isolated from OA patients and classified into lean and obese 
groups on the basis of their BMI index. Patients with a BMI below or equal to 25 
were described as LEAN while patients with BMI equal to or above 35 were 
described as OBESE. Figures 3.3-3.6 show graphs describing the differential gene 
expression between the two groups. 
 
Figure 3. 3 Semi-quantitative PCR analysis of Adiponectin Receptors (ADIPOR1 and 
ADIPOR2) in chondrocytes obtained from Lean and Obese patient with OA. 
RT-PCR semi-quantitative analysis of ADIPOR1 and ADIPOR2 expression in OA patients. Two 
groups termed “Lean” n=8 for ADIPOR1 n=7 for ADIPOR2 and “Obese” n=12 were divided 
according to BMI. GAPDH was used as a reference gene. The distribution of data, mean ratio values 
(horizontal line) for each group and standard deviation (vertical line) (SD) bars are shown in A,B. The 
correlation between ratio values and BMI score are shown in C,D. p values < 0.05 were considered 
significant and indicated *. 
 
Chondrocytes isolated from both groups of patients expressed adiponectin receptors 
ADIPOR1 and ADIPOR2. Expression of ADIPOR1 was significantly higher in 
chondrocytes from obese as compared to lean patients whereas there was no 
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difference in ADIPOR2 expression. ADIPOR1 expression correlated significantly 
with BMI. 
 
The difference between ADIPOR1 and ADIPOR2 expression in chondrocytes was 
analysed further (see Figure.3.4) 
 
Figure 3. 4 Differences in expression of adiponectin receptors, ADIPOR1 vs ADIPOR2 in OA 
chondrocytes.  
RT-PCR semi-quantitative analysis of ADIPOR1 versus ADIPOR2 expression in OA chondrocytes. 
Representative RT-PCR results shown in (A). ADIPOR1 vs. ADIPOR2 expression in all obtained 
chondrocytes is shown in (B). Lean and Obese patients’ chondrocytes n=8 ADIPOR1 vs ADIPOR2 
expression is shown in (C, D). GAPDH was used as a reference gene. The mean ratio values for each 
group and standard deviation (SD) bars are shown in (B-D). The difference was analysed by Wilcoxon 
matched-pairs signed rank test. p-value <0.05 is indicated as *, p value<0.001 as ***. 
 
Conducting a semi-quantitative analysis of ADIPOR1 versus ADIPOR2 expression 
within chondrocyte samples from the same donor, showed that regardless of the BMI 
ADIPOR2 expression was significantly lower (p<0.001) than that of ADIPOR1. 
Comparing the expression of adiponectin receptors in chondrocytes from lean or 
obese patients showed that expression of ADIPOR1 was still significantly higher 
than ADIPOR2 in both groups (p<0.05 and p<0.001 respectively). 
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Figure 3. 5 Semi-quantitative PCR analysis of CCL2/MCP1, NAMPT (visfatin) and PPARγ in 
chondrocytes obtained from Lean and Obese patients with OA 
Semi-quantitative densitometry RT-PCR analysis of CCL2/MCP1, NAMPT (visfatin) and PPARγ 
expression in chondrocytes obtained from lean and obese patients. Two groups termed “Lean” n=8 for 
CCL2/MCP-1 and PPARγ n=9 for NAMPT and “Obese” n=12 for PPARγ and n=13 for CCL”/MCP-1 
and NAMPT were divided according to BMI. GAPDH was used as a reference gene. The sample 
distribution, the mean ratio values (horizontal lane) for each group and standard deviation (vertical 
lane) (SD) are presented (A-C). The correlation between ratio values and BMI score is shown (D-F). 
p values < 0.05 were considered significant.  
 
Semi-quantitative analysis by RT-PCR showed that expression of the CCL2/MCP-1 
gene was significantly higher in the obese as compared to the lean group. Whilst, 
NAMPT (visfatin) and PPARγ expression was significantly lower in chondrocytes 
from obese patients in comparison to lean ones. The correlation with BMI score for 
the ratio of CCL2/MCP-1/GAPDH expression was positive and that of 
NAMPT/GAPDH and PPARγ/GAPDH negative (Figure 3.5).  
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Figure 3. 6 Semi-quantitative PCR analysis of genes in chondrocytes obtained from different 
OA patients. 
Two groups termed “Lean” n=8 and “Obese” n=12 were defined according to BMI. GAPDH was used 
as a reference gene. The mean ratio values for each group and standard deviation (SD) are shown. 
 
The remaining genes that were investigated did not show any significant differences 
between lean and obese chondrocytes. 
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3.2.2 Quantitative Real Time (qRT) PCR analysis of obesity-
related genes in monolayer chondrocytes. 
Genes are shown by RT-PCR to have significantly different expression in 
chondrocytes between lean and obese patients were analysed using quantitative Real-
Time qPCR. cDNA from a new set of patients for each group (lean/obese) were 
analysed in triplicate and gene expression was normalized to housekeeping gene 
beta-2microglobulin (B2M). 
 
Figure 3. 7 Real Time qPCR analysis of ADIPOR1, CCL2/MCP-1, NAMPT and PPARγ 
expression in chondrocytes from lean and obese OA patients. 
Quantitative PCR analysis of ADIPOR1 (A), MCP-1/CCL2 (B), NAMPT (C) and PPARγ (D) 
expression in chondrocytes obtained from different OA patients (A-D). Two groups termed “Lean” 
n=10 and “Obese” n=10 were defined according to BMI as before. B2M was used to normalise gene 
expression. The -ΔΔCT method was used. The mean value of Lean Group was used as a calibrator to 
investigate fold change of gene expression. The ratio values of each group and SEM bars are shown. 
p values < 0.05 were considered significant and indicated as *. 
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Quantitative Real-time PCR data confirmed the semi-quantitative RT-PCR results. 
The expression of ADIPOR1 and CCL2/MCP-1 was significantly higher, whilst 
expression of NAMPT (visfatin) and PPARγ was significantly lower in obese as 
compared to lean patients. ADIPOR2 gene expression was also investigated by Real 
Time PCR and there was no difference between Lean and Obese OA patients. 
However, there was a significantly higher expression of ADIPOR1 than ADIPOR2 
confirming obtained RT-PCR data (data are shown in Appendix 6).  
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3.3 Differences in protein expression in Cartilage and 
Chondrocytes from OA patients 
3.3.1 Visfatin protein expression in cartilage and 
chondrocytes 
To determine whether the differences in gene expression were also seen at the 
protein level explanted tissue was subjected to immunohistochemistry (IHC) while 
monolayer chondrocytes to an immunofluorescence (IF) technique using specific anti 
visfatin antibody.  
 
Figure 3. 8 Visfatin expression in OA Cartilage and chondrocytes. 
Representative IHC and IF staining of visfatin protein expression in OA Cartilage (Brown colour) 
(A,B) and Chondrocytes (Green colour) (C,D). Both nuclear (arrowheads) and cytoplasmic (arrows) 
localisation of visfatin can be detected in monolayer cell culture. Isotype control staining are 
presented in Appendix 7. Blue colour indicates nuclear staining (using DAPI staining). 
 
Visfatin was detected in cartilage, and in monolayer chondrocytes culture. IF staining 
show both nuclear and cytoplasmic locations within chondrocytes in monolayer cell 
culture (see Figure 3.8).  
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Blinded scoring of visfatin expression in cartilage explants (0-4) was conducted on 
IHC stained sections (Figure 3.9).  
  
Figure 3. 9 Visfatin expression in lean and obese OA patients’ cartilage. 
The difference in visfatin protein expression (assessed using blinded IHC scoring) in cartilage from 
lean (n=6) and obese (n=7) patients (A). Data is presented as the dot plot. Representative IHC staining 
showing the difference in visfatin expression (Brown colour) between the cartilage from Lean (B) and 
Obese (C) patients.  
IHC scoring showed that visfatin protein expression in cartilage sections trended to 
be higher in lean as compared to obese patients. The semi-quantitative differences in 
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Visfatin protein expression were assessed further by Western Blot (Figure 3.10). 
 
Figure 3. 10 Visfatin expression in monolayer chondrocyte cell culture analysed by Western Blot 
technique.  
The results showed differences in visfatin expression between chondrocytes from lean and obese OA 
patients. Representative Western Blot results shown in A n=3 for each group. Semi-quantitative 
densitometry analysis of visfatin/B-actin ratios (n=5 for each group) (B). Data are presented as mean 
ratio ± SD. Statistically, significant differences between lean and obese group are indicated as * 
(*p<0.05). 
 
WB analysis showed that chondrocyte visfatin expression in obese OA patients was 
significantly lower than in lean OA patients. Confirming previous RT-PCR and 
qPCR data that visfatin expression was significantly lower in chondrocytes from 
obese in comparison to the lean OA patients.   
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3.3.2 PPARγ protein expression in cartilage and 
chondrocytes 
The expression of PPARγ protein was assessed using immunohistochemistry and 
immunofluorescence methods (Figure 3.11).  
 
Figure 3. 11 PPARγ expressions in OA Cartilage and chondrocytes. 
Representative IHC staining of PPARγ protein expression in OA Cartilage (Brown colour) (A,B) and 
in chondrocytes (green colour) (C,D). Both nuclear (arrowhead) and cytoplasmic (arrow) localisation 
of PPARγ were detected in monolayer cell culture. Isotype control staining are presented in Appendix 
7. Blue colour indicates nuclear staining (using DAPI staining). 
 
PPARγ was detected in cartilage, and in monolayer chondrocytes culture. IF staining 
show both nuclear and cytoplasmic locations within chondrocytes in monolayer cell 
culture (see Figure 3.8).  
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Blinded scoring of PPARγ expression in cartilage (0-4) was conducted on IHC 
stained sections (see Figure 3.12).
 
Figure 3. 12 PPARγ expression in OA cartilage of lean and obese patients. 
Blinded scoring of difference in PPARγ expression in cartilage from lean (n=4) and obese (n=3) 
patients (A). Data are presented as the dot plot. Representative sections from lean (B-D) and obese (E-
G) patients showing differences in PPARγ expression (Brown colour) in cartilage.  
 
IHC scoring showed that staining of cartilage sections was consistent with PPARγ 
expression trended to be lower in obese cartilage as compared to lean, however, the 
difference was not significant. Possibly the immunohistochemical technique was not 
sensitive enough to detect a difference between the cartilage from lean and obese 
patients.  
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Assessing the difference between PPARγ protein expression in chondrocytes from 
lean and obese groups semi-quantitatively by Western Blot analysis (Figure 3.13).
 
Figure 3. 13 PPARγ expression in monolayer chondrocyte cell culture analysed by Western Blot 
technique.  
The results showed the difference in PPARγ expression between chondrocytes from lean and obese 
OA patients. Representative Western Blot result for n=3 for each group shown (A). Semi-quantitative 
densitometry analysis of PPARγ/B-actin ratios (n=5) (B). Data are presented as the mean ratio ± SD. 
Statistically significant differences between lean and obese groups are indicated as * (*p<0.05). 
 
Semi-quantitative densitometry analysis suggested that the protein expression of 
PPARγ was significantly lower in chondrocytes from obese in comparison to lean 
OA patients concurring with the previously obtained PCR data. 
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3.3.3 CCL2 protein production by cartilage and chondrocytes 
CCL2 protein production by chondrocytes and cartilage explants was analysed by 
Enzyme-Linked ImmunoAssay (ELISA). Confluent chondrocytes were serum 
starved for one day and then incubated in Serum Free media for one day. Cartilage 
explants were also serum starved for one day and incubated in serum-free medium 
for 3 days. The supernatant was then collected and analysed using a commercially 
available ELISA kit (MCP-1 Peprotech Mini Elisa kit) (Figure 3.14). 
 
Figure 3. 14 MCP-1/CCL2 secretion by OA Chondrocytes in cell culture and Cartilage explants  
The quantitative ELISA of supernatant from chondrocytes and cartilage explants (n=5 for each group) 
from lean and obese patients show that CCL2 was produced by chondrocytes and cartilage explants. 
Data are presented as mean ± SD. Statistically significant differences between lean and obese group 
are indicated as * (*p<0.05). NS- not significantly different. 
 
Results from monolayer cultures (Figure 3.14) showed that OA chondrocytes from 
both groups were able to produce MCP-1/CCL2, though there was no significant 
difference between groups. However, cartilage explants from obese patients 
produced significantly more MCP-1/CCL2 than was found in the media collected 
from those of lean patients. 
  
The Role of Severe Obesity in Osteoarthritis 
 Doctoral Degree The University of Edinburgh 2016 
 66 
3.4 Conclusions and Summary 
In conclusion, the data obtained revealed a number of important points: 
1) Chondrocytes from patients with OA express a number of obesity-related 
genes including TIG2 (chemerin), NAMPT (visfatin), LCN2 (Lipocalin 2), 
adipokines receptors (ADIPOR1, ADIPOR2, LEPR, CMKLR1), monocyte-
chemotactic protein 1 (CCL2/MCP-1), nuclear factors (C/EBPβ, PPARγ) and 
other inflammation-related proteins such as FTO, TN-C, TLR4 and VCAM1.  
2) Chondrocytes from patients with OA express higher levels of adiponectin 
receptor ADIPOR1 than ADIPOR2. 
3) Chondrocytes at monolayer cell culture from lean and obese patients with OA 
differ in expression of several genes connected with the pathogenesis of 
obesity, including ADIPOR1, NAMPT (visfatin), PPARγ and CCL2. 
Chondrocytes from obese OA patients express significantly lower NAMPT 
(visfatin) and PPARγ and higher ADIPOR1 and CCL2/MCP-1 gene in 
comparison to lean. 
4) The protein level of visfatin, PPARγ and CCL2 is different between Lean and 
Obese Subject with OA in chondrocytes. Chondrocytes from obese OA 
patients produce significantly lower NAMPT and PPARγ and higher 
CCL2/MCP-1 protein. 
5) CCL2 is secreted by both chondrocytes and cartilage explants. Cartilage 
explants from obese OA patients secrete significantly higher levels of CCL2. 
All of the above data could help to explain the correlation between obesity and OA. 
The genes and proteins investigated in this study suggest different molecular 
pathways in the cartilage from obese and lean individuals. In particular, differences 
in PPARγ, visfatin, ADIPOR1 and CCL-2 expression in chondrocytes were found 
and need to be investigated further.   
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 The differences in obesity-related 
markers expression in synovium from lean and 
obese OA patients 
4.1 Introduction 
The synovium is an integral component of the joint and is considered to play an 
important role in the pathogenesis of many arthritic diseases. The majority of studies 
focus on the synovial surface membrane layer, rather than the underlying 
fatty/fibrous layer of the synovium, and its contribution to more pro-inflammatory 
types of arthritis, including Rheumatoid Arthritis or Psoriatic Arthritis (Kruithof et 
al., 2005; Cañete et al., 2015). In these forms of arthritis, the synovial membrane is 
inflamed, thickened and oedematous. The hypothesis of the present study is that in 
OA synovium where the synovial membrane layer normally occupies a smaller 
percentage of the whole tissue, its other components including the supporting fat and 
fibrous tissue may play an important role in the pathogenesis of the disease. 
Several proteins produced by adipose tissue are considered to be potent players in 
OA progression (Lubbeke et al., 2013). Previous studies suggest that the 
concentration of some molecules whose production in obese and lean individuals in 
OA is different (Rai et al., 2014). While most previous research has focused on 
protein content in serum and/or synovial fluid from OA patients, the purpose of this 
study is to investigate the role of local tissues within the knee joint in the production 
of obesity-related markers. 
In this study, the contribution of synovium to the pathogenesis of OA was 
investigated. Expression of genes and proteins, which could play an important role in 
the involvement of obesity in OA were assayed. The gene expression in synovium of 
the main adipokines including adiponectin (ADIPOQ), leptin (LEP), visfatin 
(NAMPT), chemerin (TIG2), lipocalin 2 (LCN2) in addition to some of their 
receptors including ADIPOR1, ADIPOR2, LEPR, and CMKLR1 was assessed. 
Additionally, two important nuclear factors, namely PPARγ (Peroxisome 
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Proliferator-Activated Receptor γ) and C/EBPβ (CAAT/Enhancer-binding protein β) 
were analysed. Furthermore, inflammatory mediators, CCL2/MCP-1 a chemokine, 
the surface markers VCAM1 (Vascular Cell Adhesion Molecule 1) and TLR4 (Toll-
like receptor 4) were also screened. At the protein level, six main candidates were 
investigated: adiponectin, visfatin, PPARγ, CCL2, VCAM-1 and TLR4.  
The difference in gene and protein expression between lean and obese subjects with 
OA was assessed in order to explain the contribution of obesity to OA pathogenesis. 
4.1.1 Aims 
The main goal of the presented study was to compare differences in obesity markers 
in the synovium of patients undergoing knee replacement surgery.  
Specifically, the aims were: 
1. To screen the synovium for expression of possible obesity-related genes 
and proteins postulated to be involved in the pathogenesis of OA.  
2. To determine if there was a differential expression of obesity-related 
biomarkers in synovium between obese and lean individuals with OA 
using different molecular biology techniques. 
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4.2 Differences in Synovial gene expression 
Synovial biopsies were harvested from the knee joints of patients undergoing TKR 
(Total Knee Replacement) surgery. Patients were divided into two groups as 
previously described, i.e. Lean (BMI < 25) and Obese (BMI > 35). Each biopsy 
consisted of the synovial membrane layer and the supporting fatty/fibrous tissue The 
histological analysis did not show any correlation in the synovitis score between the 
obese and lean group (Representative H&E histology is included in Appendix 8). 
4.2.1 Semi-quantitative RT-PCR analysis 
A semi-quantitative RT-PCR technique was used to screen for candidate obesity 
markers to determine if there was a difference in gene expression in the synovium 
from lean and obese patients (Figures 4.1-4.3). 
 
Figure 4. 1 Semi-quantitative PCR analysis of ADIPOQ, NAMPT(visfatin) and PPARγ genes in 
synovium explants obtained from OA patient. 
RT-PCR semi-quantitative analysis of adiponectin (ADIPOQ), visfatin (NAMPT) and PPARγ genes 
expression in synovium from OA patients. Two groups termed “Lean” (n=8 for ADIPOQ and 
NAMPT, n=7 for PPARγ) and “Obese” (n=12 for ADIPOQ, n=13 for NAMPT and PPARγ) were 
defined according to BMI. GAPDH was used as a reference gene. The sample distribution, mean ratio 
values (horizontal lane) of each group and standard deviation (vertical lane) (SD) bars are shown in A-
C. The correlation between ratio values and BMI scores are shown in D-F. p value <0.05 is indicated 
as *. 
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ADIPOQ, NAMPT (visfatin) and PPARγ expression were significantly lower in the 
synovium of the obese patients. The ratio of ADIPOQ/GAPDH, NAMPT/GAPDH 
and PPARγ/GAPDH negatively correlated with BMI score (Figure 4.1). 
 
Figure 4. 2 RT-PCR semi-quantitative analysis of CCL2/MCP-1, VCAM1 and TLR4 expression 
in synovium from OA patients.  
Two groups termed “Lean” (n=6 for CCL2/MCP-1, n=8 for TLR4 and n=10 for VCAM1 and “Obese” 
(n=8 for CCL2/MCP-1, n=10 for TLR4 and n=11 for VCAM1) were divided according to BMI. 
GAPDH was used as a reference gene. The sample distribution, mean ratio values (horizontal lane) of 
each group and standard deviation (vertical lane) (SD) bars are shown in A-C. The correlation 
between ratio values and BMI score were shown in D-F. p value <0.05 is indicated as *.  
 
Chemokine CCL2/MCP-1 gene and two surface molecules: VCAM1 and TLR4 were 
significantly higher in the synovial tissue from the obese group compared to the lean 
one. The ratio of CCL2/MCP-1/GAPDH TLR4/GAPDH and VCAM11/GAPDH 
positively correlated with BMI score (Figure 4.2). 
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Figure 4. 3 Semi-quantitative PCR analysis of genes in synovium obtained from OA patients. 
Two groups termed “Lean” n=8 and “Obese” n=12 were defined according to BMI. GAPDH was used 
as a reference gene. The mean ratio values of each group and standard deviation (SD) bars are shown.  
 
The other obesity-related genes investigated in the present study did not show any 
significant differences. 
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4.2.2 Quantitative Real Time qRT PCR analysis 
The 6 candidate genes screened for by RT-PCR showing correlation with BMI were 
further analysed using quantitative Real Time PCR reaction. cDNA from a new set 
of  12 synovial samples for each group (lean and obese) were analysed in triplicate 
and gene expression was normalized to the housekeeping gene B2M (Figure 4.4).  
 
Figure 4. 4 Quantitative PCR analysis of ADIPOQ, NAMPT, PPARγ, MCP1/CCL2, TLR4 and 
VCAM1 gene expression in synovium obtained from OA patients. 
Quantitative PCR analysis of ADIPOQ (A), NAMPT (B), PPARγ (C), MCP-1/CCL-2 (D), TLR4 (E), 
VCAM1 (F) expression in synovium obtained from different OA patients. Two groups termed “Lean” 
n=10 and “Obese” n=12 were defined according to BMI as before. B2M was used to normalise gene 
expression. The -ΔΔCT method was used. The mean value of Lean Group was used as a calibrator to 
investigate fold change of gene expression. The ratio values of each group and SEM bars are shown. 
p values < 0.05 were considered significant and indicated as *. 
 
Real Time PCR results (Figure 4.4) confirmed the semi-quantitative RT-PCR data. 
ADIPOQ, NAMPT and PPARγ were expressed at a lower level while CCL2, TLR4 
and VCAM1 were expressed at higher level in the synovium of Obese as compared 
to Lean OA patients. 
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4.3 Protein expression in synovium 
4.3.1 Adiponectin protein expression in synovium 
Immunohistochemistry of synovial histology sections showed adiponectin protein 
expression (Figure 4.5-4.6).  
 
Figure 4. 5 Adiponectin expression in synovium. 
IHC staining of paraffin-embedded synovium confirmed expression of adiponectin (brown colour). 
Different localisation within the tissue can be detected (A-D) perivascular (black arrow in B, D) and 
in adipocytes (black arrowhead C). (For non-staining and isotype controls see Appendix 7). 
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Figure 4. 6 Adiponectin expression in synovium from Lean and Obese OA patients. 
Representative IHC adiponectin staining (brown colour/black arrows) for synovium from Lean (A) 
and Obese (B) OA patients. 
 
Adiponectin is present in the perivascular and adipose tissue areas of synovium of all 
patients tested (Figure 4.5). Adiponectin can be detected in both lean and obese 
patients synovium (Figure 4.6). Western Blot analysis of synovial tissue protein 
lysates was conducted to show differences between lean and obese OA subjects 
(Figure 4.7). 
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Figure 4. 7 Semi-quantitative WB analysis of Total Adiponectin protein expression in synovial 
protein lysates from Lean and Obese OA patients. 
Representative WB result (A) and densitometry analysis (B) showing adiponectin expression in 
synovium from Lean and Obese OA patients. Densitometry data are presented as the mean value of 
the ratios of adiponectin to β-actin for each group ± SD (n=10 for each group). p values < 0.05 were 
considered significant and indicated *. 
 
WB analysis showed there was a significant difference in total adiponectin 
expression between synovium of lean and obese patients. Synovium from obese 
subjects with OA expressed less adiponectin than from lean patients (Figure 4.7). 
Adiponectin secretion was also confirmed by enzyme-linked immunoassay (ELISA) 
technique (Figure 4.8). Synovium explants were cultivated in serum free media for 3 
days (ex vivo culture). The conditioned media were collected and adiponectin release 
was measured by ELISA. 
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Figure 4. 8 Ex vivo adiponectin release by synovium from Lean and Obese OA patients. 
Quantification of adiponectin release into the media by synovium tissue explants after 3 days in serum 
free media measured by ELISA. Each tissue explant was weighted and cultivated in duplicate. ELISA 
detection was conducted in duplicates for each sample. The duplicate has been averaged and results 
are shown as mean values from the group ± SD (n=5 for each group).  
 
ELISA confirmed that adiponectin was produced by synovium from lean at a 
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4.3.2 PPARγ protein expression in synovium 
The PPARγ protein expression was assessed in synovium in histology sections using 
an immunohistochemical technique (Figure 4.9-4.10).  
 
Figure 4. 9 PPARγ expression in synovium.  
IHC staining of paraffin-embedded synovium confirmed expression of PPARγ (brown colour). 
Different localisation within the tissue could be detected (A-D). It was seen in the synovial membrane 
(black arrows in A,B) perivascular area (black arrowhead in C), in fatty (asterix in C) and fibrotic 
tissue (white arrow in D). (For non-staining and isotype controls see Appendix 7). 
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Figure 4. 10 PPARγ expression in synovium from Lean and Obese OA patients. 
Representative IHC PPARγ staining (brown colour/black arrows) for synovium from Lean (A) and 
Obese (B) OA patients. 
 
PPARγ was present in the synovial membrane, the perivascular area, adipose and 
fibrotic tissue (Figure 4.9). PPARγ is present in the synovium of both lean and in 
obese OA subjects (Figure 4.10). The differences between two groups were analysed 
by Western Blot technique (Figure 4.11). 
 
Figure 4. 11 Semi-quantitative WB analysis of PPARγ expression in synovium from Lean and 
Obese OA patients. 
Representative WB result (A) and densitometry analysis (B) demonstrated significantly different 
PPARγ expression in synovium from Lean and Obese OA patients. Densitometry data is present as 
mean value of the ratios of PPARγ to β-actin for each group ± SD (n=10 for each group). 
p values <0.05 were considered significant and indicated *. 
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Semi-quantitative WB results confirmed the PCR data that PPARγ was significantly 
lower in the synovium from Obese in comparison to Lean OA patients (Figure 4.11). 
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4.3.3 Visfatin protein expression in synovium 
Immunohistochemical staining of synovial explants (Figures 4.12-4.13).  
 
Figure 4. 12 Visfatin expression in synovium. 
IHC staining of paraffin-embedded synovium confirmed the expression of visfatin (brown colour). 
Different localisation within the tissue was detected (A-D) synovial membrane (black asterix), 
perivascular area (white asterix) (B), in adipose (black arrowhead in C) and fibrotic tissue (white 
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Figure 4. 13 Visfatin expression in synovium from Lean and Obese OA patients. 
Representative IHC visfatin staining (brown colour/black arrows) for synovium from Lean (A-C) and 
Obese (D-F) OA patients. 
 
IHC staining showed that visfatin was present in both the lining and sublining area of 
the synovial membrane, and in perivascular, fibrotic and adipose tissue areas (Figure 
4.12).  
Visfatin can be detected in the synovium of both lean and obese OA subjects (Figure 
4.13).  
Western Blot technique was used to analyse visfatin expression in synovial tissue 
lysates (Figure 4.14). 
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Figure 4. 14 Semi-quantitative WB analysis of visfatin expression in synovium from Lean and 
Obese from OA patients. 
Representative WB result (A) and densitometry analysis (B, C) demonstrated significantly higher 
visfatin expression in Lean compared to Obese synovium obtained from OA patients. Densitometry 
data are present as mean values of the ratio of visfatin to β-actin for each group ± SD (n=10 for each 
group). p values < 0.05 were considered significant. 
 
Unexpectedly two visfatin bands were detected in synovial protein tissue lysates. The 
higher molecular weight (MW) band (about 15-20kDa bigger) was much more 
highly expressed than the lower one. Semi-quantitative analysis showed that 
expression of both lower and upper bands was reduced in obese compared to lean 
OA patients confirming the data obtained in PCR analysis (see Figure 4.14). 
WB analysis confirmed previous PCR data that visfatin had a significantly lower 
expression in the synovium of Obese OA patients in comparison to Lean ones. 
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4.3.4 CCL2 protein expression in synovium 
CCL2 production by synovium was analyzed using the quantitative ELISA technique 
(Figure 4.15). Synovium explants were cultivated in serum free media for 3 days 
(72h ex vivo culture). Conditioned media were collected after that and CCL2 release 
was measured by ELISA. 
 
Figure 4. 15 CCL-2/MCP-1 release to the media from cultured Synovial explants from Lean and 
Obese OA patients.  
Quantification of CCL-2 release into the media by synovium tissue explants after 3 days in serum free 
media measured by ELISA. Each tissue explant was weighted and cultivated in duplicates. ELISA 
detection was conducted in duplicates for each sample. Results are shown as mean values ± SD (n=5 
for each group). NS – non-significant. 
 
ELISA method showed that CCL-2/MCP-1 was produced by synovium (Figure 
4.15). There was a trend towards higher CCL2 production by obese synovium but it 
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4.3.5 TLR4 protein expression in synovium 
The expression of TLR4 protein was assessed in synovial histology sections using 
immunohistochemistry (Figure 4.16-4.17).  
 
Figure 4. 16 TLR4 expression in synovium. 
IHC staining of paraffin-embedded synovium confirmed expression of TLR4 (brown colour). 
Different localisation within the tissue was observed (A-D): synovial membrane (black arrows in 
A,B), perivascular area (white arrow in A), fibrotic tissue (asterix in C) and in adipocytes (black 
arrowhead in D). (For non-staining and isotype controls see Appendix 7). 
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Figure 4. 17 TLR4 expression in synovium from Lean and Obese OA patients. 
Representative IHC TLR4 staining (brown colour) for Lean (A-C) and Obese (D-F) synovium.  
 
TLR4 was present in the synovial membrane, perivascular area, adipose and fibrotic 
tissue (Figure 4.16). TLR4 is expressed in synovium from both lean and obese OA 
subjects (Figure 4.17). 
The TLR4 expression in the stromovascular fraction (SVF) of synovium was 
investigated by Flow Cytometry (Figure 4.18). The gating strategy is shown in 
Appendix 5. The SVF fraction was analysed by Forward Scatter (FCS) and Side 
Scatter (SCC). Cell debris was excluded. Single marker staining was visualised with 
Phycoerythrine (PE) fluorochrome antibody against TLR4 together with an isotype 
antibody control (IgG-PE) (negative control). The percentage of TLR4+ cells per 
total number of SVF cells was calculated for each patient (as shown in Figure 4.18). 
The Mean Fluorescent Intensity (MFI) of TLR4 expression in analysed samples was 
also investigated.  
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Figure 4. 18 Flow Cytometry analysis of TLR4 protein expression in SVF fraction of synovium 
from Lean and Obese OA patients.  
The isotype control staining shown in A. The representative dot plot analysis for Lean (B) and Obese 
(C) patients synovium. The percentage of TLR4+ cells per total number of SVF cells was calculated 
for each patient. The mean percentage values of each group (n=7 for each group) and standard 
deviation (SD) bars are shown in D. Example of Mean Fluorescent Intensity analysis for TLR4 
expression shown in E. The mean MFI value for each group ± SD (n=7 for each group) shown in F. 
p values < 0.05 were considered significant and indicated *, ns- non-significant. 
 
 
The data shows that a significantly higher frequency of cells expressing TLR4 in 
obese as compared to lean OA patients. Furthermore, analysis of Mean Fluorescence 
Intensity (MFI) (a measure of the intensity of expression) suggests that there is no 
significant difference in intensity of TLR4 expression in cells from obese OA 
patients synovium (Figure 4.18). 
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4.3.6 VCAM-1 protein expression in synovium 
The VCAM-1 protein expression was assessed in synovial histology sections using 
an immunohistochemical technique (Figure 4.19-4.20).  
 
Figure 4. 19 VCAM-1 expression in synovium. 
IHC staining of paraffin-embedded synovium confirmed expression of VCAM-1 (brown colour). 
Different localisation within the tissue was observed (A-D). It was detected in the synovial membrane 
(black arrows in A,D) and perivascular area (white arrow in B), in adipocytes (asterix in C) and in the 
fibrotic tissue (black arrowhead in D). (For non-staining and isotype controls see Appendix 7). 
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Figure 4. 20 VCAM-1 expression in synovium from Lean and Obese OA patients. 
Representative IHC VCAM-1 staining (brown colour/black arrows) for Lean (A-C) and Obese (D-F) 
synovium. 
 
VCAM-1 was present in the synovial membrane, perivascular area and in the adipose 
and fibrotic tissue (Figure 4.19). VCAM-1 can be detected in the synovium of both 
lean and obese OA subjects (Figure 4.20). 
VCAM-1 expression in SVF of synovium was investigated by Flow Cytometry 
(Figure 4.21). The gating strategy was as shown in Appendix 5. Single marker 
staining was visualised using Phycoerythrine (PE) fluorochrome antibody against 
VCAM-1 with an isotype control (IgG-PE). The percentage of VCAM-1+ cells per 
total number of SVF was calculated for each patient. The Mean Fluorescent Intensity 
(MFI) of VCAM-1 expression in analysed samples was also investigated. 
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Figure 4. 21 Flow Cytometry analysis of VCAM-1 protein expression in SVF fraction of 
synovium of Lean and Obese OA patients.  
The isotype control staining is shown in A. The example of dot plots for Lean and Obese patients 
synovium shown in B,C. The percentage of VCAM-1+ cells per total number of SVF was calculated 
for each patient. The mean percentage values of each group (n=7 for each group) and standard 
deviation (SD) bars are shown in D. Example of Mean Fluorescent Intensity analysis for VCAM-1 
expression shown in E. The mean MFI value for each group ± SD (n=7 for each group) shown in F. p 
values < 0.05 were considered significant and indicated *. 
 
 
Data analysis showed that there is a significantly higher frequency of cells 
expressing VCAM-1 in obese as compared to lean OA patients. MFI analysis 
suggests that there is no significant difference in VCAM-1 intensity of expression 
(Figure 4.21). 
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4.4 Conclusion and Summary 
In conclusion, obtained data revealed a number of important points: 
1) The osteoarthritic synovial tissue obtained after TKR express obesity relevant 
markers 
2) Synovium from Obese OA patients expressed pro-inflammatory markers 
including CCL2, VCAM-1, TLR4 at a higher level, both at mRNA and 
protein level than from Lean OA patients. 
3) Synovium from Obese OA patients expresses particular adipose tissue related 
markers such as adiponectin, PPARγ and visfatin at a lower level than 
synovium from Lean patients both at mRNA and protein level. 
4) Synovium from Obese Patients with OA released significantly lower levels of 
adiponectin than the synovium from Lean OA patients.  
All of the above data could help to explain the correlation between obesity and OA. 
The genes and proteins investigated in this study suggest different molecular 
pathways in the synovium from obese and lean individuals. In particular, differences 
in adiponectin, PPARγ, visfatin, CCL-2, TLR4 and VCAM-1 expression in 
synovium were found to be altered and need to be investigated further. 
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 The differences in obesity-related 
markers expression in Infrapatellar Fat Pad 
(IPFP) from lean and obese OA patients 
5.1 Introduction 
The Infrapatellar Fat Pad (IPFP) is considered to be an important secretory tissue 
within the knee joint. It produces such proteins as Prostaglandin 2 (PGE2), TNFα and 
CCL2  and is postulated to play a significant role in the pathogenesis of OA 
(Clockaerts et al., 2012). 
In the present study candidate genes and proteins, which could play an important role 
in the contribution of obesity to OA were screened. In samples from the Infrapatellar 
Fat Pad, the gene expression of the main adipokines(as in the previous chapters) 
ADIPOQ, NAMPT, TIG2, LCN2 and some of their reported receptors including 
ADIPOR1, ADIPOR2, LEPR and CMKLR1 were investigated. Additionally, gene 
expression of two important nuclear factors PPARγ and C/EBPβ were analysed. 
Furthermore, the important chemokine CCL2 and significant surface markers such as 
VCAM1 and TLR4 genes expression were also assessed. 
At the protein level, three main candidates were investigated: adiponectin, visfatin 
and PPARγ.  
5.1.1 Aims 
The main goal of the presented study was to compare differences in obesity markers 
in the IPFP of patients undergoing knee replacement surgery.  
1. To screen obesity-related candidate genes expressed by IPFP to 
determine if they have a potential role in the pathogenesis of OA. 
2. To determine the relative expression of obesity-related biomarkers in the 
IPFP from obese and lean individuals with OA. 
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3. To investigate the differences between the two adipose tissue depots 
within the knee - synovium versus IPFP.  
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5.2 Infrapatellar Fat Pad gene expression analysis 
IPFP biopsies were harvested from the knee joints of patients undergoing TKR 
(Total Knee Replacement) surgery. Patients were divided and histological analysis 
was conducted as previously described (representative histology is included in 
Appendix 8). 
5.2.1  Semi-quantitative RT-PCR analysis 
A semi-quantitative RT-PCR technique was used to screen candidate obesity marker 
to determine if there was a difference in gene expression in the IPFP from lean and 
obese patients (Figures 5.1-5.2) 
 
Figure 5. 1 Semi-quantitative PCR analysis of ADIPOQ, NAMPT (visfatin) and PPARG genes 
in the IPFP from Lean and Obese patients with OA. 
Levels of adipokine genes in the infrapatellar fat pads obtained from two groups of OA patients; (A, 
C). “Lean” (n=9 for ADIPOQ n=8 for NAMPT and n=6 for PPARγ) and “Obese”(n=11 for ADIPOQ, 
n=10 for NAMPT and PPARγ). GAPDH was used as a reference gene. The sample distribution, mean 
ratio values (horizontal lane) for each group and standard deviation (SD) bars (vertical lane) are 
shown in A-C. The correlation between ratio values and BMI score are shown in D-F. p values < 0.05 
were considered significant and indicated *. ns- non-significant. 
 
The infrapatellar fat pad from all patients tested expressed ADIPOQ, NAMPT 
(visfatin) and PPARG genes. There was no significant difference in expression of 
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ADIPOQ between the obese and lean patient groups. The gene expression of 
NAMPT and PPARγ was significantly lower in IPFP from Obese OA patients in 
comparison to Lean ones (Figure 5.1). 
 
Figure 5. 2 Semi-quantitative PCR analysis of genes expression in IPFP obtained from Lean and 
Obese subjects with OA. 
Possible candidate gene expression was analysed in the IPFP from OA patients. Two groups “Lean” 
n=8 and “Obese” n=12 were defined according to BMI. GAPDH was used as a reference gene. The 
mean ratio values of each group and standard deviation (SD) bars are shown. 
 
Other candidate genes did not show significant differences (Figure 5.2). 
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5.2.2 Quantitative Real Time qRT PCR analysis 
Three potential candidates for involvement in the interaction between OA and 
obesity were screened using the Real Time PCR reaction (Figure 5.3).  
 
Figure 5. 3 Real-Time PCR analysis of ADIPOQ, NAMPT and PPARγ expression in 
Infrapatellar Fat Pad from Lean and Obese OA patients. 
Quantitative analysis of ADIPOQ (A), NAMPT (B) and PPARγ (C) gene expression in IPFP from 
different OA groups: “Lean” n=10 and “Obese” n=10. B2M was used to normalise gene expression. 
The -ΔΔCT method was used. The mean value of Lean Group was used as a calibrator to investigate 
fold change of gene expression. The ratio values of each group and SEM bars are shown. p values < 
0.05 were considered significant and indicated as * ns- non-significant. 
Real-time PCR data confirmed the RT-PCR data. There was no significant difference 
between obese and lean groups in the expression of ADIPOQ gene in the IPFP, while 
significantly lower expression of PPARγ and NAMPT genes was detected in IPFP of 
Obese OA patients in comparison to Lean ones (Figure 5.3). 
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5.3 IPFP protein expression analysis 
5.3.1 Adiponectin protein expression in IPFP 
 IPFP adiponectin protein expression was assessed in histology sections using 
immunohistochemistry (Figures 5.4-5.5).  
 
Figure 5. 4 Adiponectin expression in IPFP. 
IHC staining of paraffin-embedded IPFP confirmed expression of adiponectin (brown colour). 
Different localisation of adiponectin within the tissue was observed (A-D): perivascular (asterix in C), 
within adipocytes (black arrows in B,D). (For non-staining and isotype controls see Appendix 7). 
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Figure 5.5 Adiponectin expression in IPFP from Lean and Obese OA patients. 
Representative IHC adiponectin staining (brown colour) for IPFP from Lean (A-C) and Obese (D-F) 
patients. 
 
IHC staining demonstrated ubiquitous adiponectin expression in IPFP tissue sections, 
within the vessels, but mainly in the adipocytes (Figure 5.4).  
Adiponectin can be detected in IPFP of both lean and obese OA subjects (Figure 
5.5). 
Western Blot technique was used to analyse the difference in adiponectin expression 
between two groups (Figure 5.6). 
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Figure 5. 6 Semi-quantitative western blot analysis of total adiponectin expression in the IPFP 
from Lean and Obese OA patients. 
Representative western blot results (A) and densitometry analysis (B) of adiponectin expression in 
Infrapatellar Fat Pad (IPFP) from Lean and Obese OA patients. Densitometry data are presented as the 
mean value of the ratios of adiponectin to β-actin for each group ± SD (n=10 for each group). p values 
< 0.05 were considered significant. 
 
 
WB analysis revealed that there is a significant difference in adiponectin expression 
in IPFP of lean and obese OA subjects. 
Adiponectin secretion was confirmed by enzyme-linked immunoassay (ELISA) 
technique (Figure 5.7). IPFP explants were cultivated in serum free media for 3 days 
(ex vivo culture). Media was collected and adiponectin release was measured by 
ELISA. 
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Figure 5. 7 Ex vivo adiponectin release by IPFP from Lean and Obese OA patients. 
Quantification of the adiponectin release into media by IPFP tissue explants after 3 days in serum free 
media measured by ELISA. Each tissue explant was weighed and cultivated in duplicates. ELISA 
detection was conducted in duplicates for each sample. Results are shown as the mean values ± SD 
(n=5 for each group). NS- non-significant. 
 
ELISA confirmed that adiponectin was produced by IPFP at similar levels in Lean 
and Obese patients with OA (Figure 5.7). 
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5.3.2 PPARγ protein expression in IPFP 
The PPARγ protein expression was assessed in the IPFP in histology sections using 
an immunohistochemical technique (Figures 5.8-5.9). 
 
Figure 5. 8 PPARγ expression in IPFP. 
IHC staining of paraffin-embedded IPFP confirmed expression of PPARγ (brown colour). Different 
localisation within the tissue was observed (A-D); synovial membrane (black arrow in A,B), in 
adipocytes (white arrow in C) perivascular (asterix in D) and fibrotic tissue (black arrowhead in D). 
(For non-staining and isotype controls see Appendix 8). 
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Figure 5. 9 PPARγ expression in IPFP from Lean and Obese patients. 
Representative IHC PPARγ staining (brown colour/black arrow) for IPFP from Lean (A-C) and Obese 
(D-F) patients. 
 
IHC staining of paraffin-embedded IPFP confirmed expression of PPARγ. Different 
localisation was observed in the synovial membrane, adipocytes, perivascular and 
fibrotic tissue (Figure 5.8). PPARγ is expressed in IPFP of both lean and obese OA 
subjects (Figure 5.9).  
 
To explore the hypothesis that PPARγ expression was lower in infrapatellar fat pads 
of obese patients, semi-quantitative WB analysis was conducted (Figure 5.10). 
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Figure 5. 10 Semi-quantitative Western Blot analysis of PPARγ expression in IPFP from Lean 
and Obese OA patients. 
Representative WB result (A) and densitometry analysis (B) PPARγ expression in IPFP from Lean 
and Obese OA patients. Densitometry data are presented as the mean value of the ratio of PPARγ to β-
actin for each group ± SD (n=10 for each group). 
 
Semi-quantitative WB results confirmed the PCR data that PPARγ was significantly 
lower in the IPFP from Obese in comparison to Lean OA patients (Figure 5.13). 
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5.3.3 Visfatin protein expression in IPFP 
The visfatin protein expression was assessed in IPFP in histology sections using 
immunohistochemistry (Figure 5.11-5.12).  
 
Figure 5. 11 Visfatin expression in IPFP. 
IHC staining of paraffin-embedded IPFP confirmed expression of visfatin (brown colour). Different 
localisation within the tissue was observed (A-D); synovial membrane (black arrows in A,B), 
adipocytes (white arrow in C) perivascular (white asterix in D) and fibrotic tissue (black arrowhead in 
B,D). (For non-staining and isotype controls see Appendix 8). 
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Figure 5. 12 Visfatin expression in IPFP from Lean and Obese OA patients. 
Representative IHC visfatin staining (brown/black arrows) for IPFP from Lean (A-C) and Obese (D-
F) OA patients. 
 
IHC showed abundant visfatin expression in synovial membrane, in adipose and 
fibrotic tissue as well as in vessels of IPFP (Figure 5.11).  
Visfatin is expressed in IPFP of both lean and obese OA patients (Figure 5.12). 
Western Blot technique was used to analyse the visfatin expression in IPFP tissues 
protein lysates (Figure 5.13). 
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Figure 5. 13 Semi-quantitative Western blot analysis of visfatin expression in IPFP from Lean 
and Obese OA patients. 
Representative Western blot result (A) and densitometry analysis (B,C) of visfatin expression in IPFP 
from Lean and Obese OA patients. Densitometry data are presented as the mean value of the ratio of 
visfatin to β-actin for each group ± SD (n=10 for each group). p values < 0.05 were considered 
significant and indicated as *. 
 
Similar to Western Blots of synovial tissue (Chapter 4), two bands were detected, 
with the lower band significantly fainter that the upper band. Semi-quantitation by 
densitometry of both bands confirmed the PCR results that visfatin had a 
significantly lower expression in IPFP from Obese compared to Lean OA patients 
(Figure 5.13). 
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5.4 Paired comparison of gene and protein 
expression in synovium and IPFP 
Markers including visfatin, PPARγ and adiponectin show differential expression in 
both synovium and IPFP of obese OA patients. The purpose of this analysis was to 








Figure 5. 14 Semi-quantitative PCR analysis of NAMPT (visfatin) expression in IPFP and 
synovium obtained from OA patients. 
GAPDH was used as a reference gene. The mean ratio values of each group and standard deviation 
(SD) bars are shown n=20 for each tissue. NS-non-significant. 
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5.4.2 Adiponectin 
5.4.2.1 Semi-quantitative RT-PCR analysis of ADIPOQ gene expression 
in paired Synovial and IPFP samples 
RT-PCR analysis of ADIPOQ gene expression showed that it was significantly lower 
in synovium as compared to IPFP of OA patients (all analysed tissues) (Figure 5.15) 
Looking at patient groups based on BMI this was also true for obese patients, 
whereas lean OA patients showed no significant difference in ADIPOQ expression in 
IPFP and synovium. 
 
Figure 5. 15 Semi-quantitative PCR analysis of adiponectin expression in IPFP and synovium 
obtained from Lean and Obese OA patients. 
GAPDH was used as a reference gene. The mean ratio values of each group and standard deviation 
(SD) bars are shown for all obtained samples (A) and separated according to BMI into Obese patients 
(B) and Lean patients (C). p values < 0.05 were considered significant and indicated as *. 
NS-non-significant. 
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5.4.2.2 Quantitative Real Time qPCR analysis of ADIPOQ gene 
expression in paired Synovial and IPFP samples 
The difference between synovium and IPFP ADIPOQ gene expression assessed by 
Real Time qPCR is shown in Figure 5.16 




























































Figure 5. 16 Quantitative PCR analysis of ADIPOQ expression in IPFP and synovium obtained 
from Lean and Obese OA patients.  
Quantitative analysis of ADIPOQ gene expression in paired IPFP and synovium from OA patients. 
B2M was used to normalise gene expression. Groups termed “Lean” n=7 and “Obese” n=9 were 
analysed. The -ΔΔCT method was used. The mean value of Lean IPFP Group was used as a calibrator 
to investigate fold change of gene expression. The ratio values of each group and SEM bars are 
shown. p values < 0.05 were considered significant and indicated as *.NS-not significant. 
 
RT-PCR (Figure 5.15) and quantitative Real Time PCR analysis (Figure 5.16) 
revealed that adiponectin was significantly higher in IPFP compared to the synovium 
of all OA patients analysis. Further, paired statistical analysis of RT-PCR and qPCR 
data showed that the IPFP of Obese patients expressed significantly higher ADIPOQ 
than synovium from the same patients, while there was no significant difference 
between tissues in Lean patients. 
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5.4.2.3 Adiponectin protein expression analysis in synovium and IPFP. 
The difference between synovium and IPFP adiponectin protein expression was 
assessed by Western blot and ELISA are shown in Figure 5.17. 
5.4.2.3.1 Western Blot analysis 
 
Figure 5. 17 Semi-quantitative WB analysis of Total Adiponectin expression in IPFP and 
synovium from Lean and Obese OA patients. 
Densitometry analysis (A) of adiponectin expression in IPFP and synovium in OA patients. Paired 
Obese and Lean IPFP and synovium ratios are presented. Densitometry data are presented as the mean 
value of the ratios of adiponectin to β-actin for each group ± SD. Quantification of adiponectin release 
into media by IPFP and Synovial tissue explants after 3 days in serum free media measured by ELISA 
(B). Each tissue explant was weighed and cultivated in duplicate. ELISA detection was conducted in 
duplicates for each sample. Results are shown as mean values ± SD (n=5 for each group). p values < 
0.05 were considered significant. NS- non-significant. 
 
 
Adiponectin protein expression was expressed at a significantly higher level in the 
IPFP than in the synovium of Obese patients with OA. Also, adiponectin levels in 
culture supernatants measured by ELISA were significantly higher in the IPFP than 
in the synovium of Obese IPFP (Figure 5.17).   
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5.4.3 PPARγ 
The difference between synovium and IPFP PPARγ gene expression is shown in 
Figure 5.18-5.19. 
5.4.3.1 Semi-quantitative RT-PCR analysis of PPARγ gene expression 
in paired Synovial and IPFP samples 
 
Figure 5. 18 Semi-quantitative PCR analysis of PPARγ expression in IPFP and synovium from 
Lean and Obese OA patients. 
GAPDH was used as a reference gene. The mean ratio values of each group and standard deviation 
(SD) bars are shown for all the samples (A) and separated according to BMI into Obese patients (B) 
and Lean patients (C). The mean values of each group and standard deviation (SD) bars are shown. 
p values < 0.05 were considered significant and indicated as *, p value< 0.01 were indicated as **, p 
value< 0.001 were indicated as ***. 
 
Semi-quantitative PCR analysis showed that PPARγ was significantly lower in 
synovium as compared to IPFP in all analysed patients and when comparing among 
the obese and lean groups.  
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5.4.3.2 Quantitative Real time qPCR analysis of PPARγ gene 
expression in paired Synovial and IPFP samples 
The difference between synovium and IPFP PPARγ gene expression assessed by 









































Figure 5. 19 Quantitative PCR analysis of PPARγ expression in IPFP and synovium obtained 
from Lean and Obese OA patients.  
Quantitative analysis of PPARγ gene expression in IPFP and synovium from OA patients. B2M was 
used to normalise gene expression. Groups termed “Lean” n=7 and “Obese” n=9 were analysed.The -
ΔΔCT method was used to investigate fold change in gene expression. The mean values of each group 
and SEM bars are shown. p values < 0.05 were considered significant and indicated as *. 
 
RT-PCR and quantitative Real Time PCR analysis revealed that PPARγ gene was 
significantly higher in the IPFP compared to the synovium of OA patients. Further 
paired statistical analysis showed that the IPFP of both Obese and Lean patients 
expressed PPARγ at a higher level than the synovium from the same patient (Figures 
5.18-5.19). 
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5.4.3.3 PPARγ protein expression analysis in synovium and IPFP 
The difference between synovium and IPFP PPARγ protein expression assessed by 
Western Blot is shown in Figure 5.20. 














































Figure 5. 20 Semi-quantitative WB analysis of PPARγ expression in IPFP and synovium from 
Lean and Obese OA patients. 
Densitometry analysis of PPARγ expression in IPFP and synovium in OA patients. The paired IPFP 
and synovium results for Obese and Lean patients are presented. Densitometry data is present as the 
mean value of the ratios of PPARγ to β-actin ± SD. p values < 0.05 were considered significant. 
 
PPARγ protein expression was significantly higher in the IPFP compared to the 
synovium. In addition, in both groups (Lean and Obese) the IPFP expression of 
PPARγ was significantly higher than in synovium (Figure 5.20). 
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5.5 Summary and Conclusions 
In conclusion, obtained data revealed a number of important points: 
1) Osteoarthritic Infrapatellar Fat Pad (IPFP) obtained after TKR express 
obesity relevant markers. 
2) IPFP from Obese OA patients expresses adiponectin at the same level as in 
Lean patients both at mRNA and protein level. 
3) IPFP from Obese OA patients expresses PPARγ and visfatin at a lower level 
than from Lean ones both at mRNA and protein level. 
4) Obese synovium express the significantly lower level of adiponectin in 
comparison to IPFP. 
5) IPFP from the same donor expresses significantly higher level of PPARγ than 
synovium. 
All of the above data could help to explain the correlation between obesity and OA. 
The genes and proteins investigated in this study suggest different molecular 
pathways in the IPFP from obese and lean individuals. In particular, differences in 
adiponectin, PPARγ and visfatin expression in IPFP were found to be altered and 
need to be investigated further. Furthermore, presented data also suggest differences 
in expression of adiponectin and PPARγ between synovium and IPFP.  
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 Regional difference in immune cell 
population in synovium and IPFP from OA 
patients  
6.1 Introduction 
Adipose tissue is a highly heterogenic tissue. It consists not only of large vacuolar 
adipocytes but also progenitor cells (MSCs, preadipocytes), endothelial and vascular 
cells in addition to cells of the immune system including macrophages, T cells, and 
mast cells. All of these have a role in adipose tissue homeostasis. In individuals of 
normal-weight, macrophages phagocyte dying adipocytes maintaining the proper 
tissue organisation. With weight gain, there is a reorganisation of the whole adipose 
tissue. Previously protective cells may become more pro-inflammatory. In addition, 
there is an influx of other cells, which can trigger inflammation of the whole tissue 
(Sun et al., 2012). In this study, the difference in immune cell populations between 
lean and obese patients suffering from OA in two different fatty tissue depots: 
synovium and IPFP were investigated.  
Macrophages originate from blood monocytes and are specialised in the 
phagocytosis of pathogens, tissue debris and apoptotic cells in addition to the repair 
of wounded tissues (Wynn et al., 2016). Because of their different roles macrophages 
display high heterogeneity. Initially, macrophages were divided into two main 
subpopulations M1 and M2 following the lymphocyte T terminology (Th1 and Th2) 
(Italiani et al., 2015).  
M1 macrophage phenotype refers to the “classically-activated” macrophages that 
manifest their activity during typical pro-inflammatory responses for example 
microbial invasion. They are activated by IFN-γ and LPS and become potent 
producers of pro-inflammatory cytokines including TNF-α, CCL-2 and iNOS 
(Mantovani et al., 2004). Their main role is to eliminate the pathogen and stimulate 
polarisation of Th1 CD4+ lymphocytes (Murray et al., 2011). M2 so-called 
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“alternatively-activated” macrophages down-regulate the initial pro-inflammatory 
activity and initiate tissue repair. They are considered to be anti-inflammatory and 
mainly activated by IL-4 and IL-14. M2 macrophages secrete anti-inflammatory 
cytokines such as IL-10 and TGF-β (Mantovani et al., 2002).  M2 macrophages are 
also important as the first line of defence against extracellular pathogens for instance 
parasites and helminths (Mantovani et al., 2005).  
The majority of the initial studies on macrophages in obesity were based on murine 
models in which M1 and M2 subpopulation of macrophages are well characterised. 
In mice, the phenotype of M2 macrophages is characterised by expressing CD206+ 
but not CD11c-, while M1 macrophages are CD206- and CD11c+. When the M1 
phenotype is blocked in obese mice there is protection from obesity. In diet-induced 
obesity in these animals the percentage of CD11c+ macrophages increases by 65-fold 
(Weisberg et al., 2003).  
Unfortunately, animal models do not fully mimic human adipose tissue leukocyte 
content. More and more studies reveal that the strict M1/M2 terminology described 
in mice may not reflect the macrophage population in humans. There are different 
studies defining M1 and M2 markers on human adipose tissue macrophages (ATM) 
but there is no consensus on the final M1/M2 macrophage profile (Zeyda et al., 
2007). Recent studies show that human ATM express a range of both pro- and anti-
inflammatory markers (Aron-Wisnewsky et al., 2009; Wentworth et al., 2010). 
According to Bourlier et al., the majority of ATM express 
CD45+/CD14+/CD206+/CD16- and their percentage correlates positively with BMI 
index. In addition, ATM express MMP-9, which is a remodelling enzyme that can 
control both adipo- and angiogenesis. The authors speculate that a small population 
of CD45+/CD14+/CD206+/CD16+ macrophages are also found within adipose tissue 
and reflect the resident macrophage population while CD45+/CD14+/CD206+/CD16- 
macrophages may be influx macrophages (Bourlier et al., 2008). 
Besides, macrophages a range of other leukocytes has been investigated. Other 
representatives of innate immune cells including eosinophils have been identified in 
adipose tissue and their number is negatively correlated with weight gain (Huh et al., 
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2014). They are an important source of anti-inflammatory factors for example IL-4 in 
adipose tissue from lean individuals. Mast cells content increases with obesity and 
pro-inflammatory factors such as IL-6 and IFN-γ produced by mast cells can 
contribute to pro-inflammatory conditions in obesity (Liu et al., 2009).  
The role of cells of the adaptive immune system in obesity is also a matter of 
investigation. B cells, which in lean adipose tissue provide protection from infection, 
with weight gain increase in number and change their profile to a more pro-
inflammatory phenotype.  
T cells defined as CD3+ have been reported to be up-regulated in obesity (O'Rourke 
et al., 2013). Both CD4+ (Winer et al., 2009) and CD8+ T-cells (Nishimura et al., 
2009) have been detected in human adipose tissue. However, some studies have 
reported that the subset of CD4+cells is reduced, whereas the CD8+ number increased 
in human obese adipose tissue. Whilst other studies, in a mouse model, have reported 
that both CD3+CD4+ and CD3+CD8+ T cells number increased in diet-induced 
obesity (Deiuliis et al., 2011). Increased T lymphocyte numbers may trigger 
macrophage influx (Nishimura et al., 2009). All of the reported studies propose that 
immune cell content is crucial in the pathogenesis of obesity-related inflammation. 
6.1.1 Aims of the study: 
The goal of the presented study was to compare differences in leukocytes markers 
expression in synovium and IPFP of patients undergoing knee replacement surgery.  
Specifically, the aims were 
 To ascertain if there is a difference in immune cell content in articular 
adipose tissues depots in obese and lean patients with OA. 
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6.2 Results 
6.2.1 Macrophages in articular adipose tissues 
The presence of macrophages in both synovium and IPFP was investigated using 
surface marker expression analysis with a Flow Cytometry technique. The strategy 
for gating is presented in Appendix 5. Figure 6.1-Figure 6.12 show the difference in 
expression of macrophage markers in synovium and IPFP from lean and obese OA 
patients. 
6.2.1.1 CD45+ CD14+ positive cells 
Two soft tissue biopsies were harvested from different compartments of the knee 
joint of each patient: synovial explant and IPFP. Patients were divided into two 
groups (Lean and Obese) as previously described. Histological analysis did not show 
any differences in synovitis score between the obese and lean groups (The 
representative histology H&E see Appendix 8). Each explant consisted of the 
synovial layer and the majority of the supporting fatty tissue layer.  
Example of CD45+ CD14+ gating are shown in Figure 6.1: 
 
Figure 6. 1 CD45+CD14+ macrophage detection in synovium and IPFP in stromovascular 
fraction (SVF).  
SVF fractions were analysed according to CD45 and CD14 marker expression. The isotype control 
(A) was analysed at the same time with the sample of interest. Representative plots for Lean (B) and 
Obese (C) Synovial SVF staining is presented.  
 
The percentage of CD45+CD14+ positive cells in the total cell population (called here 
SVF) was calculated (see Figure 6.2). 
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Figure 6. 2 Content of CD45+CD14+cells in SVF fraction of synovium and IPFP from Lean and 
Obese OA patients. 
The mean percentage for the group termed “Lean” n=14 for synovium n=13 for IPFP and “Obese” 
n=19 for synovium n=14 for IPFP ±SD was shown (A). p value <0.05 indicated as *, p value<0.005 
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The data (Figure 6.2) suggest that there was a higher frequency of macrophages in 
the synovium and IPFP of obese OA patients in comparison to lean ones. There was 
no difference in the macrophage content between paired fatty depots within the joint 
(synovium vs. IPFP) but there was a significant correlation of macrophage 
percentage and BMI score both in synovium and IPFP. MFI analysis showed no 
difference in intensity of CD14 and CD45 staining between all groups (data not 
shown). 
6.2.1.2 CD14+ CD206+ positive cells 
Another reported macrophage marker CD206 has been investigated (see Figure 6.3). 
 
Figure 6. 3 CD14+CD206+ macrophage marker detection in synovium and IPFP SVF fraction.  
SVF fractions were analysed for CD14 and CD206 expression. Isotype control (A) was analysed at 
the same time as a sample of interest. Representative plots for Lean (B) and Obese (C) SVF staining 
are presented.  
 
The percentage of CD14+CD206+ positive cells in the SVF cell population was 
calculated (see Figure 6.4). 
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Figure 6. 4 Percentage of CD14+CD206+ in SVF fraction of synovium and IPFP from Lean and 
Obese OA patients.  
The mean percentage for the group termed “Lean” n=8 and “Obese” n=14 for synovium, n=16 for 
IPFP ±SD is shown (A). p value<0.001 indicated as ***The correlation of the percentage of 
CD14+CD206+ with BMI score in the synovium and IPFP is shown in (B) and (C) respectively.  
 
The data (Figure 6.4) suggest that there was a higher frequency of CD14+ CD206+ 
cells in the synovium and IPFP of Obese OA patients in comparison to lean ones. 
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from the same joint. MFI analysis showed no difference in intensity of CD14 and 
CD206 staining between all groups (data not shown). 
6.2.1.3 CD86 CD14 positive cells 
M1 macrophage marker CD86 was also analysed (see Figure 6.5). 
 
Figure 6. 5 CD86+CD14+ macrophage markers detection in synovium and IPFP SVF fraction.  
SVF fractions were analysed for CD14 and CD86 expression. Isotype control (A) was analysed at the 
same time with sample of interest. Representative plots for Lean (B) and Obese (C) SVF of synovium 
staining is presented.  
 
The percentage of CD86+CD14+ positive cells in the SVF cell population was 
calculated (see Figure 6.6). 
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Figure 6. 6 Percentage of CD86+CD14+ in SVF fraction of synovium and IPFP from Lean and 
Obese OA patients (A).  
The mean percentage for the group termed as “Lean” n=7 and “Obese” n=6±SD is shown (A). The 
correlation of the percentage of CD86+CD14+ with BMI score in the synovium and IPFP is shown in 
(B) and (C) respectively p value<0.05 indicated as * 
 
The data obtained (Figure 6.6) suggest that there was a higher frequency of CD14+ 
CD86+ cells in the synovium of obese OA patients in comparison to Lean ones, but 




The Role of Severe Obesity in Osteoarthritis 
 Doctoral Degree The University of Edinburgh 2016 
 123 
between paired synovium and IPFP in CD86+CD14+ frequency. MFI analysis 
showed no difference in intensity of CD14 and CD86 staining between all groups 
(data not shown).  
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6.2.1.4 Other macrophage markers: HLA-DR 
Another macrophage-related marker HLA-DR has been investigated (see Figure 6.7). 
 
Figure 6. 7 HLA-DR markers detection in synovium and IPFP SVF fraction.  
SVF fractions were analysed according to HLA-DR expression. Isotype control (A) was analysed at 
the same time with a sample of interest. Representative plots for Lean (B) and Obese (C) SVF staining 
are presented. 
 
The percentage of HLA-DR positive cells in the SVF cell population was calculated 
(see Figure 6.8). 
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Figure 6. 8 Percentage of HLA-DR+ cells in SVF fraction of synovium and IPFP from Lean and 
Obese OA patients.  
The mean percentage for the group termed “Lean” n=12 for synovium, n=8 for IPFP and “Obese” 
n=12 for synovium, n=8 for IPFP ±SD is shown (A, B). The correlation of the percentage of HLA-
DR+ with BMI score in the synovium and IPFP is shown in (B) and (C) respectively p value<0.05 
indicated as *, p value<0.001 indicated as ***. 
 
The data (Figure 6.8) suggest that there was a higher frequency of HLA-DR+ cells in 
both the synovium and IPFP from obese OA patients in comparison to lean ones. 
There was no difference between paired synovium vs. IPFP HLA-DR+ cell 
percentage in both groups.  
A 
C B 
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HLA-DR mean fluorescence intensity was also analysed. MFI analysis didn’t show 
the difference in HLA-DR expression indicating that the difference between lean and 
obese samples comes from increased number of HLA-DR+ cells but not the increased 
expression of that protein on the surface (data not shown). 
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6.2.1.5 CD36 
CD36 expression was also analysed (see Figure 6.9). 
 
Figure 6. 9 CD36+ markers detection in synovium and IPFP SVF fraction.  
SVF fractions were analysed according to CD36+ expression. Isotype control (A) was analysed at the 
same time with a sample of interest. Representative plots for Lean (B) and Obese (C) SVF staining is 
presented. 
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Figure 6. 10 Percentage of CD36+ cells in SVF fraction of synovium and IPFP from Lean and 
Obese OA patients (A).  
The mean percentage for the group termed “Lean” n=12 and “Obese” n=16 ±SD is shown (A)The 
correlation of the percentage of CD36+ with BMI score in the synovium and IPFP is shown in (B) and 
(C) respectively. p value<0.001 indicated as ***. 
 
The data (Figure 6.11) suggest that there was a higher frequency of CD36+ cells in 
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difference in CD36+ cell frequency in the IPFP of obese and lean patients, but there 
was a significant difference between the paired synovium vs. IPFP CD36+ cell 
content.  
MFI analysis didn’t show the difference in CD36 expression indicating that the 
difference between lean and obese samples comes from increased number of CD36+ 
cells but not the increased expression of that protein on the surface. 
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6.2.2 T lymphocytes 
Two soft tissue were also analysed for T lymphocyte content. The gating strategy is 
shown in Figure 6.11.  
  
Figure 6. 11 T cells detection in synovium SVF fraction. 
Gating strategy (A, B, C) and representative plots for CD3, CD3CD4 and CD3CD8 cells detection. 
Percentage of T cells subpopulations in SVF fraction of synovium from Lean and Obese OA patients 
(D).  
 
The percentage of T cell subpopulation in synovial SVF is shown in Figure 6.12. 
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Figure 6. 12 T cells detection in synovium SVF fraction.  
Percentage of T cells subpopulations in SVF fraction of synovium from Lean n=6 and Obese n=10 
OA patients. The mean percentage for the group ±SD is shown. p value<0.05 indicated as *. 
 
The data obtained here (Figure 6.12) suggest that there was no difference in the 
frequency of T cells (CD3 positive cells) in the synovium of obese patients with OA 
in comparison to lean ones. The frequency of CD3 CD4 positive cells was 
significantly higher in obese OA patients in the synovium. The CD3 CD8 positive T 
cell frequency was not different between the lean and obese groups. 
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6.2.2.1.1 IPFP T lymphocytes 
The percentage of T cell subpopulation in IPFP SVF is shown in Figure 6.13. 



























































































Figure 6. 13 T cells detection in IPFP SVF fraction.  
Percentage of T cells subpopulations in SVF fraction of IPFP from Lean n=6 and Obese n=10 OA 
patients. The mean percentage for the group ±SD is shown. p value<0.05 indicated as *, NS-non-
significant. 
 
The data (Figure 6.13) suggest that there was a tendency towards a higher frequency 
of CD3 positive cells in the IPFP (p=0.08) of obese patients with OA but this 
difference was not statistically significant. The frequency of CD3 CD4 and 
CD3 CD8 positive cells was not different between obese OA patients from the two 
groups. 
6.2.2.1.2 T cell population analysis in IPFP versus synovium 
Differences in synovium and IPFP content of CD3, CD3CD4 and CD3CD8 positive 
cells was also investigated (Figure 6.14). 
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Figure 6. 14 T cells detected in synovium and IPFP SVF. 
Percentage of T cells subpopulations in SVF fraction of synovium and IPFP from OA patients. The 
mean percentage for the group ±SD is shown. p value<0.05 indicated as *. 
The data presented (Figure 6.14) suggest that there was a significantly higher 
frequency of CD3 positive cells and CD3CD8 in the synovium compared to the IPFP 
while there was no difference in the CD3CD4 population between IPFP and 
synovium from the same donor. 
T cell subtypes (CD4/CD8) ratio has been postulated to be important in several 
tissues. Differences in synovium and IPFP content of ratio of CD3CD4 to CD3CD8 
was also investigated (Figure 6.15). 
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Figure 6. 15 CD4/CD8 T cell ratio detected in synovium and IPFP SVF. 
The ratio of the percentage of T cells subpopulations in SVF fraction of synovium and IPFP from OA 
patients. The mean ratio of the percentage CD3CD4/CD3CD8 for each of the group ±SD is shown. p 
value<0.05 indicated as *.ns – non-significant. 
 
Data suggest that there is the significantly higher ratio of CD3CD4/CD3CD8 T cells 
in synovium from Obese in comparison to Lean OA patients and there is no 
difference in IPFP in both groups. Furthermore, there is no difference in 
CD3CD4/CD3CD8 ration between paired synovium and IPFP. 
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6.3 Summary and Conclusions 
In conclusion, obtained data revealed a number of important points: 
1) Osteoarthritic Infrapatellar Fat Pad (IPFP) and synovium obtained after TKR 
are potent sources of adipose tissue macrophages (ATM). 
2) IPFP and synovium from Obese OA patients have an increased number of 
Adipose Tissue Macrophages characterized by CD45+CD14+, CD14+CD206+. 
Furthermore, synovium from obese patients is characterized by increased 
number of CD86+CD14+ cells. 
3) Increase number of ATMs in synovium and IPFP is accompanied with 
increase expression of other macrophage-related proteins (e.i HLA-DR). 
4) Lean synovium express significantly lower CD36 in comparison to paired 
IPFP. CD36 expression increases in the synovium of obese patients in 
comparison to lean ones and doesn’t change in IPFP. 
5) There is a significantly higher number of CD3+ CD4+ T cells in synovium 
from Obese OA patients while there is no difference in these cells population 
in IPFP. 
6) There is a significantly higher number of CD3+ T cells and CD3+CD8+ T cells 
in synovium in comparison to IPFP from the same donor. The ratio of 
CD4/CD8 T cells is significantly higher in synovium from obese in 
comparison to lean OA patient. There is no such difference in IPFP. 
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 The differences in obesity-related 
markers in osteoblasts, cellular and structural 
changes in subchondral bone from lean and 
obese OA patients 
Skeletal bone is not only the biggest scaffold within the body and hematopoietic cells 
producer, but is also considered potent endocrine organ (Malekipour et al., 2013; 
Oldknow et al., 2015). Subchondral bone is a part of the knee having direct contact 
with cartilage. It has high porosity and is easily penetrable which allows the 
communication of bone and cartilage. Subchondral bone consists of a subchondral 
plate, in direct contact with cartilage and the subchondral trabeculae/subarticular 
spongiosa (Madry et al., 2010). Subchondral bone density and strength can adapt to 
mechanical loading. Subchondral trabecular bone is important in shock-absorbing 
and providing sufficient nutritional supply. 
It is an active component in pathological changes during OA development (Grynpas 
et al., 1991; Hayami et al., 2004). Bone modelling and remodelling depend on two 
main cell types – osteoblasts and osteoclasts (Ducy et al., 2000; Adamopoulos et al., 
2015). Osteoblasts are important in new-bone formation, while osteoclasts in bone 
resorption. 
Osteoblasts derive from mesenchymal stem cell and their main role is in initial bone 
formation in both synthesis and mineralisation, in addition to bone remodelling at 
later stages (Ducy et al., 2000). They are also responsible for regulation of osteoclast 
differentiation and activity in bone resorption (Adamopoulos et al., 2015). 
Osteoblasts entrapped in bone matrix become osteocytes. They are terminally 
differentiated, do not proliferate and reside in lacunae and canaliculi.  
Osteoclasts are multinucleated cells which differentiate from bone marrow- derived 
macrophages and are responsible for bone resorption. These cells are larger in size 
than osteoblasts and possess several nuclei (Jain et al., 2009). Osteoclasts have the 
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ability to resorb bone and can be found on the bone surface in shallow pits of 
trabecular bone. They produce specific proteins including TRAP (tartrate-resistant 
acid phosphatase) and various lysosomal enzymes and serine proteases. M-CSF 
(Macrophages Colony Stimulating Factor) plays a crucial role in osteoclastogenesis 
(Teitelbaum, 2000). Mice lacking M-CSF (op/op) exhibit osteopetrotic phenotype 
(Wiktor-Jedrzejczak et al., 1982). Together osteoblasts and osteoclasts maintain bone 
homeostasis (Adamopoulos et al., 2015).  
Micro-computed tomography (µCT) is an X-ray based 3D imaging technique. It uses 
a standard CT (computed tomography) method with high-intensity X-rays. The CT 
method is based on computerised combined X-ray images taken from different 
angles and produces a cross-sectional image. High-intensity X-rays used in µCT 
method allow the use of micrometre range pixel size and 360o degree rotation 
platform to obtain a very detailed 3D image. It is a non-invasive technique that can 
be used to calculate following values: 
Bone Volume/Total Volume (BV/TV) - which represents the volume of interest 
(VOI) that is occupied by mineralised bone (Bone Volume). BV/TV is normally 
presented as a percentage value. It is often used to evaluate changes in bone volume 
density during the pathogenesis of many diseases including osteoarthritis and 
osteoporosis (Xiao et al., 2015). Trabecular Thickness (Tb.Th.) represents an average 
thickness of trabeculae in the analysed volume of interest. Hildebrand and 
Ruegsegger et al defined local thickness as a diameter of the largest sphere which 
includes a certain point and can be fitted inside analysed structure (Hildebrand et al., 
1997). Trabecular Spacing (Tb.Sp.) is represented by the average space between 
bone structures in the volume of interest. It is determined using the mean diameters 
of fitting maximal spheres fitted into the non-bone structure (Hildebrand et al., 
1999). Trabecular Number (Tb.N.) is a number of trabeculae per unit length (1/mm) 
(Kim et. Al., 2015). Bone Mineral Density (BMD) is defined as the volumetric 
density of bone measured in g/cm3 calculated with scans of a calcium hydroxyapatite 
phantom with known density (Miller et al., 1999). 
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BMD positively correlates with OA in the knee and spine (Hart et al., 1994) but there 
is no correlation of BMD in hand OA (Sowers et al., 1999). Studies of bone 
resorption markers are contradictory, some reporting increases (Stewart et al., 1999) 
other decreases (Sowers et al., 1999) in OA where the difference correlates with 
methodology: X-Ray CT or photon measurement, sample location and size. 
Since it is difficult to analyse OA-affected compartments of the knee joint (such as 
femoral condyles and tibial plateau) due to different stages of bone sclerosis in OA 
patients, minimal or no OA-affected compartments of the joint called posterior 
lateral femoral condyles were analysed. These are also the least weight-bearing 
region in the knee joint. Their location is shown in Figure 7.1.  
 
 
Figure 7. 1 Knee parasagittal section-lateral to the midline of the knee with posterior femoral 
condyle indicated.  
Image adapted from Encyclopedia Britannica inc. 
It is important to characterize the molecular role of cells lying in the subchondral part 
of the joint, and particularly their behaviour in obesity. Additional information 
including bone density could help with the description of changes in OA tissue 
during weight gain. Many other adipose-derived factors take part in bone 
remodelling as well. It would be interesting to connect molecular and physical 
changes in this part of the joint. 
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7.1 Aims 
Specifically, the aims were: 
1) To investigate the obesity-related gene expression difference in osteoblasts 
obtained from obese and lean patients with OA. 
2) To describe the changes in the bone microstructure of the minimally OA-
affected and least-weight bearing compartment of the knee  in obese and lean 
patients with OA. 
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7.2 Results 
7.2.1 Osteoblast-specific gene expression in human primary 
osteoblasts from OA patients 
Gene expression of osteoblast isolated from subchondral region of patellofemoral 
compartment from lean and obese subjects with OA has been analysed by Real Time 
PCR technique. Osteoblast-specific genes included: alkaline phosphatase (ALPL), 
osteocalcin (BGLAP), biglycan (BGN), Bone-Morphogenic Protein 1 (BMP1), 
collagen I (COL1A1, COL1A2), matrix metalloproteinase 2 (MMP-2) and 
Transforming Growth Factor β (TGFB-1) using Osteogenesis RT2 Real Time 
Profiler (Qiagen). The choice of osteoblast-related genes was based on supplier 
suggestions. Results presented in Table 5 as a heat map (with lighter colour 
indicating lower and darker colour indicating higher expression). 
Table 4 Human Primary Osteoblast gene expression characterisation.  
 
Expression of osteoblast-specific genes: ALPL, BGLAP, BGN, BMP1, COL1A1, COL1A2, MMP-2 
and TGFB-1 has been confirmed using the commercially available Osteogenesis RT2 Real Time 
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Profiler. cDNA from 3 donors per each group (Lean and Obese) has been pulled and Real Time PCR 
has been conducted. 
The data obtained (Table 5) confirmed that human primary osteoblasts expressed 
osteoblasts related genes. 
7.2.2 Obesity-specific gene expression in human primary 
osteoblasts from OA patients 
Obesity-related genes including ADIPOQ, ADIPOR1, ADIPOR2, LEP, LEPR, 
PPARγ, CCL2, NAMPT expression was investigated in osteoblasts obtained from 
Lean and Obese OA patients (Figure 7.2). 
 
Figure 7. 2 Quantitative PCR analysis of PPARγ (A), ADIPOR2 (B), ADIPOR1 (C), MCP-
1/CCL2 (D) and NAMPT (visfatin) (E) expression in osteoblasts obtained from different OA 
patients (A-E). 
Two groups termed “Lean” (n=5) and “Obese” (n=7) were defined according to BMI as described 
before. B2M was used to normalise gene expression. The -ΔΔCT method was used to investigate fold 
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change in gene expression. The mean value of Lean Group was used as a calibrator. The control 
values were expressed as 1 to indicate a precise fold change value for each gene of interest. SEM bars 
are shown. p values < 0.05 were considered significant and indicated as *, NS-non-significant. 
 
Real Time PCR revealed that both adiponectin and leptin are expressed by 
osteoblasts but at a very low level (data not shown). Osteoblast expression of 
ADIPOQ, ADIPOR1, CCL2/MCP-1, LEP, LEPR and NAMPT was not significantly 
different between patient groups. However, expression of adiponectin receptor 
ADIPOR2 was significantly higher and of PPARγ significantly lower in obese 
patients as compared to lean patients. Figure 7.1). Osteoblasts expressed ADIPOR1 
significantly higher than ADIPOR2 (see Appendix 9). 
7.2.3 OA Subchondral bone microstructure 
The microstructure of the Femoral Condyles from OA patients was assessed by the 
µCT method as described in Materials and Methods (Chapter 2). 
An example of Femoral Condyle analysis is presented in Figure 7.3. 
 
Figure 7. 3 Example of µCT analysis of Femoral Condyle microarchitecture.  
The Volume of Interest (VOI) was defined as 3mm3 cube below subchondral plate region in non-
weight bearing Femoral Condyle from OA patients. Patients were divided into Lean and Obese as 
summarised in Table4. 
  
The Role of Severe Obesity in Osteoarthritis 
 Doctoral Degree The University of Edinburgh 2016 
 143 
24 Femoral Condyles were analysed by the µCT method. Patients summary is shown 
in Table 6. 
Table 5 Summary of the patients µCT Femoral Condyle analysis. 
 Mean Age SD P value n 
Lean Female 70 ±7 NS 6 
Obese Female 66 ±5 NS 7 
Lean Male 68 ±6 NS 5 
Obese Male 67 ±5 NS 6 
 
Bone microarchitecture values (BV/TV, Tr.Th., Tr.Sp., Tr.N. and BMD) were 
calculated using Skyscan® software and presented in Figures 7.4-7.5. 
 
 
Figure 7. 4 A) BV/TV B) Tr.Th C) Tr.N. D)Tr.Sp. values were calculated from each volume of 
interest taken from each patients.  
Patients were divided into Lean and Obese as well as in regards to gender. Patients summary in Table 
6. Mean values of the parameters±SD per group are presented. NS-not significant. 
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Figure 7. 5 BMD value was calculated from each volume of interest taken from each patients.  
Patients were divided into Lean and Obese as well as in regards to gender. Mean values of BMD ±SD 
per group are presented. p values < 0.05 were considered significant and indicated as *, NS-Not 
significant. BMD values were calculated by Dr Rob Wallace. 
 
µCT data suggest that there is no difference between patient groups in any of the 
Bone microstructure parameters measured, including BV/TV, Tr.Th., Tr. Sep. and 
Tr. Nr. regardless of the gender. (Figure 7.3). However, the BMD parameter 
(calculated by Dr Rob Wallace) while not different between obese and lean female 
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7.2.3.1 Subchondral bone adipose tissue macrophages in OA patients. 
The presence of CD68+ cells within subchondral bone marrow was investigated by 
immunohistochemical method (Figure 7.6). 
 
Figure 7. 6 Subchondral bone CD68+ cells in bone marrow.  
IHC staining of paraffin-embedded subchondral bone samples (n=3 for each group) confirmed the 
expression of CD68+ positive cells (brown colour) in bone marrow adipose tissue. Different patients 
(A-D) are presented. 
 
Data (Figure 7.5) suggest that there may be a higher number of CD68+cells in 
subchondral bone adipose tissue from obese patients with OA. 
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7.3 Conclusions and Summary 
In conclusion, the data obtained revealed a number of important points: 
1. Osteoblasts from patients with OA express a number of obesity-related 
genes including ADIPOQ (adiponectin), LEP (leptin), their receptors 
(ADIPOR1, ADIPOR2, LEPR), NAMPT, monocyte-chemotactic 
protein 1 (CCL2/MCP-1) and PPARγ. 
2. Osteoblasts from patients with OA express a higher level of adiponectin 
receptor ADIPOR1 than ADIPOR2. 
3. Osteoblasts from lean and obese patients with OA differ in expression of 
genes connected with the pathogenesis of obesity. There is a significantly 
lower expression of PPARγ and higher ADIPOR2 in obese patients’ 
osteoblasts in comparison to lean ones. No differences in other expression 
of investigated genes ADIPOQ, LEP, LEPR, ADIPOR1, NAMPT and 
CCL2/MCP-1 was found. 
4.  No differences in bone microstructure parameters were found between 
lean and obese subjects with OA. Furthermore, no difference in bone 
mineral density between lean and obese in women but significantly lower 
BMD in obese males was found in comparison to lean ones. 
5. There was a higher number of CD68 positive cells in bone marrow 
adipose tissue in obese patients in comparison to lean ones found. 
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 General Discussion and Future 
Perspectives 
Mechanical loading is commonly considered to be the main contributor to the 
pathogenesis of OA. However, emerging data suggest that molecular factors are of 
high importance as well (Guilak et al., 2004). The current knowledge of proteins 
playing a major role in OA helps in better understanding the disease as a whole. 
Recent studies have reported that obesity-related molecules have a great impact on 
the development of OA.  
Obesity is involved in dysfunction not only of adipose tissue but also in a number of 
other organs within the body. OA is now considered as a systemic disease, which 
affects all tissues within the knee joint. Knee articular tissues are potent producers of 
adipose tissue-associated markers. Several proteins produced by adipose tissue are 
considered potent players in OA progression. Data presented here and by others (Rai 
et al., 2014) suggest that expression and secretion of some molecules is altered in 
obese and lean individuals with OA.  
The limitation of the study were:  first of all, patients with end-stage OA were 
diagnosed only based on X-ray by orthopaedic surgeon. No cartilage damage scoring 
(such as Kellgren and Lawrence system) to classify OA stage has been used. Which 
may lead to differences/variation in obtained data. Secondly, this study doesn’t 
include non-OA affected subjects. Therefore the results obtained here may be not 
associated with aetiology/pathogenesis of OA but simply reflecting the lean or obese 
status of analysed patients.  
The main strength of this study was the number of analysed samples at gene 
expression level. Two different set of samples have been used for RT-PCR (26) and 
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8.1 Adipokines and adipose tissue-related markers 
8.1.1 Adiponectin 
Adiponectin is considered to be a protective adipokine in most obesity-related 
pathologies. It increases insulin sensitivity, reduces circulating fatty acids and 
triglyceride deposition in liver and muscle (Fantuzzi, 2005). It is known to attenuate 
TNF-α pro-inflammatory action in endothelial cells and thus to reduce the 
progression of atherosclerosis (Ouchi et al., 1999). Adiponectin also protects against 
cardiac inflammation mediated by angiotensin II by increasing the autophagy of 
macrophages. Therefore, adiponectin is considered to be an anti-inflammatory 
protein in terms of T2DM and atherosclerosis.  
However, the role of adiponectin in OA is still controversial. The majority of 
authors, state it has a pro-inflammatory role in cartilage metabolism (Chen et al., 
2006; Kang et al., 2010). Nevertheless, circulating levels of adiponectin have been 
reported to be higher than that of synovial fluid level in some individuals (Presle et 
al., 2006; Honsawek et al., 2010; Gandhi et al., 2011). Furthermore, serum 
adiponectin level has been found to correlate negatively with the BMI of OA patients 
(Chen et al., 2006; de Boer et al., 2012) and its synovial fluid level to correlate 
negatively with degradation markers including Aggrecan I and Aggrecan II. Thus, 
adiponectin may also be postulated as an anabolic factor. 
Hence, one of the goals of the current studies was to investigate the difference in 
adiponectin production by the local tissues within the knee of lean and obese OA 
patients. Table 7 summarises the obtained data in regards to adiponectin and 
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Table 6 Summary of adiponectin and its receptors expression data  
 
  
Adiponectin expression was detected in monolayer chondrocyte cell culture on a 
very low level. Francin et al., studied adiponectin expression in different 
chondrocytes cell culture models and found that adiponectin was present in cartilage 
but its expression is down-regulated in monolayer cell culture (Francin et al., 2011). 
There are discrepancies regarding adiponectin receptors expression in cartilage. Here 
chondrocytes from OA patients expressed both adiponectin receptors with 
significantly higher expression of ADIPOR1 compared to ADIPOR2. Further, this 
difference was significantly higher in chondrocytes from obese as compared to lean 
patients, which may imply an important role for this receptor in the OA process in 
obese patients. Other authors have recently reported that these two receptors are 
down-regulated in osteoarthritic compared to healthy chondrocytes (Wang et al., 
2014). Some authors report that only ADIPOR1 is present in cartilage (Chen et al., 
2006), while others indicate that both receptors are present, but with different 
localisation within the cartilage (Kang et al., 2010). It has been suggested that 
binding of adiponectin to ADIPOR1 receptor increases MMP-3 expression in 
chondrocytes (Tong et al., 2011). Elevated expression of this receptor could suggest 
that adiponectin has an important function in OA chondrocytes.  
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The present study also identified adiponectin expression in OA Synovium (Chapter 
4) and IPFP (Chapter 5) which concurs with previous findings (Presle et al., 2006; 
Tan et al., 2009). In addition, the presented data have demonstrated that adiponectin 
had a significantly lower expression both at gene and protein level in the synovium 
from obese subjects with OA but remained at the same level in their IPFP. 
Adiponectin was also secreted at a lower level in the media of synovium explants 
from obese patients but not from their IPFP.  
Although some researchers consider adiponectin to be a pro-catabolic protein in the 
pathogenesis of OA (Xie et al., 2007; Gomez et al., 2011; Tong et al., 2011) there is 
also evidence that it has a pro-anabolic protective role in cartilage (Bastiaansen-
Jenniskens et al., 2012). Obtained data here (Figure 4.8, 5.7) suggest that both 
synovium and IPFP were capable of producing adiponectin in the ‘ng/ml’ range. Tan 
et al. and others (Koch et al., 1992; Presle et al., 2006; Tan et al., 2009; Gandhi et al., 
2010) have reported that the synovial fluid adiponectin level reached 400-600ng/ml 
in OA while its serum level went as high as 10 µg/ml. It was interesting to note that 
the majority of studies, which have investigated adiponectin’s “pro-
inflammatory/catabolic role” in OA, have used superoptimal doses of that protein 
(Conde et al., 2012; Lee et al., 2012) as high as 100 µg/ml (Ehling et al., 2006).  
In paired samples (of synovium and IPFP) from lean subjects with OA adiponectin 
levels (both mRNA and protein) remained at the same level between these two tissue 
depots. In contrast, in Obese subjects, IPFP produced the significantly higher level of 
adiponectin than synovium. These differences could be explained by the 
developmental origin of those two tissues. Subcutaneous Adipose Tissue (SAT) was 
shown to produce more adiponectin than Visceral Adipose Tissue (VAT) during 
weight gain (Lihn et al., 2004; Hernandez-Morante et al., 2007). In addition, the 
IPFP was shown to produce more adiponectin than paired subcutaneous adipose 
(SAT) tissue from the same donor (Distel et al., 2009; Klein-Wieringa et al., 2011) 
which may suggest IPFP to be a potent adiponectin producing fatty depot. In the 
future, it would be very interesting to analyse the origin of two adipose tissue depots 
(synovial and IPFP) within the knee. 
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Osteoblast expression of adiponectin and its receptors has already been confirmed by 
others (Berner et al., 2004). Presented data also show that primary human osteoblasts 
expressed the adiponectin gene, although at a very low level. In this study results 
show that similar to chondrocytes, osteoblasts expressed significantly higher 
ADIPOR1 than ADIPOR2 (Appendix 9). ADIPOR1 is more ubiquitously expressed 
than ADIPOR2 in the majority of the tissues except liver (Yamauchi et al., 2003) and 
has been shown to be expressed at a higher level than ADIPOR2 in osteosarcoma 
cell line Saos-2 (Pacheco-Pantoja et al., 2014). The data presented here didn’t show a 
significant difference in adiponectin and ADIPOR1 gene expression between lean 
and obese patients’ osteoblasts. However, ADIPOR2 gene expression was 
significantly higher in osteoblasts from obese OA patients in comparison to lean ones 
(Figure 7.2) , whereas chondrocytes from obese patients, expressed significantly 
higher ADIPOR1 (Figure 3.3 and 3.7). It may suggest that adiponectin plays a 
different role in these two tissue types in obesity. 
ADIPOR1 and ADIPOR2 are transmembrane receptors sharing about 67% 
homology. They both are important in adiponectin-mediated glucose level regulation 
and fatty acid oxidation. ADIPOR1 is involved in activation of 5’ adenosine 
monophosphate-activated protein kinase (AMPK) pathway while ADIPOR2 induce 
PPARα receptor activation cascade. 
Adiponectin knockout mice have impaired bone growth and adiponectin inhibits 
RANKL expression (an important factor in osteoclast activity), in macrophage 
cell-line (Tu et al., 2011). Conversely, other authors suggest that adiponectin 
stimulates RANKL and down-regulate OPG expression in osteoblasts (Luo et al., 
2006; Pacheco-Pantoja et al., 2014) by ADIPOR1 mediated pathway. This could 
postulate that this protein has a dual role in bone homeostasis and be responsible for 
balancing the bone remodelling processes. There is no available literature about the 
precise role of ADIPOR2 in osteoblasts. 
Adiponectin has been also shown to upregulate MMP-3 (important cartilage 
destruction/pro-catabolic enzyme) in cartilage through ADIPOR1 but not ADIPOR2 
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(Tong et al., 2011). What’s more, adiponectin-induced migration of chondrosarcoma 
cells through the AMPK mediated pathway (Chiu et al., 2009).  
It is interesting how a small number of researchers focus on adiponectin receptor in 
bone and cartilage as well as on the full mechanism of adiponectin action in those 
tissues. It would be interesting to further explore the role of this protein and its 
receptors in knee joint tissues by small molecules targeting or knockout experiments. 
8.1.2  PPARγ 
PPARγ is a nuclear receptor in the family of receptors, which is important in the 
regulation of many processes within the cells, including (1) glucose and lipid 
homeostasis, (2) adipogenesis, (3) the immune response and (4) cell differentiation. 
PPARγ expression in obesity is still controversial: it has been reported to be both up- 
and down-regulated in obese tissues (Vidal-Puig et al., 1997; Hammes et al., 2012). 
Several studies have described the expression of PPARγ in human cartilage and 
chondrocytes (Francois et al., 2004; Shao et al., 2005; Grogan et al., 2013). The 
putative protective role of PPARγ against OA is supported by reports that PPARγ 
expression is higher in normal as compared to OA cartilage (Afif et al., 2007) and 
that mice with PPARγ knocked out develop OA (Vasheghani et al., 2015). Many 
PPARγ agonists (called thiazolidinediones/TZD) are now used as potent anti-diabetic 
and anti-inflammatory factors (Monsalve et al., 2013). It has been suggested that 
PPARγ agonists may also be potential therapeutic drugs for arthritic diseases 
including RA (Giaginis et al., 2009). In addition, the PPARγ agonist – pioglitazone, 
has been shown to inhibit OA progression in a guinea pig experimental model of OA 
(Kobayashi et al., 2005). Pro-inflammatory cytokines such as IL-1β and TNF-α have 
been reported to down-regulate PPARγ expression in human chondrocytes (Afif et 
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Data obtained in this study are summarized in Table 8. 
Table 7 Summary of PPARγ expression data   
 
In the presented chondrocyte monolayer model, it was possible to demonstrate lower 
expression of both PPARγ gene and protein expression in obese patients cells. 
Further studies (including mass spectrometry) would help to investigate in vivo 
difference in PPARγ cartilage expression. Demonstrating a key role for reduced 
PPARγ activity in the pathogenesis of OA in obese patients is challenging as both 
mRNA and protein isolation from cartilage are very difficult. It was not possible to 
show differences in PPARγ expression in obese vs. lean patients cartilage 
PPARγ has been described in RA synovium mainly in macrophages and synovial 
fibroblasts in the lining area, but also in fibroblasts and endothelial cells in sublining 
compartments (Kawahito et al., 2000). Immunohistochemical staining in this study 
confirms expression of PPARγ in several cell types in OA Synovium and IPFP. 
Furthermore, obtained data suggest that PPARγ gene and protein is expressed at 
lower level in both of those tissues in obesity (Chapter 4 and 5). In contrast, it has 
been reported that PPARγ expression was up-regulated in the IPFP at the endstage of 
OA (Clockaerts et al., 2012) however, no distinction between obese and lean patients 
was made. PPARγ anti-inflammatory role was confirmed by Mouilin et al. and 
others, who described that PPARγ agonists inhibited IL-1β mediated cyclooxygenase 
2 (COX-2) production in synovial fibroblasts (Simonin et al., 2002; Moulin et al., 
2006). 
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Comparison of PPARγ expression between paired IPFP and synovium showed it is 
significantly higher in IPFP. Some studies have demonstrated that PPARγ is 
expressed at a lower level in visceral than subcutaneous adipose tissue (Hammes et 
al., 2012; Garin-Shkolnik et al., 2014). Other studies have shown a significantly 
lower expression of PPARγ in the IPFP in comparison to paired subcutaneous 
adipose tissue (Distel et al., 2009). Therefore, this significant difference between 
IPFP and synovium in PPARγ expression can suggest a potential different 
developmental origin as was seen in adiponectin expression. 
Furthermore, PPARγ is a known activator of adipogenesis and a repressor of 
osteoblastogenesis. PPARγ agonists including rosiglitazone or pioglitazone (both 
from TZD family) are known to cause bone resorption in mice (Ali et al., 2005). 
However, pioglitazone has been postulated to increase bone mineral density in 
induced arthritis (Koufany et al., 2013). PPARγ depletion in bone marrow-derived 
mesenchymal stem cells facilitated pro-osteoblastogenic phenotype, with increased 
bone formation markers and trabecular architecture (James et al., 2014). PPARγ is 
also a confirmed promotor of osteoclastogenesis and positive modulator of bone 
resorption. PPARγ deletion in hematopoietic but not mesenchymal cells resulted in 
osteopetrosis. In addition, PPARγ ligand stimulation accelerated osteoclast 
maturation and bone resorption (Wan et al., 2007). Osteoclasts in mice display M2 
phenotype and PPARγ agonist stimulation increase expression of M2 type markers 
including CD206 expression.  
The data presented show that primary human osteoblasts express PPARγ and that its 
expression is significantly lower in obese patients’ osteoblasts in comparison to lean 
ones as was seen in chondrocytes.To mimic juvenile obesity Shu et al. fed young 
mice with a high-fat diet and observed lowered bone quality, increased osteoclast 
activity which correlated with increased total bone PPARγ expression. Interestingly 
the group also found increased osteoblast activity in the same model (Shu et al., 
2015). Similarly to adiponectin the PPARγ role in bone may be to maintain bone 
homeostasis. 
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To sum up, PPARγ expression was lower in all obese tissue/cell types investigated in 
the present study. These results suggest that PPARγ could be a potent OA/obesity 
target in future research, especially given that PPARγ agonists are already used in 
treating obesity-related diseases for example T2DM. 
8.1.3 Visfatin 
Visfatin was initially described as an adipokine produced predominantly by visceral 
fat (Fukuhara et al., 2005), however, it has now been described in many cell and 
tissue types. It has three different roles which are reflected by its three different 
names: (1) PBEF (from Pre-B-cell colony-Enhancing Factor 1) reflecting its role as 
an active cytokine involved in lymphocyte survival, (2) NAMPT (from 
NictotinAMide PhosphoribosyloTransferase) reflecting its role as an intracellular 
rate limiting enzyme and (3) visfatin reflecting its role as a hormone involved in 
obesity. Nonetheless, its specific role in the pathogenesis of obesity and OA has still 
not been fully determined. 
Visfatin has been suggested to play a pro-inflammatory role in cartilage(Gosset et al., 
2008; Laiguillon et al., 2014). Furthermore, its level is elevated in the Synovial Fluid 
from OA patients compared to normal subjects (Duan et al., 2012) and varies 
between 10-50 ng/ml (Nowell et al., 2006; Rho et al., 2009). However, most of the 
studies postulating its pro-inflammatory role in OA have used non-physiological 
concentrations in in vitro studies (100ng/ml up to 5 µg/ml) (McNulty et al., 2011; 
Yammani et al., 2012). Additionally, in the majority of studies related to arthritic 
disease visfatin is considered only as a secretory protein with no acknowledgment of 
its important intracellular enzymatic role. However, this protein is very important in 
several intracellular pathways including the biosynthesis of nicotinamide adenine 
dinucleotide (NAD) a coenzyme crucial in many cellular metabolic processes.  
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Data from this study are summarized in Table 9. 
Table 8 Summary of visfatin/NAMPT expression  
 
The results reported here confirm abundant expression of visfatin in chondrocytes 
both in monolayer cell culture and in cartilage. IF stainings show both cytoplasmic 
and nuclear location of this protein which may suggest that visfatin has not only a 
role as a secreted adipokine but also an intracellular enzyme in chondrocytes. 
Previous studies have shown that visfatin localisation within the cell is strictly 
correlated with cell cycle (Kitani et al., 2003) and the presence of pro-inflammatory 
factors including IL-1β (Romacho et al., 2013). IL-1β has also been shown to 
markedly up-regulate visfatin gene expression in chondrocytes (Gosset et al., 2008). 
Surprisingly, in the current studies, mRNA expression of the visfatin gene 
(NAMPT), which has previously been reported as a pro-inflammatory adipokine in 
chondrocyte biology, was significantly lower in the chondrocytes from obese OA 
patients. Lower expression of visfatin gene and protein in chondrocytes from obese 
patients may suggest different molecular processes occurring in ‘obese’ 
chondrocytes. 
Visfatin expression has been previously described in the synovium of RA and OA 
patients (Brentano et al., 2007; Laiguillon et al., 2014). Furthermore, visfatin 
secretion by IPFP has also been reported previously (Chen et al., 2010). 
Interestingly, visfatin is produced by the IPFP at a higher level than by paired 
subcutaneous fat depots mainly by cells other than adipocytes (Barth et al., 2010; 
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Klein-Wieringa et al., 2011). However, Chen et al reported that the synovium and 
IPFP produced visfatin at similar levels  (Chen et al., 2010).  
The data reported here also indicated that visfatin was present in OA synovium and 
IPFP which concurred with Chen’s group’s data. visfatin was expressed at similar 
levels in the IPFP and synovium. However, the data reported here indicated that 
intracellular visfatin was down-regulated at both gene and protein level in the 
synovium and IPFP from obese patients with OA.  
Surprisingly, in this study, two bands were detected in Western Blot analysis for 
visfatin, 54 and approximately 72kDa, in both synovium and IPFP. The majority of 
published studies presented only a 54kDa visfatin band (Brentano et al., 2007). 
However, some investigators detected the higher molecular weight band (Laiguillon 
et al., 2014) but didn’t discuss its presence. The 72kDA band could be a non-specific 
binding of the primary antibody or as yet unexplained post-translational modification 
of this protein. UniProt analysis of visfatin protein reveals that it has several possible 
ubiquitination regions (NX_P43490). Furthermore, auto-phosphorylation of the 
active enzyme has been also postulated (Wang et al., 2006). In the future 
immunoprecipitation or mass spectrometry analysis of visfatin production could help 
with understanding its role in OA tissues. 
The NAMPT gene was expressed by the human osteoblasts analysed in this study. 
There was no significant difference in NAMPT expression between lean and obese 
patients’ osteoblasts. visfatin has been reported to promote osteoblast proliferation 
and collagen secretion (Xie et al., 2007) and to block osteoclast differentiation 
(Moschen et al., 2010). Conversely, Moschen et al. in the same study showed that 
visfatin circulating level negatively correlated with BMD in inflammatory bowel 
disease.  
In summary, data presented here unexpectedly show that visfatin expression is lower 
in chondrocytes, synovium and IPFP of obese patients than in lean ones. Further 
investigation of the role of intracellular/enzymatic visfatin may be helpful in 
explaining the role of this protein in osteoarthritic tissues. 
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Adipokines and obesity-related proteins combined summary is shown in Table 9. 




To sum up, all obtained data may suggest that there are diverse molecular patterns in 
the pathogenesis or progression of OA between lean and obese subjects. Differential 
expression of ADIPOR1 and ADIPOR2 between two cell types (chondrocytes and 
osteoblasts) and altered adiponectin expression in synovium and IPFP may point this 
protein as an important factor at the crossroad between obesity and OA. It can also 
suggest that all tissues forming the knee joint can have differential roles in OA 
pathogenesis. Furthermore, PPARγ expression was significantly lower in all obtained 
tissue types in obesity which can suggest an important role of this nuclear factor. 
Similarly, visfatin’s lower expression in obese patients chondrocytes, synovium and 
IPFP raise importance for the further analysis of this molecule. 
Although presented data don’t fully explain the differences in obese and lean OA 
patients, they can suggest some molecular variances between those two groups. 
Interestingly PPARγ agonists are known inducers of adiponectin (Maeda et al., 2001; 
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Kudoh et al., 2011) and adiponectin receptors (Sun et al., 2006) which could partially 
connect data obtained in synovium but doesn’t explain high adiponectin production 
by IPFP. Furthermore, Rosiglitazone – one of the PPARγ agonist significantly 
induced both visfatin and adiponectin expression in rat adipose tissue (Choi et al., 
2005). Parallel down-regulation of both ADIPOQ and PPARγ has also been reported 
in Visceral Adipose Tissue of extremely obese subjects (Hammes et al., 2012). 
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8.2 Immune System Related Markers 
 
8.2.1 CCL2 
Monocyte chemotactic protein-1 (MCP-1, also known as Chemokine (C-C) ligand 2 
– CCL2) is a 13.8kDa peptide with four highly conserved residual cysteines, which 
have chemotactic properties. MCP-1/CCL2 is an important chemokine, which 
stimulates macrophage chemotaxis. Its expression is upregulated in obesity (Huber et 
al., 2008) and has an effect on tissue pathologies including plaque formation in 
coronary diseases (Gonzalez-Quesada et al., 2009). It is also chemotactic for T-cells 
and NK cells. MCP-1/CCL-2 mediates its effect mainly by engagement of the CCR2 
receptor (C-C motif chemokine receptor 2).  
CCL2/MCP-1 is a major factor in the pathogenesis of articular diseases including 
RA (Pavkova Goldbergova et al., 2012). Its expression was confirmed in OA 
chondrocytes by Yuan et al., and its up-regulation in chondrocytes was detected after 
IL-1β and TNF-α stimulation (Yuan et al., 2001).  
The data obtained in this study are presented in Table 11. 
Table 10 Summary of CCL2/MCP-1 expression data  
 
 
The present data show higher MCP-1/CCL2 gene expression in chondrocyte cell 
culture and higher protein production by cartilage from obese patients, which may 
suggest that ‘obese’ chondrocytes possess a more pro-inflammatory phenotype.  
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MCP-1/CCL2 is also produced by both synovium and infrapatellar fat pad explants 
as previously reported (Clockaerts et al., 2012). The data obtained confirm both 
mRNA and protein expression of MCP-1/CCL2 along with its secretion in synovium. 
MCP-1/CCL2 has been reported to be produced by fibroblast-like synoviocytes 
(FLS) after stimulation by pro-inflammatory cytokines (Ogura et al., 2010). 
Furthermore, its receptor (CCR2) can be found on fibroblast-like cells and it has 
been postulated to have a role in cell migration in RA (Garcia-Vicuna et al., 2004). 
Villiger et al showed that MCP-1/CCL2 was present in the synovial membrane of the 
synovium and in the perivascular area (Villiger et al., 1992). Another group 
(Vangsness et al., 2011) showed that the synovial fluid concentration of MCP-
1/CCL2 was greater in more advanced OA. Unfortunately, the correlation with BMI 
was not explored in those studies. MCP-1/CCL-2 has also been reported to be 
expressed by synovial fluid macrophages in RA and in OA (Koch et al., 1992). Its 
role in RA and inflammation of synovium has been well described (Patterson et al., 
2002). In samples from OA patients, MCP-1/CCL2 has previously been reported to 
be expressed in the sublining layer of the synovium along with the perivascular and 
interstitial areas of the synovium (Villiger et al., 1992).  
Local production of MCP-1/CCL2 in OA was measured using both PCR and ELISA 
techniques. The data obtained suggested that there was higher MCP-1/CCL2 gene 
expression in synovium from obese patients. The MCP-1/CCL2 secretion by 
synovial explants was not significantly higher; however, there was a trend towards 
higher MCP-1/CCL2 production in the specimens of synovium from obese in 
comparison to lean OA patients. MCP-1/CCL2 gene was also expressed by 
osteoblasts, but there was no significant difference between lean and obese patients’ 
osteoblasts. 
In conclusion, obtained data may suggest that MCP-1/CCL2 can be another potential 
protein for further investigation in the correlation between obesity and OA.  
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8.2.2 TLR4  
The innate immune system has developed several mechanisms to fight infection. 
Pattern-Recognition Receptors (PRR) evolved to recognise conserved structures 
called Pathogen-Associated Molecular Patterns (PAMPs) including 
Lipopolysaccharides (LPS), Mannose Binding Lectin (MBL), C-reactive protein 
(CRP), DNA or free fatty acids (FFA). The TLR (Toll-like receptor) family is a 
highly conserved group of type I transmembrane receptors which belong to PRR. 
TLRs play an essential role in pathogen recognition and in the innate immune 
response. There are more than 10 TLRs described in humans (Jialal et al., 2014). 
Furthermore, TLRs are also potent receptors for by-products produced by the host 
cells called damage-associated molecular patterns (DAMPs) including nucleic acids, 
low-density lipoproteins, extracellular matrix or free fatty acids, which can trigger 
the immune system without the actual presence of a pathogen. 
The two best-characterised TLRs are TLR2 and TLR4. Both have been described as 
playing an important role not only in bacterial infection but also in the development 
of such diseases as T2DM, atherosclerosis and obesity (Reyna et al., 2008). Obesity 
is associated with elevated levels of circulating free fatty acids (FFA) especially 
saturated fatty acids (SFA). SFA are potent agonists of TLR2 and TLR4 and can 
induce pro-inflammatory proteins production. In obese mouse models including 
ob/ob, db/db and diet-induced obesity (DIO), the TLR4 expression is elevated in 
adipocytes (Song et al., 2006; Tsukumo et al., 2007). Whereas, TLR4 knock out mice 
are protected from insulin resistance and do not display elevated pro-inflammatory 
proteins including IL-6, TNF-α and MCP-1/CCL2 despite increased adipose tissue 
mass (Shi et al., 2006; Davis et al., 2008). TLR4 is a protein, which plays a 
fundamental role in pathogen recognition and being a very potent signal transducer 
in many diseases not related to bacterial infection. It can bind and respond to many 
DAMPs. A study conducted by Sohn et al. (Sohn et al., 2012) suggested that 
circulating cytokines, which could be detected in synovial fluid of OA patients, could 
trigger an inflammatory process in joints by binding to TLR4. 
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TLR4 is present in healthy cartilage (Bobacz et al., 2007) and is induced in injured 
cartilage (Kim et al., 2006). Bobacz et al, state that TLR4 activation induces IL-1β 
and down-regulates collagen II and aggrecan expression. The data obtained in the 
present study are presented in Table 12. 
Table 11 Summary of TLR4 expression data  
 
Data presented here did not show any difference in TLR4 gene expression in 
chondrocytes and IPFP between the lean and obese OA groups. However, Synovial 
gene and protein expression revealed significantly higher TLR4 expression in obese 
samples which might suggest a more pro-inflammatory status of the synovium from 
obese patients with OA. 
TLR4 plays a crucial role in monocytosis and the accumulation of macrophages in 
adipose tissue of obese patients (Nagareddy et al., 2014). Macrophage cell death, 
which occurs in the lipotoxic condition of obesity is mediated by TLR4 (Schilling et 
al., 2013). 
In humans, VAT express higher levels of TLR4 than SAT. Furthermore, TLR4 
expression is up-regulated in obese human VAT but not SAT (Catalan et al., 2012). 
TLR4 deficiency promotes an alternative (M2) activation of macrophages (Orr et al., 
2012). In addition, TLR4 and PPARγ play important roles in the regulation of 
chemokine expression in adipocytes and macrophages (Nguyen et al., 2012). 
In summary, data presented here suggests that TLR4 is expressed at a significantly 
higher level in the synovium of obese compared to lean OA patients which indicate 
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that TLR4 may have an important role in linking OA and obesity. Additionally, 
chondrocytes and IPFP TLR4 expression is not different between two analysed 
groups. TLR4 expression was not analysed in osteoblast and can be a matter of future 
investigation. 
8.2.3 Vascular Cell Adhesion Molecule 1 (VCAM-1) 
Vascular Cell Adhesion Molecule 1 (VCAM-1) is an integrin which is important in 
the migration process of immune cells through vessels. It binds to the Very Late 
antigen 4 (VLA-4) integrin, which is expressed by many immune cells including T-
cells and monocytes. VCAM-1 mRNA and protein expression has been reported to 
be up-regulated in obese VAT (Bosanska et al., 2010). VCAM-1 has also been 
reported to be expressed in human synovial tissue, but only in the FLS and not in the 
fatty layer. Fibroblast-Like Synoviocytes are able to express VCAM-1 on their 
surface and its expression is induced by pro-inflammatory cytokines including IL-
1β (Morales-Ducret et al., 1992). There is an increased serum level of soluble 
VCAM-1 in erosive hand OA (Pulsatelli et al., 2013) and this protein is suggested to 
be a potent predictor of hand (Kalichman et al., 2011), hip and knee (Schett et al., 
2009) OA. Up-regulation of VCAM-1 expression by synovial cells is suggested to 
enhance leukocyte extravasation and adhesion of such cells as monocytes (Shang et 
al., 1998) and B-lymphocyte (Burger et al., 2001). VCAM-1 mediates adhesion of 
cells (lymphocytes, monocytes or eosinophils) to blood vessel walls for migration 
into tissues in inflammatory responses. It is expressed in normal chondrocytes and its 
expression is regulated by cytokines such as IL-1β or TNF-α (Kienzle et al., 1998). 
VCAM-1 expression is also induced by leptin and adiponectin (Conde et al., 2012).  
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Obtained data are summarized in Table 13. 
Table 12 Summary of VCAM-1 expression analysis 
 
The data presented here may suggest that there was no significant difference in 
chondrocytes and IPFP VCAM1 expression, but that was a higher VCAM1 mRNA 
production in obese OA synovium. Flow Cytometry analysis also suggested that the 
VCAM-1 protein expression in a stromovascular fraction of synovium was higher in 
obese subjects compared to lean ones. These data can possibly suggest VCAM-1 is 
an important molecule in the more pro-inflammatory phenotype of OA in obese 
patients. Increased Synovial VCAM-1 expression may suggest an increased immune 
cell intravasation in obese in comparison to lean OA patients. VCAM-1 expression 
was not analysed in osteoblasts and is a matter for future investigation. 
Table 13 Immune Cells related protein expression summary 
 
 
The Role of Severe Obesity in Osteoarthritis 
 Doctoral Degree The University of Edinburgh 2016 
 166 
Macrophage-related proteins including MCP-1/CCL2 and TLR4 in synovium of 
Obese subjects may suggest an augmented influx of those cells and maybe more pro-
inflammatory status of this tissue. Higher VCAM1 expression in synovium of Obese 
OA patients may suggest increased signal in this tissue for immune cells 
intravasation.  
8.2.4 Immune cells content in OA fatty tissues samples 
Macrophages are the most abundant leukocytes in adipose tissue. In lean patients, the 
majority of them display anti-inflammatory M2 phenotype (Lumeng et al., 2007) and 
express anti-inflammatory cytokines including IL-10 which helps in maintaining 
insulin sensitivity. In obese subjects, the number of macrophages increases and there 
is a “switch” from M2 type to M1 type and production of pro-inflammatory proteins 
including IL-1β, TNF-α, IL-6. Pro-inflammatory macrophages aggregate around 
dying and necrotic adipocytes, in addition to contributing to further adipose tissue 
inflammation. With weight gain up to 30% of genes upregulated in obesity are 
related to macrophages (Weisberg et al., 2003). However, the macrophage content in 
adipose tissue differs between fat depots. 
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Obtained data in Chapter 6 are summarized in Table 15 
Table 14 Summary of macrophage-related markers in SVF fraction of 
synovium and IPFP analysis 
 
 
The data obtained in this study suggested that the population of CD45+CD14+ cells 
was higher in the synovium and IPFP from obese OA subjects in comparison to lean 
ones. The number of CD14+CD206+ cells was also significantly higher in the 
synovium and IPFP from obese patients. CD206 is considered to be an M2-type 
macrophage marker in mice and has been reported to be up-regulated in humans with 
obesity (Bourlier et al., 2008; Wentworth et al., 2010; Haase et al., 2014). CD206 is a 
mannose receptor C type 1 (MRC1) and belongs to the mannose receptor family. It 
can be found in numerous cell types including macrophages, immature dendritic 
cells, epithelium and smooth muscle cells. It recognises terminal mannose and other 
monosaccharides which can be found on the surface of many microbial 
glycoproteins. Its main function is phagocytosis and internalisation of pathogens. 
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CD206 plays an important role in the resolution of inflammation by M2 
macrophages as it recognises glycoproteins (including the lysosomal hydrolases), 
which play a role in pathogen elimination but with prolonged exposure are 
potentially harmful to the host.  
CD86 is an M1 macrophage marker that has been reported to play an important role 
during foam cells formation in atherosclerotic plaques (Chavez-Sanchez et al., 2014). 
CD86 has been reported to be present in both IPFP and the synovium (Bastiaansen-
Jenniskens et al., 2012; Fahy et al., 2014). Furthermore, the medium from synovial 
M1 type macrophages, which express CD86 is able to down-regulate chondrogenic 
gene expression during mesenchymal stem cells chondrogenic differentiation (Fahy 
et al., 2014). Results presented here indicate that the number of CD86+CD14+ 
positive cells was significantly higher in the synovium from obese patients but there 
was no difference in these cells number between obese and lean patients in the 
samples of the IPFP. 
CD36 is a transmembrane glycoprotein, which is a member of the scavenger receptor 
family. It is expressed on various types of cells including monocytes and 
macrophages, platelet and myocytes. It has a number of ligands including oxLDL 
and long chain fatty acids. CD36 is also a fatty acid translocase: after binding to its 
ligand it facilitates fatty acid transport into cells including myocytes and adipocytes, 
thereby providing an energy source for these cells. CD36 also exists in a soluble 
form. Its concentration is fivefold higher in obese diabetic patients than healthy 
normal-weight patients (Handberg et al., 2006). Macrophages bind CD36 ligands 
including oxLDL which can trigger secretion of many pro-inflammatory cytokines 
such as MCP-1/CCL2 and TNF-α. Lipid accumulation in macrophages contributes to 
foam cell formation (and atherosclerosis progression) and to pro-inflammatory 
cytokine secretion. CD36 coordinates its action with other signalling partners for 
example TLRs. CD36 is proposed to mediate crosstalk between adipose tissue 
macrophages and adipocytes. Mice genetically depleted of CD36 display higher 
insulin sensitivity and have a lower level of pro-inflammatory cytokines for instance 
MCP-1/CCL2 and TNF-α (Kennedy et al., 2011).  
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The data obtained here suggested that CD36 was expressed at a significantly higher 
level in the IPFP than in synovium in paired sample. There was no difference in 
CD36 expression by IPFP between the two patient groups (obese vs lean). However, 
there was a significantly higher expression of CD36 in the synovium of obese OA 
patients in comparison to lean ones. Barth et al and Rasouli et al found that CD36 
gene expression was up-regulated in diabetic subjects (Barth et al., 2010) (Rasouli et 
al., 2009). Mice with CD36 knockout demonstrated a less inflammatory adipose 
tissue phenotype and improved insulin sensitivity (Kennedy et al., 2011). 
Furthermore, subcutaneous and visceral CD36 expression was up-regulated in 
obesity with no difference between the two fatty tissue depots (Bonen et al., 2006). 
HLA-DR (Human Leukocyte Antigen DR) belongs to MHC-II (major 
histocompatibility complex II). It is expressed by antigen presenting cells (APC), 
which include macrophages, dendritic cells and others. Its expression in other cell 
type can be stimulated by IFNγ. Macrophages are the predominant APC in adipose 
tissue. Diet-induced obesity in mice significantly increases MHC-II expression on 
gene and protein level and co-localises with CD4+ T cells (Kintscher et al., 2008; 
Morris et al., 2013). In humans HLA-DR is co-expressed on Adipose Tissue 
Macrophages (ATM) with CD206 and also co-localises with CD4+ T cells. The same 
study also showed that mice with genetic depletion of MHC-II were protected from 
diet-induced obesity, had reduced CD4+ T cells numbers and improved insulin 
sensitivity (Cho et al., 2014). However, some authors suggest that the majority of 
cells expressing HLA-DR are adipocytes (Deng et al., 2013). HLA-DR (MHC II) 
mRNA expression has been reported to be up-regulated in obese subjects (Nair et al., 
2005). Adipose tissue macrophages express HLA-DR and the expression of this 
protein has been shown to be increased in obesity (Bourlier et al., 2008). Mice 
lacking MHC II have been found to be protected from diet-induced obesity and it has 
been concluded that MHC II plays an important role in CD4+ T cell activation in 
obese adipose tissue (Kintscher et al., 2008; Cho et al., 2014). The data presented 
here suggested that there was an increase in HLA-DR expression in obese subjects in 
the synovium and IPFP, which may suggest a more pro-inflammatory phenotype of 
articular adipose tissues in OA in obese patients.  
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All of the data obtained here suggest that there was a difference in macrophages and 
macrophage-related markers content in the fatty articular tissues in obese OA 
patients. 
T cells in articular adipose tissue analysis is shown in Table 16: 
Table 15 Summary of T cells analysis in SVF fraction of synovium and IPFP 
 
 
Analysis of the subsets of T cell populations indicated that there may be differences 
between lean and obese individuals in these cells content. There was no difference in 
the total T cell (CD3+) frequency in synovium and IPFP but there was a higher 
frequency of CD3+CD4+ positive cells in the synovium from obese subjects with OA. 
However, further T cell subpopulation analysis is required as the approach used in 
this thesis was not sufficient to distinguish T cells subsets including Th1, Th2 or 
Treg lymphocytes. Tregs, which represent 5-20% of all CD3+CD4+ T cells 
(Cipolletta, 2014) and Th2 (anti-inflammatory) T cell subpopulation (Lee et al., 
2014) are for example down-regulated in obesity. 
As previously mentioned increased expression of antigen presenting cells (expressing 
HLA-DR) is reported to induce CD4+ lymphocyte influx in visceral adipose tissue 
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and mediate meta-inflammation (Kintscher et al., 2008; Cho et al., 2014) what 
concurs with data obtained in this study. Synovial HLA-DR and CD3CD4 cells were 
increased in obese OA patients. Kintscher et al. also reported that CD4+ T 
lymphocytes are predominant types of T cells in diet-induced obesity. The ratio of 
CD4/CD8 was increased in the present study in the synovium of Obese OA patients. 
However, these differences were not detected in IPFP of the same patient which may 
suggest that the preliminary pro-inflammatory events may occur mainly in synovium. 
Although the number of analysed patients in T cells analysis was rather small, 
therefore in the future these need to be increased. 
All obtained data suggest that there are differences in immune cells content in obese 
articular fatty tissues. These can lead future research into the further characterisation 
of macrophage and other leukocytes within synovium and IPFP of OA patients in 
addition to the investigation of their immune role within the knee articular adipose 
tissue depots. 
8.3 Subchondral Bone Related Changes  
 
The lateral posterior femoral condyles have been chosen to study the role of obesity 
on the subchondral bone because of the minimally or no OA-affected subchondral 
compartment in this region. OA is a disease which is known to correlate with bone 
sclerosis in such compartments as tibial plateau and medial femoral condyle where 
cartilage damage and mechanical loading alter the bone microstructure (Li et al., 
2013). In the region of choice, no osteoarthritic changes have been detected, therefore 
all obtained data may be the result of obesity and adipose tissue-derived factors. 
Furthermore, this is also minimally weight-bearing compartment of the joint which 
excludes the mechanical role of weight and facilitates the hypothesis of molecular or 
cellular changes due to obesity. 
Calculated bone microstructure parameters (including BV/TV, Tr.Th., Tr.Sp., Tr.N.) 
on the whole did not show a significant difference between lean and obese patients. 
The main reason for this may be the low number of samples analysed in this study 
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(and in future work it may be helpful to increase the sample number). However, after 
adjustment for the bone mass density (BMD) using hydroxyapatite phantom scan, the 
data presented here show surprisingly that obese male patients may have a 
significantly lower bone mass density in comparison to lean ones. The lack of 
significance in female samples may be due to the postmenopausal/osteoporotic 
changes. Lean women, although not significantly, were in general older than obese 
ones. It would be interesting to correlate subchondral bone changes in a higher 
number of patients with adjustment for age and gender.  
Furthermore, a pilot anti-CD68 immunohistochemical staining of subchondral bone 
indicated that there may be more macrophages within marrow adipose tissue in obese 
patients with OA. The presence of CD68 positive cells in the marrow of OA patients 
has been previously characterised (Geurts et al., 2015). My obtained IHC data may 
suggest that there is an increased number of CD68 positive cells in marrow of obese 
OA patients. As previously, a higher samples number is necessary in order to draw 
any conclusion.  
 
The analysis in Chapter 7 has been limited in comparison to previous chapters due to 
the lack of time. More samples need to be analysed in order to obtain more powerful 
results. However, these preliminary bone microstructure analysis and osteoblasts 
gene expression analysis may suggest that the modelling and remodelling processes 
in the bone of OA patients may be disturbed in association with obesity. 
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8.4 Summary and Future Directions 
 
To sum up, all presented data can contribute to our further understanding of OA. 
Obtained results may broaden our knowledge about obesity and OA interactions and 
support the hypothesis that OA in the obese subjects may, in fact, have different 
origin/pathogenesis than post-traumatic OA. Moreover, the presented study may 
support the hypothesis that OA in obese subjects may be one of the compartments of 
the broadly described metabolic syndrome and should be treated/targeted with a 
different approach than post-traumatic OA. For the future, obesity-related markers 
(such as adiponectin and PPARγ) are very potent candidates in designing OA 
modifying drugs. Immune cell-related differences seen in the presented results also 
suggest different OA phenotype in obese subjects.  
Further investigation of the role of adiponectin in cartilage, bone, synovium and 
IPFP would be beneficial to understand its differential role in all knee joint tissues. It 
would be interesting to examine the role of two adiponectin receptors and the 
cascades they are involved in by using such techniques as gene silencing. This could 
help in explaining reported both catabolic and anabolic role of adiponectin. In the 
future, it is important to investigate ADIPOR1 and ADIPOR2 protein expression (by 
Western blot and IHC techniques) in all tissues within knee joint with the special 
focus on cartilage and subchondral bone to see if obtained gene expression data 
correlates with protein expression. 
Significantly lower PPARγ expression in obese compared to lean osteoarthritic 
tissues suggests this protein as a very important molecule in OA studies. PPARγ 
agonists are in common use as anti-diabetic factors. Targeting this nuclear receptor 
by its agonists (TZDs) or at gene expression level by knock-in techniques (plasmid 
or viral transgenic methods) may help in modifying OA pathogenesis.  
Expression of other obesity-related molecules such as visfatin in OA tissues needs to 
be further explored by such techniques as mass spectrometry. Visfatin intracellular 
expression and possible role can be detected with the use of cell fractionation protein 
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isolation method. That would help in investigating its role as an intracellular enzyme 
next to the widely reported extracellular adipokine.  
Immune cell-related protein (CCL2, TLR4 and VCAM1) higher expression in 
cartilage (CCL2) and synovium (TLR4 and VCAM1) of obese compared to lean OA 
patients suggest more proinflammatory phenotype of OA in these patients. Further 
investigation of the role of the TLR4 receptor by using potent antagonists (such as 
LPS-RS) could help in examining its role in OA tissues. VCAM-1 mediates immune 
cell extravasation from the bloodstream. Targeting these events has been previously 
suggested as a potent anti-inflammatory approach in such diseases as RA or 
autoimmunity (Yusuf-Makagiansar et al., 2002).  
Further characterisation of immune cells content in obese patients synovium and 
IPFP would be important in defining their role in OA tissues. Subtypes of 
macrophages and T cells can differentially regulate the immune response in OA 
obese patients. Thanks to flow cytometry sorting technique it can be also possible to 
analyse the gene and protein profile of selected cell subtypes (such as CD206+ 
macrophages or CD3+CD4+ T cells) and to investigate their possible contribution to 
OA. 
It would be of high interest to conduct a more detailed study on modelling and 
remodelling processes in subchondral bone in OA in obese patients and to 
characterise the role of osteoblasts and osteoclasts in this processes. TRAP staining 
could help to detect osteoclasts in the subchondral compartment of the posterior 
femoral condyle and define the role of those cells in obesity. Obtained µCT data 
were not sufficient to conclude if there is a difference between lean and obese 
women. It would be important in the future to collect a higher number of age-
matched samples to analyse the hypothesised difference in obese and lean OA 
subjects. 
To conclude, presented data although do not explain the entire interaction between 
OA and obesity, adds several novel findings to the knowledge about those two 
comorbidities. 
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Appendices 
Appendix 1  
RNA stability test 
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ATCTGGGTC CTG GCTTTCTT GCAAGCTGTGATGATGAGGA 




GAPDH (197bp) GGA GCG AGA TCC CTC CAA 
AAT 
GGC TGT TGT CAT ACT TCT 
CAT GG 
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FTO (231bp) ACCCCTTCACCAAGGAGACT AAAACTGCAGGCTCAAAGGA 




LEPR (196bp) TCCCATATCTGAGCCCAAAG TGCTTTCACACTGGATGGAG 










TLR4 (152bp) AGCTGTACCGCCTTCTCAGC CCTGCCAATTGCATCCTGTA 
VCAM1 (149bp) TCCTGCTCCGAAAATCCTGT CTGCTTCTTCCAGCCTGGTT 
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Appendix 3 Primers for Real Time PCR (designed using PRIMER3 software) 
Gene (product 
size) 
Forward Primer 5’-3’ Reverse Primer 5’-3’ Efficien
cy(%) 













B2M (90kb) TGTGCTCGCGCTACTCTCTC CCATTCTCTGCTGGATGA
CG 
100 
CCL2 (197bp) CTTCTGTGCCTGCTGCTCAT CTTGGCCACAATGGTCTT
GA 
95 
NAMPT (167bp) GCCAGCAGGGAATTTTGTTA GATGTGCTGCTTCCAGTT
CA 
105 
PPARG (225bp) GCTGTGCAGGAGATCACAGA GGGCTCCATAAAGTCAC
CAA 
100 
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Appendix 4 Anti-Human Primary Antibodies used for IF, IHC and WB 
technique 
Marker Species Type Dilution in 
WB 
Dilution in 
IF and IHC 
Company 
Adiponectin Mouse Monoclonal 1:500 1:100 Peprotech 
Visfatin Rabbit Polyclonal 1:10000 1:1000 Peprotech 
PPARγ Rabbit Polyclonal 1:500 1:100 Santa Cruz 
Biotech 
TLR4 Rabbit Polyclonal  1:100 BIOSS 
VCAM1 Rabbit Polyclonal  1:100 Peprotech 
Β-actin Mouse Polyclonal 1:1000  ABDSEROTEC 
Β-actin Rabbit Polyclonal 1:1000  BIOSS 
GAPDH Rabbit Polyclonal 1:1000  SigmaAldrich 
 
Secondary Antibody 












Polyclonal Rabbit Mouse HRP 1:10000  DAKO 




Polyclonal Goat Rabbit Alexa 
Fluor 
488nm 
1:1000  Santa 
Cruz 
Biotech 
IgG Polyclonal Goat Mouse IRDYE68
0RD 
 1:10000 LiCOR 
IgG Polyclonal Goat Rabbit IRDYE80
0CW 
 1:10000 LiCOR 
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Antibodies for Flow Cytometry 
Marker Isotype Conjugate Species Dilution Company 
VCAM1 IgG1 PE Mouse 1:100 BioLegend 
TLR4 IgG1 PE Mouse 1:100 BioLegend 
CD45 IgG1 FITC Mouse 1:100 ImmunoTool 
CD14 IgG1 PE Mouse 1:100 ImmunoTool 
CD206 IgG1 Alexa Fluor Mouse 1:100 BioLegend 
CD86 IgG1 FITC Mouse 1:100 ImmunoTool 
CD36 IgG1 FITC Mouse 1:100 ImmunoTool 
HLA-DR IgG2a FITC Mouse 1:100 ImmunoTool 
CD11b IgG2a PE Mouse 1:100 ImmunoTool 
CD18 IgG1 PE Mouse 1:100 ImmunoTool 
CD3 IgG1 FITC Mouse 1:100 ImmunoTool 
CD4 IgG2a PE Mouse 1:100 ImmunoTool 
CD8 IgG2a PE/Dy647 Mouse 1:100 ImmunoTool 
control IgG2a PE Mouse 1:100 ImmunoTool 
control IgG2a FITC Mouse 1:100 ImmunoTool 
control IgG1 PE Mouse 1:100 ImmunoTool 
control IgG1 FITC Mouse 1:100 ImmunoTool 
control IgG2a PE/Dy647 Mouse 1:100 ImmunoTool 
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Appendix 5 
Flow Cytometry Gating Strategy for SVF from IPFP and synovium analysis. 
 
Gating strategy shown in A. Isotype control staining for single (B) and double 
marker staining (C) example shown.
 
Example of double colour staining (B) for CD14CD206 cells in SVF. Single colour 
staining shown in (C,D). Isotype control shown in A. 
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Appendix 6  
































Difference between ADIPOR1 and ADIPOR2 in chondrocytes assessed by Real 
Time PCR 
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Appendix 7 
IgG controls for IF and IHC techniques 
 
Figure 1 Isotype control staining for chondrocyte IF analysis. Isotype non-specific 
rabbit IgG plus secondary goat anti Rabbit IGG conjugated with FITC was used as 
described in Material and Methods. 
A        B 
   
Figure 2 Isotype control staining for cartilage IHC and synovium analysis. Isotype 
non-specific rabbit IgG plus secondary goat anti Rabbit IgG conjugated with HRP 
was used as described in Material and Methods. 
 
Figure 3 Isotype control staining for synovium IHC analysis. Isotype non-specific 
mouse IgG plus secondary Rabbit anti-mouse IgG conjugated with HRP was used as 
described in Material and Methods. 
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Appendix 8 
Synovial and IPFP Histology 
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Figure 4 Representative Hematoxylin and Eosin (H&E) staining for Synovial and 
IPFP biopsies.  
Appendix 9 Osteoblasts ADIPOR1 and ADIPOR2 gene expression analysis 
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Appendix 10  
Poster Presentation 
September 2013  
Edinburgh Pathology 2013 meeting Poster Presentation on “Osteoarthritis (OA) and 
Obesity- Are the Co-Culprits?” 
September 2013  
British Orthopaedic Research Society meeting. Poster presentation on “Are 
Osteoarthritis and Obesity Accomplices” 
National (UK) Conference oral presentation 
September 2015  
British Orthopaedic Research Society meeting. Podium presentation on “Are adipose 
tissue macrophages potent agents in the pathogenesis of OA?” 
July 2014  
British Orthopaedic Research Society meeting. Podium presentation on “The role of 
adipokines in End-Stage knee Osteoarthritis” 
International Conference Oral Presentation 
March 2016  
Orthopaedic Research Society meeting. Podium presentation in Spotlight Session on 
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